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Abstract
Bacteria are able to switch between two mutually exclusive lifestyles, motile single cells and
sedentary multicellular communities that colonize surfaces. These behavioral changes contribute to
an increased fitness in structured environments and are controlled by the ubiquitous bacterial
second messenger c-di-GMP. In response to changing environments, fluctuating levels of c-di-
GMP antagonistically affect motility and virulence of single, planktonic cells as well as cell surface
adhesins and persistence of sedentary, multicellular communities. The cellular levels of c-di-GMP
are controlled by opposing enzymatic activities of diguanylate cyclases (DGCs) and
phosphodiesterases (PDEs), which represent two large families of output domains found in
bacterial one- and two-component systems. The present work investigates structural, functional
and regulatory aspects of diguanylate cyclases and phosphodiesterases, and explores their role in
signal transduction processes transmitting environmental stimuli into a range of different cellular
functions. Furthermore we report the isolation and characterization of novel components of the c-
di-GMP signaling network mediating its output functions.
In (Christen et al. 2005, JBC 280:30829-30837), we report the finding that the c-di-GMP specific
phosphodiesterase activity resides in the widespread EAL domain. By analyzing the enzymatic
reaction products and investigating the substrate specificity of wild type and various mutant
enzymes, we demonstrate that a single EAL domain itself catalyzes, in a Mg2+ dependent manner,
the cleavage of the second messenger c-di-GMP into the linear dinucleotide pGpG. Furthermore,
we report the discovery that in a GGDEF-EAL protein a catalytic inactive GGDEF domain can bind
GTP and in response allosterically activates the EAL domain. Thus we conclude that GGDEF
domains can have either catalytic or regulatory function and suggest, that the cellular GTP pool
may serve as an input signal into c-di-GMP-mediated signal transduction.
In (Christen & Christen et al. 2006, JBC 281:32015-32024), we describe an important novel feature of
GGDEF proteins, which produce the ubiquitous bacterial signaling molecule c-di-GMP. This paper
reports the results of in depth structure-function analysis of an allosteric feedback inhibition
mechanism that generally acts to regulate diguanylate cyclase activities in bacteria. The
mechanism involves binding of the second messenger product, c-di-GMP at an inhibition site (I-
site) that is coupled via a conserved beta-strand to the active site (A-site) of the enzyme. The study
involves an array of biochemical and genetic techniques applied on various diguanylate cyclases to
establish the sequence determinants of the I-site as well as the in vivo physiological relevance of I-
site function. Allosteric product inhibition of diguanylate cyclases turns out to have fundamental
functional and physiological implications, including threshold setting for c-di-GMP production by
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particular GGDEF proteins, which can contribute to precision, robustness, noise reduction and
accelerated kinetics of c-di-GMP signaling. The definition of the I-site binding pocket provides an
entry point into unraveling the molecular mechanisms of ligand-protein interactions involved in c-di-
GMP signaling, and makes DGCs a valuable target for drug design to develop new strategies
against biofilm-related diseases.
In (Christen & Christen et al. 2007, PNAS), we enlighten the signal transduction mechanism of the
bacterial second messenger c-di-GMP and demonstrate the existence of diguanylate receptor
proteins mediating its output functions. We report the biochemical purification of c-di-GMP receptor
proteins from C. crescentus crude extract and describe their physiological role in c-di-GMP
dependent repression of cell motility. A multitude of biochemical, genetic and NMR experiments
was used to characterize these effector proteins and homologs from S. enterica and P. aeruginosa
down to molecular level. In particular we used [33P] c-di-GMP UV cross linking studies to
demonstrate that these receptors specifically bind c-di-GMP in the sub micromolar range and, in
combination with NMR spectrometry, to elicit determinants for c-di-GMP binding. Furthermore, we
performed genetic suppressor analysis and epistasis experiments with receptor deletion and
pointmutants, to corroborate that the identified diguanlyate receptors from C. crescentus act in vivo
downstream of the second messenger c-di-GMP.
We further report the isolation and characterization of a C. crescentus adenylosuccinate
synthetase (PurA, CC3103), an enzyme of the purine biosynthesis pathway that has high affinity
for c-di-GMP. Using recombinant purified PurA for kinetic and ligand binding studies, we show that
c-di-GMP is a potent inhibitor of PurA activity. Initial rate kinetics revealed that c-di-GMP inhibition
is competitive with respect to GTP and noncompetitive with respect to IMP. These findings suggest
a role for c-di-GMP as regulator of the cellular nucleotide pool. We propose that c-di-GMP inhibits
the first step of the de novo biosynthesis of AMP and by that directs IMP toward guanine
biosynthesis, thereby preventing the drainage of the guanine pool.
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Abbreviations
AC adenylate cyclase
c-di-GMP cyclic diguanylic acid
CR Congo Red
DGC diguanylate cyclase
DgcA diguanylate cyclase A (CC3285)
DgrA diguanylate receptor protein A (CC1599)
DgrB diguanylate receptor protein B (CC3165)
EAL glutamate-alanine-leucine domain harboring c-di-GMP specific PDE activity
EDTA ethylenediaminetetraacetic acid
EGTA ethylene glycol-bis(?-aminoethyl ether)-N,N,N',N'-tetra acetic acid
ESI-MS electrospray ionization-mass spectrometry
EXSY exchange spectroscopy
GC guanylate cyclase
GGDEF glycine-glycine-aspartate-glutamate-glutamate A-site motiv of DGC?s
H6 hexa-histidine tag
Hepes N-2-Hydroxyethylpiperazin-N-2-ethansulfonic acid
HPLC high performance liquid chromatography
HSQC heteronuclear single quantum coherence
IPTG isopropyl 1-thio-?-D-galactopyranoside
LB luria broth
MeOH methanol
NMR nuclear magnetic resonance
NOESY nuclear overhauser effect spectroscopy
PAGE polyacrylamide gel electrophoresis
PDE phosphodiesterase
PYE peptone yeast extract medium
PdeA phosphodiesterase A (CC3396)
pGpG linear diguanylic acid
rdar red, dry, and rough phenotype
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1 Introduction
Signal transduction mechanisms
The simultaneous coordination of metabolic processes within a multicomponent system is
characteristic for the chemical machinery of life. Cellular homeostasis is the result of tight
coordination and regulation of different interconnected metabolic pathways. The required
information transfer within different components of the network is accomplished through highly
selective molecular recognition between signaling molecules and their respective regulatory
receptor molecules.
Bacteria regulate their cellular metabolic state in response to a vide variety of external
environmental signals including change in temperature, light, pH-shift, availability of oxygen and
nutrients. These environmental stimuli are sensed and converted into internal signals leading to a
reprogramming of the cellular metabolic state by a process termed signal transduction. During
signal transduction processes an increasing number of enzymes and other molecules become
engaged in the events that proceed from the initial external stimulus. In a widely used signal
transduction mechanism, stimulus sensing is initiated upon binding of the signaling molecule to its
corresponding membrane-bound receptor, which, in turn, transfers the information upon structural
changes across the cell membrane to its cytosolic output domain and thereby activates the
synthesis of small diffusible signaling molecules called second messengers, which are then fed
into cytoplasmatic second messenger cascades. Regulatory networks based on the controlled
synthesis and degradation of second messengers are able to integrate a wide variety of signaling
inputs and offer flexibility of recognition combined with signal amplification, autoregulation and
signal adaptation.
Two widely used bacterial second messengers are adenosine 3?,5?-monophosphate (cAMP) and
guanosine-3?,5?-bis(pyrophosphate) (ppGpp) (Figure 1). Upon carbon source starvation, adenylate
cyclases (AC) synthesize the second messenger cAMP, which allosterically activates a
transcription factor called catabolite regulatory protein (CRP), in order to regulate transcriptionally
catabolic operons for the use of alternative carbon sources and other cellular processes (1).
The stringent response ppGpp is produced from GTP by the ribosome-associated protein RelA in
response to low levels of charged tRNAs. The second messenger ppGpp binds to RNA
polymerase and alters its activity to repress genes encoding ribosomal RNA and tRNA (2),
whereas genes involved in amino acid synthesis and transport are activated (3). While guanosine
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3?,5?-monophosphate (cGMP), is an important second messenger in eukaryotes, it appears to be
rarely used in bacteria. Rather, new evidence suggests that the cyclic dinucleotide 3?,5?-cyclic
diguanylic acid (c-di-GMP) is widely used by bacteria as a second messenger.
Figure 1 Ubiquitous ribonucleotide second messengers
C-di-GMP is an allosteric activator of cellulose synthase
The bacterial second messenger (3?-5?)-cyclic-di-guanosine monophosphate (c-di-GMP) has been
discovered 20 years ago by Ross et al. (4) as an allosteric activator of the cellulose synthetase in
the fruitdegrading bacterium Gluconactetobacter xylinus. Further biochemical isolation and
characterization of enzymes involved in the synthesis and degradation of this unusual cyclic
nuleotide provided the basis for the molecular analysis of the c-di-GMP signaling network (5).
Biochemical studies revealed that c-di-GMP is synthesized from two molecules of GTP by
enzymes called diguanylate cyclases (DGCs) and degraded by c-di-GMP-specific
phosphodiesterases (PDEs) into the linear dinucleotide pGpG. Using GTP-agarose affinity
chromatography Tal et al. isolated a soluble diguanylate cyclase and identified 3 operons involed in
c-di-GMP turnover (5). Each of these operons consists of a pair of isoenzymes harboring opposing
enzymatic DGC and PDE activity. Multiple alignments of the DGC and PDE protein sequences
revealed that all six isoenzymes share significant structural conservation over a stretch of 390
amino acid residues and contain GGDEF and EAL domains. Both the GGDEF and the EAL
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domains are ubiquitous in bacteria and are often linked to regulatory domains, such as
phosphorylation receiver or oxygen sensing domains, however, their physiological function was to
that time unknown. Their occurrence in transmembrane or membrane-associated proteins, that
contain N-terminal sensory domains, led to the assumption, that GGDEF and EAL domains are
important in relaying external sensory information into the cytoplasm. Environmental stimuli such
as oxygen, amino acids, light etc. are believed to regulate the assumed enzymatic activity of
GGDEF and EAL domain proteins. GGDEF and EAL domain proteins consist of the largest known
family of othologs with up to 60 paralogs existing in some species. Whereas GGDEF domain
proteins are found in most bacterial species, they are absent in archae and eucaryotes.
The discovery that the DGC and PDE isoenzymes from Gluconactetobacter xylinus contain
GGDEF and EAL domains, strongly suggested that GGDEF and the EAL domain might be involved
in c-di-GMP metabolism (5). This key discovery raised the possibility, that c-di-GMP plays a more
general role as a bacterial signaling molecule and might have a broader scientific significance than
acting as an allosteric regulator of cellulose biosynthesis in G. xylinus.
c-di-GMP regulates bacterial cell adhesion and extracellular matrix production.
Bacterial genetics provided a number of functional analyses of GGDEF proteins supporting the
idea that DGCs might have evolved to control bacterial growth on surfaces though the regulation of
cellular adhesion components that enable cells for cell–cell and cell–surface interactions.
The production and secretion of cellulose by G. xylinus leads to a dramatic change in colony
morphology resulting in aggregation of cells into a thick pellicle in liquid culture and colonies with a
rough surface on agar plates (7, 8). Both, pellicle formation and colony morphology represent
visible phenotypes, associated with the production of extra-cellular matrix components. These
phenotypes were used in genetic screens in diverse bacterial species to identify components
required for the synthesis of extra cellular matrix components. These studies provided stong
evidences for a role of GGDEF proteins in the regulation of cell suface adhesives and extra cellular
matrix components: In P. aeruginosa, the wrinkled colony morphology phenotype was linked to the
activity of the GGDEF-type response regulator WspR (9). Salmonella enterica serovar
Typhimurium and other related Enterobacteria including E. coli K-12 typically form after prolonged
incubation below 37°C colonies with a distinctive morphology named rdar (congo-red binding, dry
and rough) (10-13). In the absence of the GGDEF-type regulator AdrA, colonies are unable to
develop the rdar phenotype (14). Similarly, it has been reported that the GGDEF-type regulator
hmsT is required for auto-aggregation and plaque formation in Yersinia pestis (15). Deletions in
mbaA, a GGDEF-type regulator from Vibrio cholera, result in altered biofilm structure caused by a
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decrease in the amount of extra-cellular matrix material (16). From Myxococcus xanthus whose
development of fruiting bodies resembles biofilm formation, it has been reported that expression of
CsgA, a cell surface associated protein required for fruitingbody formation, is dependent on ActA, a
PleD ortholog. Mutant M. xanthus cells lacking functional actA are able to aggregate but fail fruiting
body formation and do not form spores (17, 18). In all these bacterial species, regulation of cellular
adhesion components and synthesis of extra-cellular matrix components has been linked
genetically to the activity of GGDEF-type regulators, suggesting an important role for c-di-GMP
signaling in the coordination of these cellular processes.
C-di-GMP is involved in polar organell morphogenesis and cell differentiation
Several lines of evidence have suggested that c-di-GMP-dependent signaling is used by the ?-
proteobacterium Caulobacter crescentus to control cell differentiation. In C. crescentus, obligate
asymmetric cell division at each replicative cycle generates two genetically identical but
morphologically different daughter cells, which undergo different developmental programs (Figure
2A): The sessile stalked cell, equipped with an adhesive holdfast and stalk, initiates a new
replication cycle immediately after cell division has completed, whereas the motile, polar flagellated
swarmer cell undergoes an obligate, planktonic stage, during which cell division programs and
DNA replication are inhibited (19, 20). In order to become replication competent and progress cell
cycle, the swarmer cell has to differentiate and undergoes subsequent remodeling of its polar
organelles, which involves ejection of the flagellum, retraction of the pili, and generation of a stalk
and adhesive holdfast at the pole previously occupied by the flagellum. Precise timing of assembly
and loss of polar organelles is critical for optimal surface colonization. Both acquisition of flagellar
motility in the predivisional cell and its replacement by an adhesive holdfast later in development
are dependent on the polar localized diguanylate cyclase PleD (21-26), which originally has been
identified in a genetic screen for regulators of bacterial development by Hecht et al. (22). PleD
contains two N-terminal receiver domains and an unusual novel output domain, which has been
termed GGDEF according to a highly conserved amino acid motif. C. crescentus cells lacking a
functional PleD protein, retained motility throughout the cell cycle, fail to shed the flagellum during
swarmer-to-stalk cell transition and do not form stalks. The presence of a constitutive active mutant
protein PleD* results the opposite way around in non motile cells, which harbor elongated stalks
(23, 27).
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Figure 2 The cell cycle of Caulobacter crescentus and polar localization of PleD
A) Caulobacter crescentus divides asymmetrically to produce two daughter cells with different function and morphology.
The PleD-GFP localization pattern is shown in green (the figure was drawn according to Jacobs-Wagner 2004 (28) and
adapted according to Paul 2004 (25)). B) Polar localization of the diguanylate cyclase PleD according to Paul 2004 (25).
Subsequent biochemical characterization revealed that PleD is a diguanylate cyclase, catalyzing
the conversion of GTP into the second messenger c-di-GMP (25). The diguanylate cyclase activity
of PleD resides in the C-terminal GGDEF domain and is activated upon phosphorylation by DivJ
and PleC (23), two sensor histitdine kinases involved in C. crescentus cell differentiation, that
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dynamically localise to opposing cell poles. In vivo studies with PleD-GFP fusions revealed that
PleD is sequestered to the differentiating cell pole in dependence of its phosporylation state (25)
(Figure 2B) this suggesting that only activated PleD reaches the stalk pole and therefore providing
a possible mechanism that restricts PleD activity and consequently the synthesis of the second
messenger c-di-GMP to the locus where it coordinates polar morphogenesis. The finding that pole
morphogenesis in C. crescentus is controlled by the diguanylate cyclase PleD implicated that the
role of the second messenger c-di-GMP goes beyond a function as an allosteric regulator of
cellulose synthetase and regulator of exopolysaccharide synthesis.
Biochemistry of the GGDEF domain
Although known to be involved in c-di-GMP turnover for some time, the enzymatic role of the
GGDEF and EAL domain in c-di-GMP turnover remained obscure. Since the previously
characterized diguanylate cyclases and c-di-GMP specific phosphodiesterases isoenzymes from
G. xylinus are composed of highly homologous GGDEF-EAL composite proteins it was, based on
these data, not possible to assign neither the enzymatic diguanylate cyclase nor its opposing
phosphodiesterase activity to one of these signaling domains. But exactly this knowledge is
extremely important to link the second messenger c-di-GMP with its genetically defined output
functions and to unravel mechanisms controlling its synthesis and degradation.
Therefore, the biochemical finding that the GGDEF domain itself has diguanylate cyclase activity
(25) represented a key discovery, challenging the c-di-GMP field (25). Using purified C. crescentus
PleD protein, Paul et al. demonstrated for the first time, that a GGDEF protein synthesizes c-di-
GMP, and further that the conserved GGDEF residues are required for enzymatic diguanylate
cyclase activity. An additional major effort, opening the field for structure function analyses on DGC
enzymes, was provided by the first X-ray structure of the diguanylate cyclase PleD by Chan et al.
(24). The resolution of the three-dimensional structure of the full-length PleD response regulator in
complex with c-di-GMP not only revealed that the overall fold of the GGDEF domain is virtually
identical to the adenylate cyclase, but has also proposed a catalytic mechanism for the
condensation of two GTP molecules into c-di-GMP (24).
The demonstrated activation of PleD DGC activity upon phosphorylation of the N-terminal receiver
domain represents a model system for the tightly controlled synthesis of the second messenger c-
di-GMP upon signal-induced activation. This concept seems to represent a general signal
transduction mechanism, since many GGDEF domain proteins are associated in a modular fashion
to a vide variety of N-terminal fused signal-sensing domains of known or predicted signal input.
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Thus, the DGC activity of the GGDEF domain appears to be part of a novel complex bacterial
signaling system dedicated to convert environmental stimuli of various cellular compartments into
the synthesis of the second messenger c-di-GMP.
In contrast to the molecular nature of the DGC, the c-di-GMP-specific PDE activity had not been
determined so far. Initial genetic and biochemical studies have linked PDE activity to proteins that
contain both GGDEF and EAL domains (5, 29-31). Like GGDEF, the EAL domain, named after its
signature amino acid motif Glu- Ala-Leu, is found only in bacteria and its distribution more or less
mirrors that of the GGDEF domains (32, 33). Together, this has led to the proposal that the c-di-
GMP-specific PDE activity might reside in the EAL domain (32). But biochemical data validating
this hypothesis were still missing.
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2 Aim of the thesis
The aim of this PhD project was to identify and characterize novel components of the c-di-GMP
signaling network. In a first part, mechanisms involved in the regulation of c-di-GMP turnover
should be identified and analyzed with respect to their biochemical function, enzymatic activity, role
in c-di-GMP metabolism and their effect on c-di-GMP related phenotypes. In particular, the nature
of the c-di-GMP specific PDE activity responsible for the degradation of the second messenger has
to be determined and the protein domain in which this activity is confined has to be identified.
Furthermore, the molecular mode of action and the regulatory mechanisms controlling PDE activity
and DGC activities inside the cellshould be adressed And finally, beside these questions focusing
on the turnover of the second messenger c-di-GMP, the remaining key question concerns the yet
unknown downstream effectors of the second messenger c-di-GMP mediating its output function.
The wide variety of cellular functions that are affected by the second messenger c-di-GMP calls for
multiple receptors and signaling mechanisms. However, little information was available on specific
targets of c-di-GMP action. In particular, how are increased levels of c-di-GMP sensed and how is
this information transmitted to the flagellar motor? With the exception of a component of the
cellulose synthetase complex from G. xylinum, which is absent in the C. crescentus genome, no c-
di-GMP binding proteins had been reported. Therefore, a biochemical purification strategy had to
be developed in order to purify and characterize c-di-GMP binding proteins from C. crescentus
crude cell extracts. For this, an array of biochemical methods had to be designed, including a
method for the synthesis of radio-labeled second messenger, an appropriate c-di-GMP binding
assay to monitor and characterize ligand-receptor interactions, a procedure for labeling specifically
c-di-GMP binding proteins within a protein crude extract, the development and optimization of
enzymatic assays to monitor c-di-GMP turnover and finally an analytic method allowing the
detection and quantification of the intracellular second messenger concentration in various mutant
strains.
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3 Results
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3.1 Identification and Characterization of a Cyclic di-GMP-specific Phospho-
diesterase and Its Allosteric Control by GTP
M. Christen, B. Christen, M. Folcher, A. Schauerte, and U. Jenal
JBC 280:30829-30837 (2005)
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Summary
This paper adds a new twist to the story of the signaling molecule c-di-GMP (c-di-GMP), which
controls motility and biofilm formation in bacteria and is produced by GGDEF domain proteins. We
report the finding that the c-di-GMP specific phosphodiesterase activity resides in the widespread
EAL domain. By analyzing the enzymatic reaction products and investigating the substrate
specificity of wild type and various mutant enzymes, we demonstrate that a single EAL domain
itself catalyzes in Mg2+ dependent manner the cleavage of the second messenger c-di-GMP into
the linear dinucleotide pGpG. Furthermore we report the discovery that in a GGDEF-EAL protein a
catalytic inactive GGDEF domain can bind GTP and in response allosterically activates the EAL
domain. Thus we conclude that the GGDEF domain can have either catalytic or regulatory function
and suggest, that the cellular GTP pool may serve as an input signal into c-di-GMP-mediated
signal transduction.
Identification and Characterization of a Cyclic di-GMP-specific
Phosphodiesterase and Its Allosteric Control by GTP*
Received for publication, April 22, 2005, and in revised form, June 23, 2005
Published, JBC Papers in Press, July 1, 2005, DOI 10.1074/jbc.M504429200
Matthias Christen, Beat Christen, Marc Folcher, Alexandra Schauerte, and Urs Jenal‡
From the Division of Molecular Microbiology, Biozentrum, University of Basel, Klingelbergstrasse 70,
4056 Basel, Switzerland
Cyclic diguanylic acid (c-di-GMP) is a global second
messenger controlling motility and adhesion in bacte-
rial cells. Synthesis and degradation of c-di-GMP is cat-
alyzed by diguanylate cyclases (DGC) and c-di-GMP-spe-
cific phosphodiesterases (PDE), respectively. Whereas
the DGC activity has recently been assigned to the wide-
spread GGDEF domain, the enzymatic activity respon-
sible for c-di-GMP cleavage has been associated with
proteins containing an EAL domain. Here we show bio-
chemically that CC3396, a GGDEF-EAL composite pro-
tein from Caulobacter crescentus is a soluble PDE. The
PDE activity, which rapidly converts c-di-GMP into the
linear dinucleotide pGpG, is confined to the C-terminal
EAL domain of CC3396, depends on the presence of Mg2
ions, and is strongly inhibited by Ca2 ions. Remark-
ably, the associated GGDEF domain, which contains an
altered active site motif (GEDEF), lacks detectable DGC
activity. Instead, this domain is able to bind GTP and in
response activates the PDE activity in the neighboring
EAL domain. PDE activation is specific for GTP (KD
4 M) and operates by lowering the Km for c-di-GMP of
the EAL domain to a physiologically significant level
(420 nM). Mutational analysis suggested that the sub-
strate-binding site (A-site) of the GGDEF domain is in-
volved in the GTP-dependent regulatory function, argu-
ing that a catalytically inactive GGDEF domain has
retained the ability to bind GTP and in response can
activate the neighboring EAL domain. Based on this we
propose that the c-di-GMP-specific PDE activity is con-
fined to the EAL domain, that GGDEF domains can ei-
ther catalyze the formation of c-di-GMP or can serve as
regulatory domains, and that c-di-GMP-specific phos-
phodiesterase activity is coupled to the cellular GTP
level in bacteria.
The cyclic nucleotides cAMP and cGMP are universally used
as second messengers in intracellular signal transduction path-
ways. They mediate cellular processes such as vision, electro-
lyte homeostasis, or smooth muscle relaxation by modulating
the activity of protein kinases, GTPases, or ion channels (1, 2).
The intracellular levels of cAMP and cGMP are tightly con-
trolled by their rate of synthesis (catalyzed by adenylyl or
guanylyl cyclases) and hydrolysis (catalyzed by phosphodies-
terases). Phosphodiesterases (PDE)1 play a mayor role in the
cellular response mediated by cyclic nucleotides and are used
as primary therapeutic targets for several diseases (3). They
act as effectors of signal transduction, function as homeostatic
regulators of cyclic nucleotide levels, have been implicated in
desensitization and termination of stimulation, and may also
play an important role in controlling the diffusion of cyclic
nucleotides and in channeling cyclic nucleotide signals (4, 5)
(e.g. photoreception in human rod cells is mediated by rhodop-
sin and light signal transduction results from a dramatic re-
duction in cGMP concentrations, catalyzed by cGMP-specific
PDE (1)).
Whereas cAMP signaling is common to both prokaryotes and
eukaryotes, cGMP does not seem to be used by bacterial cells.
However, there is accumulating evidence that the cyclic dimer
of GMP, c-di-GMP, plays a critical role in bacterial signaling (6,
7). c-di-GMP is synthesized from two GTP molecules by digua-
nylate cyclases (DGCs), and hydrolyzed by PDEs via the linear
intermediate pGpG to GMP (Fig. 1A). Even though c-di-GMP
was discovered almost two decades ago (8), its global role in
bacterial signaling has become apparent only recently in the
view of the growing bacterial genome sequence information
available. In recent years, a rapidly increasing number of ge-
netic studies has linked proteins involved in c-di-GMP synthe-
sis or turnover to the ability of different bacteria to switch
between a motile, single-cell state and a multicellular behavior
associated with the production of extracellular matrix compo-
nents and surface adhesion (9–21). Biochemical studies have
associated the DGC activity with the readout domain of the
Caulobacter crescentus PleD response regulator protein (22).
This domain, termed GGDEF (after its signature amino acid
motif Gly-Gly-Asp-Glu-Phe), is widespread in bacteria but is
not found outside the bacterial kingdom (23). The observation
that GGDEF domains are often associated with domains in-
volved in signal perception or signal transduction, argued for
the existence of a dedicated regulatory network that converts a
variety of different signals into the production of the second
messenger c-di-GMP (6, 23). The resolution of the three-dimen-
sional structure of the PleD response regulator in complex with
c-di-GMP has not only revealed that the overall fold of the
GGDEF domain is virtually identical to the adenylate cyclase,
but has also proposed a catalytic mechanism for the condensa-
tion of two GTP molecules into c-di-GMP (24). In contrast to the
molecular nature of the DGC, the c-di-GMP-specific PDE ac-
tivity has remained somewhat of a mystery. Initial genetic and
biochemical studies have linked PDE activity to proteins that
contain both GGDEF and EAL domains (18, 19, 25, 26). Like
* This work was supported by Swiss National Science Foundation
Fellowships 31–59050.99 and 3100A0–108186/1 (to U. J.). The costs of
publication of this article were defrayed in part by the payment of page
charges. This article must therefore be hereby marked “advertisement”
in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
‡ To whom correspondence should be addressed: Division of Molecu-
lar Microbiology, Biozentrum, University of Basel, Klingelbergstrasse
70, 4056 Basel, Switzerland. Tel.: 41-61-267-2135; Fax: 41-61-267-2118;
E-mail: urs.jenal@unibas.ch.
1 The abbreviations used are: PDE, phosphodiesterase; c-di-GMP, cyclic
diguanylic acid; pGpG, linear diguanylic acid; MeOH, methanol; DGC,
diguanylate cyclase; H6, hexahistidine tag; HPLC, high performance liq-
uid chromatography; ESI-MS, electrospray ionization-mass spectrometry.
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GGDEF, the EAL (after its signature amino acid motif Glu-
Ala-Leu) domain is found only in bacteria and its distribution
more or less mirrors that of the GGDEF domains (23, 27).
Together, this has led to the proposal that the c-di-GMP-spe-
cific PDE activity might reside in the EAL domain (23).
The PleD response regulator is required for pole develop-
ment during the C. crescentus cell cycle (11). During Cau-
lobacter cell differentiation PleD specifically sequesters to one
pole of the cell, where the morphological changes take place
(22). Polar sequestration of PleD is coupled to the activation of
the C-terminal GGDEF output domain via phosphorylation of
the N-terminal receiver domain (22). This observation was
lending support for the idea that synthesis of c-di-GMP by PleD
might be limited to one cell pole may be to locally activate
downstream targets or to restrict c-di-GMP production to one
compartment during Caulobacter asymmetric cell division (22).
One would imagine that in both cases, a potent cellular PDE
activity is required to rapidly counteract the DGC activity over
time and to maintain spatial gradients established by PleD. To
monitor and characterize the c-di-GMP-specific PDE activity in
C. crescentus, we first developed an assay based on the hydrol-
ysis of 33P-radiolabeled c-di-GMP. We then showed that the
soluble fraction of C. crescentus cell extracts indeed contains a
strong PDE activity. To characterize this activity more closely,
we concentrated on EAL proteins encoded in the C. crescentus
chromosome. A mutant lacking gene CC3396, which codes for a
GGDEF-EAL composite protein, showed a more than 80% re-
duction of the soluble PDE activity (Table I). Enzymatic assays
and UV cross-link experiments with purified full-length pro-
tein and single domain fragments confirmed that the PDE
activity is contained within the EAL domain of CC3396. Re-
markably, EAL-based PDE activity of CC3396 is allosterically
controlled by GTP. Consistent with this, the GGDEF domain of
CC3396, which contains an unorthodox active site motif (GE-
DEF), lacks DGC activity, but has retained the ability to bind
GTP at the active site. Based on this and on the finding that the
GGDEF domain is strictly required for the GTP-specific acti-
vation of the EAL phosphodiesterase, we postulate that in
CC3396 and possibly in other GGDEF-EAL protein homo-
logues, the GGDEF domain acts as an allosteric regulatory
domain for the EAL-borne PDE activity (Fig. 1B).
MATERIALS AND METHODS
Strains, Plasmids, and Media—C. crescentus strains were grown in
complex peptone yeast extract or in minimal glucose media (28). Es-
cherichia coli strains were grown in Luria broth (LB) supplemented
with antibiotics for selection, where necessary. The exact procedure of
strain and plasmid construction is available on request.
Purification of CC3396 and Preparation of C. crescentus Cell Ex-
tracts—E. coli BL21 cells carrying the respective expression plasmid
were grown in LB medium with ampicillin (100 g/ml), and expression
was induced by adding isopropyl 1-thio--D-galactopyranoside at A600
0.4 to a final concentration of 0.4 mM. After harvesting by centrifuga-
tion, cells were resuspended in buffer containing 50 mM Tris-HCl, pH
8.0, 250 mM NaCl, 5 mM -mercaptoethanol, lysed by passage through
a French pressure cell, and the suspension was clarified by centrifuga-
tion for 10 min at 5,000  g. Soluble and insoluble protein fractions
were separated by a high-spin centrifugation step (100,000  g, 1 h).
The supernatant was loaded onto nickel-nitrilotriacetic acid affinity
resin (Qiagen), washed with buffer, and eluted with an imidazol gradi-
ent. Protein preparations were examined for purity by SDS-PAGE, and
fractions containing pure protein were pooled and dialyzed for 12 h at
4 °C.
C. crescentus CB15 cells were grown in peptone yeast extract and
harvested by centrifugation at an A660 of 0.4. Cells were resuspended in
buffer containing 50 mM Tris-HCl, pH 8.0, 250 mM NaCl, 5 mM mer-
captoethanol, and 5 mM EDTA. Soluble and insoluble protein fractions
were separated by a high-spin centrifugation step (100,000  g, 1 h).
The supernatant was dialyzed for 4 h in buffer containing EDTA and
then for 8 h in the same buffer without EDTA. Protein concentrations
were measured by UV absorption.
Synthesis and Purification of [33P]c-di-GMP—33P-Labeled c-di-GMP
was produced enzymatically using -labeled [33P]GTP (3000 Ci/mmol,
Amersham Bioscience) and purified hexahistidine-tagged PleD*, a
phosphorylation independent constitutive active form of the PleD
diguanylate cyclase (22). To a mixture of 87.5 l of reaction buffer (250
mM NaCl, 25 mM Tris-HCl, pH 8.0, 10 mM MgCl2, 5 mM -mercaptoeth-
anol, and 10.5 M PleD*-H6), 12.5 l of -labeled [33P]GTP (125 Ci,
41.66 pmol, 3000 Ci/mmol) was added. After 5 min at 25 °C, the reaction
was stopped by adding an equal volume of 0.5 M EDTA, pH 8.0. The
protein was precipitated by heating for 5 min at 95 °C followed by
centrifugation for 2 min at 10,000  g. The supernatant was loaded on
a batch RP-18 column, salt was removed by washing 5 times with 200
l of 25 mM triethylenammonium carbonate buffer, pH 7.0, containing
1% (v/v) MeOH. c-di-GMP was eluted with 2  200 l of triethylenam-
monium carbonate containing 5% (v/v) MeOH. The buffer was subse-
quently removed in the SpeedVac and the purity of the compound was
tested by separation on polyethyleneimine-cellulose plates (1:1.5 (v/v)
saturated NH4SO4 and 1.5 M KH2PO4, pH 3.6).
Phosphodiesterase Assay—c-di-GMP-specific phosphodiesterase
activity was measured by monitoring the decrease of [33P]c-di-GMP
and the increase of [33P]pGpG by thin-layer chromatography. The
PDE reaction buffer for the 100,000  g supernatant of C. crescentus
cell extracts or purified preparations of hexahistidine-tagged protein
contained 250 mM NaCl, 25 mM Tris, pH 8.0, 10 mM MgCl2, and 5 mM
-mercaptoethanol. The GTP/protein mixtures were preincubated for
2 min prior to the addition of c-di-GMP. The reactions were carried out at
30 °C, aliquots were removed at different time points, and the reaction
was stopped by adding an equal volume of 0.5 M EDTA, pH 8.0.
Diguanylate Cyclase Assay—The reaction mixtures with purified
hexahistidine-tagged protein contained 25 mM Tris-HCl, pH 8.0, 250
mM NaCl, 10 mM MgCl2 and were started by the addition of 100 M
[33P]GTP (Amersham Biosciences; 3000 Ci/mmol). At regular time in-
tervals the reaction was stopped with an equal volume of 0.5 M EDTA,
pH 8.0.
Polyethyleneimine-cellulose Chromatography—Samples were dissolved
in 5 l of running buffer containing 1:1.5 (v/v) saturated NH4SO4 and 1.5
M KH2PO4, pH 3.60, and blotted on Polygram® CEL 300 polyethylenei-
mine-cellulose thin-layer chromatography plates (Macherey-Nagel).
Plates were developed in 1:1.5 (v/v) saturated NH4SO4 and 1.5 M KH2PO4,
pH 3.60 (Rf(c-di-GMP) 0.2, Rf(pGpG) 0.4), dried, and exposed on a Storage
PhosphorScreen (Amersham Biosciences). The intensity of the various
radioactive species was calculated by quantifying the intensities of the
relevant spots using ImageJ software, version 1.33.
Limited Tryptic Proteolysis—To 90 l of purified hexahistidine-
tagged protein samples (0.5–11 mg/ml) dissolved in PDE Reaction
Buffer (see above), 10 l of trypsin solution (2 g/ml trypsin in 1 mM
HCl and 250 mM NaCl) was added. After incubation for 5 min at 37 °C,
2 l of freshly prepared phenylmethylsulfonyl fluoride (AppliChem)
solution (0.1% in ethanol) was added, and the reaction was filtered
though a 0.45-m syringe filter (Whatman) before the digest products
were separated by gel filtration. Gel filtration experiments were per-
formed on a SMART System using a Superdex 75 column (Amersham
Biosciences) at a flow rate of 80 l/min. The buffer contained 250 mM
NaCl, 25 mM Tris, pH 8.0, 10 mM MgCl2, and 5 mM -mercaptoethanol.
Fractions of 80 l were collected for the phosphodiesterase activity
assay and for UV cross-linking experiments.
UV Cross-linking with [33P]GTP and [33P]c-di-GMP—Protein sam-
ples were incubated for 10 min on ice in PDE reaction buffer containing
10 M c-di-GMP, 100 M GTP, and [33P]c-di-GMP (0.75 Ci, 6000
Ci/mmol) or [33P]GTP (0.75 Ci, 3000 Ci/mmol). Samples were irradi-
ated at 254 nm for 20 min on an ice-cooled, parafilm-wrapped 96-well
aluminum block in an RPR-100 photochemical reactor with a RPR-3500
UV lamp (The Southern New England Ultraviolet Co.). After irradia-
tion, samples were mixed with 2 SDS-PAGE sample buffer (250 mM
Tris-HCl, pH 6.8, 40% glycerol, 8% SDS, 2.4 M -mercaptoethanol,
0.06% bromphenol blue, 40 mM EDTA) and heated for 5 min at 95 °C.
Labeled proteins were separated by SDS-PAGE and quantified by
autoradiography.
HPLC Analysis and ESI-MS Mass Spectrometry—Reaction products
were analyzed on an Agilent 1100 analytical reverse phase high per-
formance liquid chromatography system with a diode array detector at
254 nm. Macherey-Nagel CC125/3 LiChrospher 100 RP-18, 5-m par-
ticle size, was used at 30 °C with 25 mM triethylammonium carbonate
buffer, pH 7.0, containing 5% (v/v) methanol as mobile phase and a flow
rate of 0.3 ml/min. ESI-MS mass spectra were measured on an Esquire
3000plus (Bruker Daltonics) and on a TSQ7000 (Finnigan) mass spec-
trometer. Matrix-assisted laser desorption ionization spectra were
measured on a Reflex III spectrometer (Bruker Daltonics).
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RESULTS
PDE Activity in the Soluble Fraction of C. crescentus Cell
Extracts—To analyze the C. crescentus protein fractions for
c-di-GMP-specific PDE activity, we developed an enzymatic
assay, which is based on the hydrolysis of radiolabeled c-di-
GMP and separation of the products on thin layer chromatog-
raphy plates (see “Materials and Methods”). The constitutive
active PleD mutant form, PleD*-H6 (22), was purified to homo-
geneity and used to enzymatically convert [33P]GTP to [33P]-
c-di-GMP. When purified [33P]c-di-GMP was added to aliquots
of the dialyzed 100,000  g supernatant of cell extracts of
C. crescentus wild-type strain CB15, the dicyclic nucleotide was
rapidly hydrolyzed (Table I), arguing for the presence of a
potent PDE activity in the soluble fraction of these cells.
A total of five genes encoding soluble EAL proteins were
found on the C. crescentus chromosome. To identify a candidate
PDE protein and to verify that it contributes to the enzymatic
activity found in cell extracts, we selected CC3396 for further
analysis. This decision was mainly based on the relatively
small size and simple domain architecture of CC3396 (Fig. 1B).
An in-frame deletion mutation of gene CC3396 was generated,
and extracts of the resulting mutant strain UJ2812 were as-
sayed for PDE activity in vitro. As shown in Table I, PDE
activity of strain UJ2812 was reduced by about 80% as com-
pared with wild-type, arguing that under the conditions tested,
CC3396 is responsible for a major fraction of the PDE activity
of the cell.
Purified CC3396 Is a c-di-GMP-specific PDE, Which Con-
verts c-di-GMP into the Linear Form pGpG—The above exper-
iments suggested that CC3396 is a prime candidate for a sol-
uble PDE in C. crescentus. A hexahistidine-tagged version of
the CC3396 protein was expressed in E. coli and purified to
homogeneity on a nickel affinity column. When used in the
PDE assay described above, purified fractions of the CC3396
protein could readily hydrolyze radiolabeled c-di-GMP (Table
I). Separation of the reaction mixture on TLC plates revealed
that the labeled c-di-GMP was rapidly converted into a new
nucleotide species (Fig. 2B). HPLC analysis (Fig. 2A) and mass
spectrometry identified this compound as the linearized digua-
nylate derivative pGpG (Fig. 2C, m/z 689.0, for c-di-GMP and
m/z 707.0 for pGpG). Although the conversion of c-di-GMP
into pGpG was relatively rapid (turnover rate: 2.42  0.28
min1), GMP appeared as a secondary product of the reaction
at an about 10-fold slower rate (Table I). Thus, CC3396 specif-
ically and rapidly cleaves c-di-GMP into its linear form,
whereas the formation of GMP might be a nonspecific byprod-
uct of the enzymatic reaction. The PDE activity of CC3396 is
highly specific for the cyclic dimer of GMP and showed no
significant affinity for monocyclic nucleotides cGMP and
cAMP (data not shown). Also, whereas Mg2 ions were crit-
ical for PDE activity, Ca2 showed a strong inhibitory effect
on the hydrolysis of c-di-GMP (Table II). Under no conditions
were we able to detect DGC activity of the purified protein,
arguing that the GGDEF domain of CC3396 is not a DGC
(Table I).
Stimulation of the c-di-GMP-specific PDE Activity of CC3396
by GTP—The activity of monocyclic PDEs is controlled by bind-
ing small effector molecules (including cAMP or cGMP) to
N-terminal regulatory domains (5). To test the possibility that
CC3396 could also be allosterically regulated, we measured the
c-di-GMP-specific PDE activity of CC3396 in the presence or
absence of different nucleotides (Table II). cAMP, cGMP, and
dibuturyl-cGMP did not affect PDE activity of CC3396. Simi-
larly, AMP, ATP, GMP, and GDP showed no effect. However,
when the reaction mixture was supplemented with GTP (100
M) the initial rate of the reaction increased by about 40-fold to
106.8  1.5 mol of c-di-GMP formed per mol of protein and
minute (Table II, Fig. 2B). The same positive effect was ob-
served for an equimolar mixture of either GTP and GDP or
GTP and GMP, arguing that both GDP and GMP do not coun-
teract the positive effect of GTP. Interestingly, the GTP-acti-
vated form of CC3396 quantitatively converted c-di-GMP into
the linear form pGpG, but failed to produce substantial
amounts of GMP (Fig. 2, A and B, Table I). Together this
suggested that the enzymatic activity of CC3396 responsible
for the cleavage of c-di-GMP into pGpG is positively controlled
FIG. 1. Schematic of c-di-GMP synthesis and degradation (A)
and model for GTP controlled PDE activity of CC3396 (B). A, the
conversion of GTP into c-di-GMP is catalyzed by diguanylate cyclases
that reside in the GGDEF domain (22, 41). Synthesis of c-di-GMP can
be subject to negative allosteric feedback regulation (24) (indicated by
the dashed line). Degradation of c-di-GMP into the linear form 5-pGpG
is catalyzed by the EAL domain and positively regulated by GTP
(dashed line). The protein(s) responsible for the hydrolysis of pGpG into
GMP have not been identified so far. B, the PDE activity of CC3396 is
fully comprised within the EAL domain. The associated GGDEF do-
main with its altered active site motif (GEDEF) mediates activation of
the C-terminal PDE by GTP. This domain lacks DGC activity but
presumably binds GTP in a similar way, like the catalytic active GG-
DEF domains (22). We postulate that this novel role for GGDEF is
either caused by the selective loss of DGC catalytic activity because of
a slightly altered active site pocket formed by the GDEEF motif or is the
result of an altered interaction surface of the DGC that prevents
dimerization.
TABLE I
Comparison of specific PDE activities in C. crescentus crude extracts and purified CC3396
PDE activity
Strain/protein c-di-GMP-specific pGpG-specific DGC activitya
C. crescentus CB15b 0.12  0.02 mol/(mg min) 0.054  0.004 mol/(mg min) NDc
UJ2812 (CC3396)b 0.02  0.01 mol/(mg min) ND ND
CC3396-His6
d 2.42  0.28 mol/(mol min) 0.12  0.06 mol/(mol min) 10  5pmol/(mol min)
a Diguanylate cyclase activity of purified CC3396-His6 was determined as indicated in Ref. 22.
b c-di-GMP and pGpG-specific activity of 100,000  g supernatant as measured by TLC.
c ND, not determined.
d c-di-GMP and pGpG-specific activity of purified CC3396-His6 as measured by thin layer chromatography.
Allosteric Control of a c-di-GMP-specific Phosphodiesterase 30831
 at M
ED
IZIN
BIBLIO
THEK on O
ctober 29, 2006 
w
w
w
.jbc.org
D
ow
nloaded from
 
FIG. 2. C. crescentus protein CC3396 is a phosphodiesterase. A, HPLC analysis of the PDE reaction products. Purified CC3396 protein (5
M) was incubated for 1 min with 100 M c-di-GMP, and 4 M GTP. Nucleotides were separated on a RP-18 column before (top panel) and after
the enzymatic reaction (bottom panel), and fractions were analyzed by ESI-MS. GTP, which was added to activate the reaction, was not hydrolyzed.
B, PDE activity of CC3396 in the absence (open symbols) or presence of GTP (4 M GTP, closed symbols). The c-di-GMP hydrolysis activity of
purified CC3396 is indicated as a function of the absolute concentrations of c-di-GMP (circles) and pGpG (squares) as determined by thin layer
chromatography. Reactions included 150 nM purified CC3396 protein and 20 M c-di-GMP and were incubated at 30 °C in buffer as described under
“Materials and Methods.” The polyethyleneimine-cellulose thin layer chromatogram with the raw data is shown below the graph with each time
point spotted in triplicate (upper panel, with GTP; lower panel without GTP). C, mass spectrometry analysis of the reaction products of the CC3396
PDE. Mass spectrometry analysis of the reaction product of the PDE (top panel) and c-di-GMP (bottom panel) as shown in A and B. Top panel,
ESI-MS of pGpG (m/z) 352.9 (pGpG)2, and 707.0 (pGpG). Bottom panel, ESI-MS of c-di-GMP m/z 689.0 [c-di-GMP*H], m/z 699.9
[(c-di-GMP)2*H*Na]
2, m/z 710.9 [c-di-GMP*Na]. D, determination of the equilibrium constant for GTP. Initial velocities of the PDE reaction
were measured at increasing concentrations of GTP and Vmax/2 was determined to be 4 M.
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by GTP, whereas the consecutive hydrolysis step, which gen-
erates GMP is probably a nonspecific side reaction and not
subject to allosteric control by GTP. It is important to note that
we found no indication for GTP hydrolysis during the enzy-
matic reaction in the presence of the inducer (Fig. 2A).
When logarithmically growing cells were analyzed by nucle-
otide extraction and HPLC, the internal concentration of c-di-
GMP was determined to be 1.1 M ( 0.11 M) (data not
shown). This is well below the Km for c-di-GMP, which was
determined for the basal level PDE activity of CC3396 (100
M). To test if GTP activation substantially lowers the Km for
c-di-GMP to a physiologically relevant level, PDE activity was
determined at different substrate concentrations. The Km for
c-di-GMP in the presence of 4 M GTP (at half-maximal PDE
activity, see below) was determined to be 420 nM, close to the
cellular concentration of c-di-GMP measured in growing cells.
The intracellular concentration of GTP in bacterial cells
growing exponentially in rich medium is in the submillimolar
range (29, 30) but can drop by 70–80% upon entry into station-
ary phase (29). To find out if the concentration of GTP required
for activation of CC3396 is physiologically relevant, the KD for
GTP was determined at saturating substrate concentrations.
Half-maximal induction of CC3396 was found to occur at a GTP
concentration of 4 M, well below the GTP concentrations nor-
mally found in bacterial cells (Fig. 2D). The Vmax of the GTP-
activated protein was 115  4 mol/(mol min) (Fig. 2D). This
argues that under physiological conditions promoting cell
growth and division, the PDE activity of CC3396 is likely to be
fully induced.
The PDE Activity of CC3396 Resides in the C-terminal EAL
Domain—The observation that CC3396 harbors PDE but lacks
DGC activity raised the question of whether the enzymatic
activity is entirely comprised within the GGDEF or the EAL
domain, or is maybe the result of a catalytic interaction be-
tween the two domains. To distinguish between these possibil-
ities, we attempted to separate the two domains by a limited
tryptic digest of the full-length CC3396 protein and to deter-
mine the enzymatic activities of the individual domains. Treat-
ment with trypsin resulted in the specific cleavage of CC3396
into two distinct peptide fragments of 	30 and 27 kDa in size,
according to their migration behavior in polyacrylamide gels
(Fig. 3A). Separation of these two cleavage products by gel
filtration, followed by mass spectrometry analysis (Fig. 3,
C and D) revealed that the slightly larger peptide corresponds
to the N-terminal portion of CC3396, which includes the entire
GGDEF domain (amino acids 1–279; fractions 8 and 9 in Fig.
3C), whereas the smaller peptide corresponds exactly to the
C-terminal EAL domain (amino acids 280–554; fractions 10
and 11 in Fig. 3C). The cleavage site mapped to the Arg279
residue positioned in the center of the linker that connects the
GGDEF and the EAL domain (Fig. 3D). It is reasonable to
assume that the two domains can be separated by proteolysis
because this charged residue is easily accessible for the prote-
ase because of its position in the flexible inter-domain linker.
PDE activity was found exclusively in fractions 10 and 11 of
the gel filtration column used to separate the tryptic digest of
CC3396 (Fig. 3C). Because fractions 10 and 11 contain the
C-terminal EAL fragment, this strongly supported the view
that the c-di-GMP-specific PDE activity is fully contained
within the EAL domain. As shown in Table III, the specific
activity of the separated EAL domain is similar to the activity
found for the full-length CC3396 protein, arguing that the
overall PDE activity is not significantly reduced upon separa-
tion of the catalytically active EAL from the GGDEF domain.
Interestingly, when analyzing a CC3396 mutant with a muta-
tion in the highly conserved aspartic acid residue of the EAL
motive (E323Q), we found that both PDE activity and induction
by GTP was not affected by this change (Table III). In vivo
studies with the Vibrio cholerae EAL protein VieA had shown
that a glutamate to alanine exchange at this position resulted
in loss of activity (19). It is possible that the more conservative
mutation chosen for CC3396 might still support PDE activity.
Allosteric Activation of the PDE Activity in EAL Through
Binding of GTP to the GGDEF Domain—Whereas the EAL
signature sequence of the C-terminal EAL domain is conserved
in CC3396, the GGDEF domain has one of the highly conserved
Gly residues of the active site (A-site) motif (24) replaced by
Glu (GEDEF) (Fig. 3D). It is possible that this altered A-site in
GGDEF is still able to bind GTP but cannot catalyze the digua-
nylate cyclase reaction. Such an altered domain might have
been recruited as a regulatory module for the PDE activity
residing in the C-terminal EAL domain. This would be in
agreement with the observation that CC3396 has no apparent
DGC activity (Table I). Also, a regulatory role for the GGDEF
domain would be consistent with the finding that the isolated
EAL domain almost fully retained the specific PDE activity of
full-length CC3396, but in contrast to the intact protein could
not be activated by GTP (Table III).
To obtain evidence in support of this idea we performed UV
cross-link experiments with [33P]c-di-GMP and [33P]GTP using
purified full-length CC3396 and the two individual domains
separated by trypsin treatment (Fig. 3A). [33P]c-di-GMP spe-
cifically bound to full-length CC3396 and to the C-terminal
EAL domain, but not to the N-terminal GGDEF domain frag-
ment (Fig. 4A). In contrast, [33P]GTP, while also cross-linking
to the full-length protein, did not bind to the EAL domain
fragment but instead specifically reacted with the N-terminal
GGDEF domain fragment (Fig. 4B). This suggested that GTP
imposes allosteric control on the PDE enzyme activity of
CC3396 by binding to its regulatory GGDEF domain.
Catalytically active GGDEF domains bind GTP in their A-
site pocket, which in part is formed by a loop structure consist-
ing of the highly conserved GGDEF (often GGEEF) motif (24).
One possibility is that the slightly altered A-site motif (GE-
DEF) of the N-terminal domain of CC3396 has retained the
ability to bind GTP and in response activates the associated
EAL domain. To test this we generated a mutant CC3396
protein with the A-site motif changed to GQNEF. As shown in
Table III, the mutant fully retained its PDE activity. But in
contrast to the wild-type protein, the PDE activity was more or
less constitutive with a 10-fold higher basal level activity in the
absence of GTP as compared with wild-type (Table III). The
TABLE II
Activation of c-di-GMP-specific PDE by GTP
Specific activity (initial velocities) of purified CC3396 was deter-
mined in the presence of 10 M c-di-GMP and one additional nucleotide
(100 M). All reaction mixtures (except the no Mg2 control) contained
10 mM Mg2 and 10 mM Ca2 that were used to show PDE inhibition by
calcium ions.
Nucleotide PDE activity
mol c-di-GMP/mol min
AMP 1.93  0.08
ATP 2.09  0.22
cAMP 1.17  0.46
cGMP 2.13  0.32
dibu-cGMPa 1.79  0.18
GMP 1.87  0.20
GDP 1.92  0.40
GTP 106.8  1.5
GTP  GDP 113.2  1.9
GTP  GMP 97.2  1.5
GTP, no Mg 0.23  0.10
GTP  Ca 1.61  0.37
a 200 M.
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FIG. 3. The PDE activity of CC3396 resides in the C-terminal EAL domain. A, SDS-polyacrylamide gel with purified full-length CC3396
(FL), CC3396 after trypsin treatment (see “Materials and Methods”) (TT), and elution fractions 8–11 of the gel filtration column used to separate
the tryptic fragments (see “Materials and Methods” and panel C). Note that lane TT was pasted from an independent gel. Samples of undigested
(B) and trypsin-digested CC3396 protein (C) were separated by gel filtration (see “Materials and Methods”), and the PDE activity of fractions 5–18
eluting from the column was determined as described under “Materials and Methods.” The TLC plates with the resolved reaction products
originating from each fraction are shown below the graphs. The bars in the graphs indicate the relative activity measured for each fraction, and
the curve shows the protein concentration as determined by UV spectrometry. The protein peak of fractions 8 and 9 in panel C corresponds to the
N-terminal GGDEF domain of CC3396, and the protein peak of fractions 10 and 11 (C) corresponds to the C-terminal EAL domain of CC3396. Note
that on the gel filtration column, the N-terminal GGDEF fragment runs at the position of a dimer, whereas the full-length CC3396 protein and
the N-terminal EAL fragment run at the equivalent position of monomers. Fraction 15 corresponds to the cleaved C-terminal His tag, as
determined by antibody staining with anti-His antibody.D, mass spectrometry analysis of the peptides originating from a tryptic digest of fractions
9 and 10 from panel C. A total of seven fragments of the GGDEF domain of CC3396 could be assigned to fraction 9, and a total of six fragments
of the EAL domain could be assigned to fraction 10 digest. The corresponding fragments are highlighted in capital letters. LC-MS analysis of the
undigested sample of fraction 10 revealed a mass of 29650.86 (Da 4.16) (amino acids 280–554, theoretical mass: 29655.0). The proposed trypsin
cleavage site (Arg279) is highlighted.
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addition of GTP resulted in an only 3-fold activation of
the GQNEF mutant and resulted in similar activity as the
GTP-induced wild-type protein (Table III). This implied that
the amino acid changes in the A-site motif are able to switch
this domain into the regulatory ON state and is consistent with
the view that in CC3396 a catalytically inactive GGDEF do-
main imposes allosteric regulation by binding of GTP in its
substrate binding pocket (A-site).
DISCUSSION
The pioneering work of the late Moshe Benziman and collab-
orators has not only identified dicyclic guanosine monophos-
phate as a signaling molecule involved in bacterial metabolism,
but has also led to the recognition of proteins containing GG-
DEF and EAL domains as being involved in the synthesis and
breakdown of c-di-GMP (reviewed in Ref. 6). Building on this
foundation, an increasing number of genetic studies have in
recent years highlighted a global role for c-di-GMP as a signal-
ing molecule in bacteria. Most of these studies have reported
mutant and/or overexpression phenotypes of proteins contain-
ing GGDEF or EAL domains (9–21). The common pattern
appearing from these studies is that genetic changes associated
with an increase of the cellular concentration of c-di-GMP
negatively modulates cell motility and induce biofilm forma-
tion, whereas genetic modifications that led to a presumable
decrease of c-di-GMP in the cell had the opposite effect. How-
ever, limited information is available on the downstream ac-
tivities and possible targets of c-di-GMP and on the specific
biochemical properties of enzymes involved in synthesis and
hydrolysis of c-di-GMP. Genetic studies had predicted that
GGDEF domains are DGCs and that EAL domains should
harbor the c-di-GMP-specific PDE activity. But whereas many
of the several thousand bacterial GGDEF and EAL proteins
listed in the non-redundant data bases have either a GGDEF or
an EAL domain fused to other signaling domains, a large
fraction combines both domains in the same polypeptide (31). A
similar heterogeneity is found for cNMP (cAMP or cGMP)-
specific cyclases and PDEs in eukaryotic cells, where several
families of each enzyme class vary in ligand and co-factor
specificities, in regulatory properties, and in tissue distribution
(1, 4). This raised several important questions: Are the enzy-
matic activities responsible for the “make and break” of c-di-
GMP really confined to these highly modular single domains?
And if so, do all multidomain proteins that contain both a
GGDEF and an EAL domain harbor both activities or have
some of these proteins “specialized” in that they catalyze only
the synthesis or degradation of c-di-GMP, respectively? The
few examples studied so far have either been associated with
DGC or PDE activity (25). No bifunctional enzyme has been
described as yet. And finally, how would these activities be
controlled if no obvious regulatory domains are fused to GG-
DEF or EAL?
Recent biochemical and structural studies have proposed a
catalytic and regulatory mechanism for the synthesis of c-di-
GMP by the GGDEF protein PleD (22, 24). Here we show that
CC3396, a GGDEF-EAL protein of C. crescentus harbors c-di-
GMP-specific PDE activity but lacks DGC activity. Analysis of
the catalytic activities of the individual domains strongly sug-
gested that the PDE activity of CC3396 is confined to the
C-terminal EAL domain, and does not depend on the physical
presence of the N-terminal GGDEF domain. To our knowledge,
this is the first report that directly links an isolated EAL
domain with the ability to catalyze the hydrolysis of c-di-GMP
in vitro. Our data further propose a regulatory role for the
N-terminal GGDEF domain of CC3396. The in vitro PDE ac-
tivity of CC3396 is increased about 40-fold upon addition of
GTP. Activation of the PDE activity seems to occur via the
reduction of the Km for c-di-GMP from above 100 M in the
absence of GTP to 420 nM when GTP was present. Several lines
of evidence suggest that GGDEF mediates this allosteric con-
trol through an interaction with the associated EAL domain. (i)
Whereas the basal level PDE activity of full-length CC3396 and
the isolated EAL domain are comparable, GTP activation could
only be detected if the GGDEF domain was present. (ii) Com-
pared with the bona fide DGC PleD (22), the GGDEF domain of
CC3396 has a slightly altered consensus sequence A-site motif
(GEDEF). Consistent with this, CC3396 does not seem to pos-
sess diguanylate cyclase activity in vitro. (iii) GTP specifically
binds to the GGDEF but not to the associated catalytic EAL
domain. (iv) A defined mutation in the A-site motif of the
GGDEF domain (GQNEF) abolished allosteric activation and
resulted in a constitutive activity of the associated EAL do-
main. This last observation implies that the GGDEF domain of
CC3396 is a GGDEF-like domain, which is still able to bind
GTP in the A-site cavity with a relatively high affinity (KD 4
M) but does not catalyze the formation of c-di-GMP. If so, an
original GGDEF domain might have been recruited as sensory
domain for GTP through the loss of its catalytic function and
the evolution of a regulatory interaction with EAL. If such a
regulatory role of a GGDEF domain has indeed evolved from an
enzymatically active GGDEF domain, two scenarios are possi-
ble. Either the GGDEF domain has lost DGC activity because
key catalytic residues are missing, or because, in the context of
the GGDEF-EAL composite protein, it is no longer able to form
a dimeric structure required to condense two GTP molecules
into c-di-GMP (24).
Thus, we propose that GGDEF domains, depending on their
sequence conservation or on their oligomeric status, can have
TABLE III
Activation of CC3396 wild-type and mutant forms by GTP
Protein c-di-GMP-specific PDE activitya
10 M c-di-GMP 4 M GTP
CC3396 2.42  0.28 57.9  5.9
EAL domainb 1.32  0.33 2.54  1.10
E323Q 1.2  4.2 76.2  8.9
ED213QN 26.9  3.8 77.3  7.7
a PDE activity (initial velocities) was measured in the presence of 10
M c-di-GMP and in the presence or absence of 4 M GTP.
b The isolated EAL domain of CC3396 corresponds to fraction 10 of
Fig. 3C.
FIG. 4. GGDEF of CC3396 is a GTP binding regulatory domain.
Full-length CC3396 (FL) and protein from elution fractions 8–11 of the
gel filtration column used to separate the tryptic fragments were sep-
arated by SDS-PAGE (see Fig. 3A) and were used to UV cross-link with
[33P]c-di-GMP (A) or [33P]GTP (B) as outlined under “Materials and
Methods.” Samples were separated by SDS-PAGE, and the dried gels
were analyzed by autoradiography.
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two alternative biological activities and can play different roles
in the controlled formation and hydrolysis of c-di-GMP. It is
conceivable that at least a subgroup of the large family of
bacterial GGDEF-EAL composite proteins represents PDEs
with an associated regulatory GGDEF domain that can act as
GTP sensor. At the same time, GGDEF-EAL proteins may exist
that combine both a GGDEF-born DGC and an EAL-associated
PDE activity. And finally it is equally possible that the EAL
domain of GGDEF-EAL composite proteins also engages in a
regulatory function by controlling the N-terminal DGC activity
in response to the prevailing c-di-GMP concentration. Such a
regulatory mechanism has been proposed recently for the DCG
activity of the PleD response regulator, which is under tight
negative allosteric control by its own product, c-di-GMP (24). A
direct consequence of our findings is that each GGDEF or EAL
domain will first have to be carefully analyzed biochemically
before it can be assigned a catalytic or regulatory role.
The model that we propose for catalysis and regulation of the
CC3396 PDE is shown in Fig. 1B. The protein architecture with
an N-terminal regulatory and a C-terminal catalytic domain is
reminiscent of cNMP-specific PDEs found in eukaryotes (e.g.
PDE5, a phosphodiesterase highly specific for cGMP has two
non-catalytic cGMP binding sites located at the N terminus).
Binding of cGMP to these allosteric sites stimulates PDE ac-
tivity, increases cGMP hydrolysis, and thus forms a negative
feedback mechanism regulating the cellular cGMP concentra-
tion (32). Other N-terminal regulatory domains of cNMP-spe-
cific PDEs can serve as phosphorylation sites, can interact with
transducing proteins, or act as an allosteric binding site for
Ca2/calmodulin effectors (5). It is reasonable to assume that
c-di-GMP-specific PDEs in bacteria are also tightly controlled
and that the allosteric control of CC3396 reported here repre-
sents a general phenomenon of this class of enzymes.
PDE activity is likely to be a critical component of c-di-GMP
signaling in bacterial cells. But why would phosphodiesterase
activity be coupled to the cellular concentration of GTP? Ro¨m-
ling and colleagues (18) have reported that upon expression of
the DGC protein AdrA in Salmonella typhimurium, the cellular
GTP to c-di-GMP ratio reverses from about 100:1 to 1:10 (18).
Thus, it is possible that when c-di-GMP synthesis is fully
induced, uncontrolled hydrolysis of c-di-GMP to pGpG and
GMP would deplete the cellular GTP pool. A massive reduction
of the cellular GTP concentration has been reported as a con-
sequence of the increased production of the “alarmone” pppGpp
upon amino acid starvation in Bacillus subtilis (33). Similarly,
the GTP concentration decreases considerably upon nitrogen
starvation in C. crescentus (34). It is possible that to prevent
drainage of the cellular GTP pool, specific PDEs are quickly
turned off when the GTP concentration drops under a thresh-
old level. Considering that the KD for GTP of CC3396 is about
4 M, one would expect such a threshold GTP concentration to
be in the low micromolar range. Together with the observation
that DGCs can be subject to tight allosteric feedback inhibition
by their own product (24), this could be interpreted as a simple
means for flux-controlled sensitivity, which would allow
breaching the threshold for signal transduction by either in-
creased production or decreased degradation of the second mes-
senger. Alternatively, the prevailing GTP level of the cell itself
could be used as a physiological signal to control the internal
concentration of c-di-GMP through the controlled activity of
PDEs. A drastic drop of the GTP concentration to the low
micromolar range could lead to a rapid and substantial in-
crease of the cellular c-di-GMP concentration through the in-
hibition of one or several key PDEs, which respond to GTP in a
similar manner as observed for CC3396. Whereas such a reg-
ulatory role for GTP remains speculative, cellular GTP pools
are known to affect developmental transitions in bacteria. A
decrease in the cellular GTP concentration, but not of other
purine or pyrimidine nucleotides, correlates with the initiation
of morphological differentiation during nutrient starvation of
B. subtilis and Streptomyces griseus (29, 35, 36). The signal
responsible for the induction of sporulation is the reduced GTP
pool, rather than pppGpp, which is formed under the same
starvation conditions (29). The cellular GTP concentration is
sensed by CodY, a transcriptional repressor of several sporu-
lation and motility genes, whose repression activity depends on
binding of GTP with a KD in the physiologically relevant mil-
limolar range (37, 38). It remains to be shown if the GTP
concentration plays a similar regulatory role in cellular c-di-
GMP signaling.
Finally, what is the physiological role of CC3396? CC3396
substantially contributes to the PDE activity in the soluble
fraction of actively growing C. crescentus cells. It is possible
that this protein adds to a more or less constant and rapid
degradation of the freely diffusible cytoplasmic pool of c-di-
GMP and would only be turned off under severe depletion of
GTP. The cellular concentration of c-di-GMP has been deter-
mined to be about 1 M in growing C. crescentus cells (this
study) or 5–10 M in cellulose producing Acetobacter xylinum
(39). This is in good agreement with a Km for c-di-GMP of 420
nM, which was determined for the PDE activity of CC3396 in
the presence of GTP. It has been argued that specifically local-
ized DGCs might act as “local pacemakers” of metabolic reac-
tions resulting in cellular gradients of c-di-GMP (6, 40). In such
a model, c-di-GMP synthesis and signaling would be locally
confined and one would imagine that a strong and constitutive
PDE activity is critical to spatially confine different c-di-GMP
signaling pathways. Further studies are needed to test this
idea more thoroughly.
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3.2 Allosteric Control of Cyclic di-GMP Signaling
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Summary
In this publication we describe an important novel feature of GGDEF proteins, which produce the
ubiquitous bacterial signaling molecule c-di-GMP. This paper reports the results of in depth
structure-function analysis of an allosteric feedback inhibition mechanism that generally acts to
regulate diguanylate cyclase activities in bacteria. The mechanism involves binding of the second
messenger product, c-di-GMP at an inhibition site (I-site) that is coupled via a conserved beta-
strand to the active site (A-site) of the enzyme. The study involves an array of biochemical and
genetic techniques applied on various diguanylate cyclases to establish the sequence
determinants of the I-site as well as the in vivo physiological relevance of I-site function. To assist
the interpretation of the present data and to provide information on binding induced mobility,
atomistically detailed simulations were carried out. Normal mode calculations on ligated and
unligated PleD were used to analyze the structural transitions that occur during I-site binding of c-
di-GMP. Allosteric product inhibition of diguanylate cyclases turns out to have fundamental
functional and physiological implications, including threshold setting for c-di-GMP production by
particular GGDEF proteins, which can contribute to precision, robustness, noise reduction and
accelerated kinetics of c-di-GMP signaling.
The molecular modeling was performed by Franziska Schmid, kinetic data on PleD activity was
provided by Ralf Paul, and the mass spectroscopic analysis of trypsin digested PleD was done by
Suzette Moes an Paul Jenö
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Cyclic di-guanosine monophosphate is a bacterial second
messenger that has been implicated in biofilm formation, anti-
biotic resistance, and persistence of pathogenic bacteria in their
animal host. Although the enzymes responsible for the regula-
tion of cellular levels of c-di-GMP, diguanylate cyclases (DGC)
and phosphodiesterases, have been identified recently, little
information is available on the molecular mechanisms involved
in controlling the activity of these key enzymes or on the specific
interactions of c-di-GMPwith effector proteins. By using a com-
bination of genetic, biochemical, and modeling techniques we
demonstrate that an allosteric binding site for c-di-GMP (I-site)
is responsible for non-competitive product inhibition of DGCs.
The I-site was mapped in both multi- and single domain DGC
proteins and is fully contained within the GGDEF domain itself.
In vivo selection experiments and kinetic analysis of the evolved
I-sitemutants led to the definition of an RXXDmotif as the core
c-di-GMP binding site. Based on these results and based on the
observation that the I-site is conserved in a majority of known
and potential DGC proteins, we propose that product inhibi-
tion of DGCs is of fundamental importance for c-di-GMP
signaling and cellular homeostasis. The definition of the
I-site binding pocket provides an entry point into unraveling
the molecular mechanisms of ligand-protein interactions
involved in c-di-GMP signaling and makes DGCs a valuable
target for drug design to develop new strategies against bio-
film-related diseases.
A global signaling network that relies on the production of
the second messenger cyclic diguanylic acid has recently been
discovered in bacteria (1, 2). The c-di-GMP3 system emerges as
a regulatory mastermind orchestrating multicellular behavior
and biofilm formation in a wide variety of bacteria (2). In addi-
tion, c-di-GMP signaling also plays a role in bacterial virulence
and persistence (3–7). The broad importance of this novel sig-
naling molecule in pathogenic and non-pathogenic bacteria
calls for careful analysis of themolecularmechanisms that con-
trol cellular levels of c-di-GMP and regulate its downstream
targets. c-di-GMP is formed by the condensation of two GTP
molecules (8–10) and is hydrolyzed toGMPvia the linear inter-
mediate pGpG (11–14). Two widespread and highly conserved
bacterial protein domains have been implicated in the synthesis
and hydrolysis of c-di-GMP, respectively (15). The breakdown
of c-di-GMP is catalyzed by the EAL domain (12–14), and the
diguanylate cyclase (8) activity resides in the GGDEF domain
(10, 16). The highly conserved amino acid sequence GG(D/
E)EF forms part of the catalytically active site (A-site) of the
DGC enzyme (8). In agreement with this, mutations that
change the GG(D/E)EF motif generally abolish the activity of
the respective proteins (14, 16–18).
GGDEF domains are often found associated with sensor
domains, arguing that DGC activity is controlled by direct sig-
nal input through these domains (1). The best understood
example for controlled activation of a DGC is the response reg-
ulator PleD, which constitutes a timing device for Caulobacter
crescentus pole development (17, 19, 20). PleD is activated dur-
ing C. crescentus development by phosphorylation of an N-ter-
minal receiver domain and, as a result, sequesters to the differ-
entiating cell pole (17, 19). An additional layer of control was
suggested by the crystal structure of PleD solved recently in
complex with c-di-GMP (8) (Fig. 1). A c-di-GMP binding site
was identified in the crystal, spatially separated from the cata-
lytically active site (A-site). Two mutually intercalating c-di-
GMP molecules were found tightly bound to this site, at the
interface between the GGDEF and the central receiver-like
domain of PleD (Fig. 1). Based on the observation that PleD
activity shows a strong non-competitive product inhibition, it
was proposed that this site might constitute an allosteric bind-
ing site (I-site) (8). Based on the observation that functionally
important residues of the PleD I-site are highly conserved in a
majority of GGDEF proteins listed in the data base, we tested
the hypothesis that allosteric product inhibition is a general
regulatory principle of bacterial diguanylate cyclases.
MATERIALS AND METHODS
Strains, Plasmids, and Media—Escherichia coli and Salmo-
nella enterica serovar Typhimurium strains were grown in
Luria broth (LB). C. crescentus strains were grown in complex
peptone yeast extract (21). For DGC activity assays in vivo,
E. coliwas plated onto LB Congo Red plates (Sigma, 50 g/ml).
To determine the IPTG induction phenotype, 3 l of a liquid
log phase culture was spotted onto LB Congo Red plates with-
* This work was supported by Swiss National Science Foundation Fellowship
3100A0-108186 (to U. J.) and by a Swiss National Science Foundation
Fo¨rderprofessur (to M. M.). The costs of publication of this article were
defrayed in part by the payment of page charges. This article must there-
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tion 1734 solely to indicate this fact.
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3 The abbreviations used are: c-di-GMP, cyclic diguanylic acid; pGpG, linear
diguanylic acid; LB, Luria broth; DGC, diguanylate cyclase; PDE, phospho-
diesterase; H6, hexa-histidine tag; rdar, red, dry, and rough; IPTG, isopropyl
1-thio--D-galactopyranoside; DgcA, diguanylate cyclase A; PdeA, phos-
phodiesterase A; CR, Congo Red; AC, adenylate cyclase; GC, guanylate
cyclase.
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out and with 1 mM IPTG. Biofilm formation was quantified
after overnight growth by staining with 1% Crystal Violet as
described (22). Motility phenotypes were determined using LB
or peptone yeast extract motility plates containing 0.3% Difco-
Agar. The exact procedure of strain and plasmid construction is
available on request.
Random I-site Tetrapeptide Library—The dgcA gene
(CC3285)was amplified by PCRusing primers #1006 and #1007
(for primer list see supplemental text). The PCR product was
digested with NdeI and XhoI and cloned into pET21a (Nova-
gen). In a next step adgcARESDallelewith a silent PstI restric-
tion site was generated by splicing with overlapping extension
PCR using primers #1129, #670, and #1132. The resulting PCR
product was digested with NdeI and XhoI and cloned into
pET42b (Novagen) to produce pET42::dgcARESD. The PstI/
XhoI fragment of pET42b::dgcARESD was replaced by 20
independent PCR products, which had been generated using
pET42b::dgcARESD as a template and primers #1131 and
#670. The resulting 20 independent random libraries were indi-
vidually transformed into E. coli BL21 and screened on Congo
Red plates (LB plates supplementedwith 50g/ml Congo Red).
As a control reaction, the deleted I-site was reverted back to the
wild-type RESD motif by cloning the PCR product generated
with primers #1130 and #670 into the PstI and XhoI site of
pET42b::dgcARESD.
Diguanylate Cyclase and Phosphodiesterase Activity Assays—
DGC reactions were performed at 30 °C with 0.5 M purified
hexahistidine-tagged DgcA or 5 M PleD in DGC reaction
buffer containing 250 mM NaCl, 25 mM Tris-Cl, pH 8.0, 5 mM
-mercaptoethanol, and 20 mM MgCl2. For inhibition assays
the protein was preincubated with different concentrations of
c-di-GMP (1–100 M) for 2 min at 30 °C before 100 M
[33P]GTP (Amersham Biosciences) was added. The reaction
was stopped at regular time intervals by adding an equal volume
of 0.5 M EDTA, pH 8.0. DGC/PDE tandem assays were carried
out using 1Mhexahistidine-taggedDgcA, which was preincu-
bated for 2 min in the presence or absence of 4.5 M hexahisti-
dine-tagged phosphodiesterase PdeA. The reaction was started
by adding 100 M [33P]GTP. The reactions were stopped at
regular time intervals of 15 s by adding equal volumes of 0.5 M
EDTA, pH 8.0, and their nucleotide composition was analyzed
as described below.
Initial velocity (Vo) and inhibition constants were deter-
mined by plotting the corresponding nucleotide concentration
versus time and by fitting the curve according to allosteric prod-
uct inhibited Michaelis-Menten kinetics with the program
ProFit 5.6.7 (with fit function [c-di-GMP]t
 a(1)*t/(a(2) t),
where the initial velocity Vo is defined as a(1)/a(2)) using the
Levenberg-Marquardt algorithm.Ki values were determined by
plotting Vo versus c-di-GMP concentration and using the fol-
lowing fit function, Vo[c-di-GMP]
 Vo[c-di-GMP]
 0 *(1 ([c-di-
GMP]/(Ki [c-di-GMP])).
Polyethyleneimine Cellulose Chromatography—Samples were
dissolved in 5 l of running buffer containing 1:1.5 (v/v) satu-
rated NH4SO4 and 1.5 M KH2PO4, pH 3.60, and blotted on
Polygram CEL 300 polyethyleneimine cellulose TLC plates
(Macherey-Nagel). Plates were developed in 1:1.5 (v/v) satu-
rated NH4SO4 and 1.5 M KH2PO4, pH 3.60 (Rf(c-di-GMP) 0.2,
Rf(pGpG) 0.4), dried, and exposed on a storage phosphor imag-
ing screen (Amersham Biosciences). The intensity of the vari-
ous radioactive species was calculated by quantifying the inten-
sities of the relevant spots using ImageJ software version 1.33.
Vo and Ki were determined with the Software ProFit 5.6.7.
UVCross-linking with [33P]c-di-GMP—The 33P-labeled c-di-
GMP was produced enzymatically using [33P]GTP (3000
Ci/mmol) and purified according to a previous study (14). Pro-
tein samples were incubated for 10 min on ice in DGC reaction
buffer (25mMTris-HCl, pH 8.0, 250mMNaCl, 10mMMgCl2, 5
mM -mercaptoethanol) together with 1 M c-di-GMP and
33P-radiolabeled c-di-GMP (0.75Ci, 6000 Ci/mmol). Samples
were then irradiated at 254 nm for 20 min in an ice-cooled,
parafilm-wrapped 96-well aluminumblock in an RPR-100 pho-
tochemical reactor with a UV lamp RPR-3500 (Southern New
EnglandUltraviolet Co.). After irradiation, samples weremixed
with 2 SDS-PAGE sample buffer (250mMTris-HCl at pH 6.8,
40% glycerol, 8% SDS, 2.4 M -mercaptoethanol, 0.06% brom-
phenol blue, 40 mM EDTA) and heated for 5 min at 95 °C.
Labeled proteins were separated by SDS-PAGE and quantified
by autoradiography.
Nucleotide Extraction andAnalysis—2.0ml of E. coli cell cul-
tures (A600 0.4) were harvested by centrifugation, and superna-
tant was discarded. The cell pellet was dissolved in 200l of 0.5
M formic acid, and nucleotides were extracted for 10 min at
4 °C. Insoluble cell components were then pelleted, and the
supernatant was directly analyzed by chromatography. Nucle-
otides were extracted and separated according to a previous
study (23) on a 125/4 Nucleosil 4000-1 polyethyleneimine col-
umn (Macherey-Nagel) using the SMART-System (Amersham
Biosciences). The nucleotide peak corresponding to c-di-GMP
was verified by co-elution with a chemically synthesized c-di-
GMP standard.
DgcA Protein Expression Levels—DgcA protein expression
levels in E. coli BL21 were determined byWestern blot analysis
usingAnti-His(C-Term) antibody (Invitrogen) andhorseradish
peroxidase conjugate of goat anti-mouse IgG (Invitrogen) as
secondary antibody. The protein concentration was deter-
mined by measuring the intensities of the relevant spots using
ImageJ software version 1.33. Signals were calibrated to defined
concentrations of purified wild-type DgcA.
Molecular Modeling of PleD—All-atom simulations were
carried out using the CHARMM (24) program and the
CHARMM22/27 force field (25). For additional information
see the supplemental material.
RESULTS
Feedback Inhibition of the PleDDiguanylate Cyclase Requires
Binding of c-di-GMP to the I-site—The PleD crystal structure
indicated the existence of an allosteric binding pocket (I-site) at
the interface of theGGDEF and REC2 domains (8). Binding of a
c-di-GMP dimer in the I-site is mediated by specific electro-
static interactions with charged residues of the GGDEF and
REC2 domain (Fig. 1). To provide evidence for c-di-GMP bind-
ing to the I-site pocket in solution, trypsin digests were per-
formed with purified PleD protein (5 M) in the presence or
absence of c-di-GMP (25 M). The resulting peptide fragments
were separated on a C18 column and analyzed by matrix-as-
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sisted laser desorption ionization time-of-flight. Both chro-
matograms were identical, with the exception of two peaks that
were only detected in the absence of ligand but were protected
when c-di-GMP present during tryptic digest (supplemental
Fig. S1). One of the two peptides (T47, retention time 25.6min)
was identified by mass spectrometry and corresponds to the
amino acids 354–359 (supplemental Fig. S1), arguing that c-di-
GMP specifically protects from trypsin cleavage at Arg-359. To
provide additional evidence for ligand binding in solution, we
performedUVcross-linking assays using 33P-labeled c-di-GMP
(14). Residues Arg-148 and Arg-178 of the REC2 domain and
Arg-359, Asp-362, and Arg-390 of the GGDEF domain were
replaced with alanine, and the resulting protein variants were
analyzed. As shown in Fig. 2, mutating I-site residues of the
GGDEF domain abolished (R359D362) or strongly reduced
(R359A and R390A) c-di-GMP binding. In contrast, mutations
in theA-site (E370Q, E371Q, and EE370GG), which completely
abolished enzymatic activity (Table 1), had no effect on c-di-
GMP binding (Fig. 2), indicating that labeling with radioactive
c-di-GMP results from ligand binding at the I-site. Although
mutations R359A, R359V, R359D362, and D362A all
showed a dramatically reduced or complete loss of enzymatic
activity, mutant R390A showed wild-type-like DGC activity
(Table 1). In agreement with the reduced binding of c-di-GMP
(Fig. 2), the Ki of mutant R390A was increased	20-fold (Table
1). PleD proteins harboring mutations in the REC2 portion of
the I-site (R148A and R178A) showed an increased binding
of c-di-GMP (Fig. 2) and slightly lower Ki values than wild
type (Table 1). Surprisingly, R148A/R178A single and double
mutants displayed a 5- to 20-fold higher DGC activity com-
pared with wild-type PleD (Table 1). Finally, c-di-GMP binding
was normal in mutant proteins that either lacked the REC1
receiver domain or had a bulky tryptophan residue introduced
at the REC2-GGDEF interface (G194W, Fig. 2). Together these
results implied that the structural requirements for c-di-GMP
binding are contained within the GGDEF domain of PleD and
that residues Arg-359, Asp-362, and Arg-390 form the core of
an allosteric binding pocket for c-di-GMP.
FIGURE 1. Crystal structure of the response regulator PleD. A, domain
architecture of PleD with receiver domain REC1 (blue), receiver domain REC2
(green), and GGDEF domain harboring diguanylate cyclase activity (red). The
active site (A-site) loop and the allosteric binding site (I-site) are indicated. B,
zoom in view of the I-site pocket with a bound dimer of c-di-GMP with inter-
calated purine bases. Residues Arg-148 and Arg-178 (green) from the REC2
domain and residues Arg-359, Asp-362, and Arg-390 (red) from the GGDEF
domain make specific contacts to the ligand in the crystal structure. C, sche-
matic of c-di-GMP synthesis and degradation reactions.
FIGURE 2. c-di-GMP labeling efficiency of different PleD mutants. The
upper lane shows autoradiographs of [33P]c-di-GMP UV cross-linked hexahis-
tidine-tagged PleD mutant proteins separated by SDS-PAGE. Relative label-
ing efficiencywith c-di-GMP is shownbelowwithwild-type PleD correspond-
ing to 100%. Specificmutants in different domains are colored in gray (REC1),
dark gray (REC2) and light gray (GGDEF).
Diguanylate Cyclase Feedback Control
OCTOBER 20, 2006•VOLUME 281•NUMBER 42 JOURNAL OF BIOLOGICAL CHEMISTRY 32017
 at M
ED
IZIN
BIBLIO
THEK on O
ctober 17, 2006 
w
w
w
.jbc.org
D
ow
nloaded from
 
Evidence for an in Vivo Role of I-site-mediated Feedback
Control—To test a possible role for feedback inhibition of
diguanylate cyclases in vivo, we developed a simple assay based
on the observation that in E. coli and other Enterobacteriaceae
increased cellular levels of c-di-GMP correlate with Congo Red
(CR) staining of colonies on plates (28). Low level expression (in
the absence of the inducer IPTG) of active pleD alleles caused a
red colony phenotype in the E. coli B strain BL21, whereas cells
expressing inactive pleD alleles under the same conditions
stained white (Fig. 3). Interestingly, PleDmutants with dramat-
ically different diguanylate cyclase activities in vitro showed
only minor differences of CR staining in vivo. For instance,
PleDR148A/R178A, which showed a 20-fold increased activity
(Table 1), or PleD*, a constitutively active mutant of PleD sev-
eral 100-fold more active than wild-type (9), caused virtually
identical CR values like PleD wild type (Fig. 3). In contrast,
expression of the feedback inhibition mutant PleDR390A
resulted in a significantly higher CR staining even though its in
vitro DGC activity was lower than wild-type PleD (Table 1).
This argued that in vivo steady-state concentrations of c-di-
GMP were determined mainly by the PleD inhibition constant
(as opposed to the overall activity of the enzyme) and that a
functional I-site is critical for DGC control in vivo.
DgcA, a Single Domain Diguanylate Cyclase, Is Subject to
Allosteric Product Inhibition—Sequence alignments of 1000
annotated GGDEF domain proteins revealed that that I-site
residues Arg-359 and Asp-362 of PleD are highly conserved.
57% of the proteins containing a GGDEF domain and 27% of
GGDEF/EAL composite proteins possess this motif. This sug-
gested that c-di-GMP product inhibition could be a general
regulatorymechanism of bacterial diguanylate cyclases. To test
this, hexahistidine-tagged derivatives of two C. crescentus
GGDEF domain proteins were analyzed biochemically with
respect to their DGC activities and c-di-GMP binding proper-
ties. Purified DgcA (diguanylate cyclase A, CC3285), a soluble,
single domain GGDEF protein that lacks an obvious N-termi-
nal input domain, showed strong diguanylate cyclase activity
(Fig. 5A). DgcA has an RESDmotive five amino acids upstream
of the conservedGGDEF active site andwas readily labeledwith
[33P]c-di-GMP in a cross-linking experiment (Fig. 4). Consist-
ent with this, DgcA showed strong feedback inhibition (Fig. 5A)
with its Ki (1 M) being in the same range as the inhibition
constant determined for PleD (8). In contrast, the GGDEF
domain of PdeA (phosphodiesterase A, CC3396), which lacks
catalytic activity (14), had no conserved I-site residues and did
not bind radiolabeled c-di-GMP (Fig. 4). Thus, specific binding
of c-di-GMP correlated with the presence of a conserved I-site
motif RXXD (Fig. 4).
Diguanylate cyclase activity assays revealed strong and rapid
product inhibition of DgcA. DgcA alone was able to convert
only a small fraction of the availableGTP substrate pool into the
product c-di-GMP (Vo 
 2.8 mol of c-di-GMP mol pro-
tein1 min1) (Fig. 5B). In contrast, GTP consumption and
conversion into c-di-GMP and pGpG was rapid (Vo 
 43.0
mol of c-di-GMP mol protein1 min1) and almost com-
plete when the PDE CC3396 was added in excess to the enzy-
matic reaction (Fig. 5B). This argued that c-di-GMP feedback
inhibition is abolished in a sequential DGC-PDE reaction,
because the steady-state concentration of the inhibitor c-di-
GMP is kept low by continuous degradation of c-di-GMP into
the linear dinucleotide pGpG. As a consequence of rapid feed-
back inhibition, the experimentally determinedVo values of the
DGC reaction are generally underestimated. In conclusion,
these results strengthen the view that allosteric product inhibi-
FIGURE 3. In vivo activity of different PleD and DgcA mutant proteins.
E. coli BL21 strains expressing different pleD alleles and dgcA wild type were
spotted onto Congo Red plates. Relative Congo Red bindingwas determined
using imageJ software with BL21 corresponding to 100%. FIGURE 4. UV cross-linking of different GGDEF domains with 33P-labeled
c-di-GMP. A, Coomassie-stained SDS-PAGE and B, autoradiograph of BSA
(control), PleDREC1,DgcA, and the isolatedGGDEFdomain of the c-di-GMP-
specific phosphodiesterase PdeA (CC3396) after UV cross-linking with [33P]c-
di-GMP. C, alignment of I- and A-site sequence of PleD, DgcA, and PdeA. I-site
(RXXD) and A-site residues (GGDEF) are marked in black and gray,
respectively.
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tion is a general principle of diguanylate cyclases and that high
affinity binding of c-di-GMP requires an RXXD I-site motif
positioned in close proximity to the active site.
Development of an in Vivo Assay to Genetically Probe Allos-
teric Control of DgcA—DGCs from different bacterial species
have been shown to be functionally interchangeable (17, 26, 27).
To determine if DgcA is active in vivo we expressed a plasmid-
based copy of the dgcA gene in C. crescentus, S. enterica, and
Escherichia coli B and tested the respective strains for the phe-
notypes known to result from increased cellular levels of c-di-
GMP (17, 26, 27). Consistentwith these earlier findings, expres-
sion of dgcA strongly inhibited flagellar-based motility in all
three organisms, dramatically increased the ability of S. enterica
and E. coli for surface colonization, and produced the charac-
teristic red, dry, and rough (rdar) colony morphotype when
plated on CR plates (Fig. 6, A–F) (29). The red phenotype pro-
vided the basis for a visual genetic screen on CR plates. Under
these conditions, cells producing active DgcA variants would
produce dark red single colonies, whereas cells producing inac-
tive DgcA mutants would remain white. This prompted us to
use the CR screen to isolate dgcAmutants, which had a specific
defect in feedback regulation, and to define the minimal
requirements for product inhibition of this class of enzymes.
Randomization of c-di-GMP Binding Pocket Reveals Three
Mutant Classes—To probe the minimal requirements of the
I-site for c-di-GMP binding and product inhibition, a dgcA
mutant library was constructed with the RESD signature
replaced by a randomized tetrapeptide sequence (see “Materi-
als and Methods”). In short, a dgcA gene, which carried a dele-
tion of the four I-site codons, was used as template for a PCR
reaction. For the amplification step a primer complementary to
the 3-end of dgcA was used in combination with a mixture of
oligonucleotides that spanned the deletion site and contained
12 randomized base pairs at the position coding for the deleted
amino acids. The resulting PCR fragments were fused in-frame
with the 5-end of dgcA in the expression plasmid pET42b and
were transformed into E. coli BL21. The resulting gene library
contains a theoretical number of 1.67 107 (412) different dgcA
alleles, coding for DgcA variants with different combinations of
I-site residues.
When plated onCR plates, colonies transformedwith a wild-
type dgcA allele showed the typical rdar colony morphology
(Fig. 6G). Transformation of E. coli BL21 with a plasmid
expressing a mutant DgcA, which lacked the four amino acids
of the I-site (DgcARESD), produced white colonies on CR
plates (Fig. 6H), indicating that this mutant form had lost DGC
activity. About 10% of the clones with random tetrapeptide
insertions stained red on CR plates and thus had retained DGC
activity (Fig. 6I). This result is consistent with the observation
that alanine scanning of the PleD I-site almost exclusively pro-
duced non-active enzyme variants (Table 1) and argues that the
majority of amino acid substitutions introduced at the I-site are
detrimental for the catalytic activity of the DGC. To further
characterize active DgcA I-site variants, a total of 800 red col-
onies was isolated and patched onto CR plates without (Fig. 6, J
andK) or with the inducer IPTG (Fig. 6, L andM). This second-
ary screen was based on the observation that IPTG-induced
expression of the pleDR390A allele (Table 1), but not of the
pleDwild-type allele, abolished growth of E. coli BL21 (data not
shown). This suggested that at elevated protein levels, DGCs
that lack feedback control are toxic in vivo (see below). The
majority of the I-site library clones tested failed to grow on
plates containing IPTG, indicating that their activity is no lon-
ger controlled by product inhibition (Fig. 6, L and M). Only 7
mutants (out of 9000 colonies screened) showed a wild type-
like behavior in that they stained dark red on CR plates and
tolerated the presence of the inducer IPTG (Fig. 6, L andM).
This genetic screen led to the isolation of three different
I-site mutant classes with the following characteristics: 1) cat-
alytically inactive mutants (A, frequency 	90%); 2) feedback
control negative mutants (IA, frequency 	10%); and wild-
type-like mutants (IA, frequency	0.1%). A subset of class 1
and 2 mutants and all seven class 3 mutants were selected, and
hexahistidine-tagged forms of the respective proteins were
purified for biochemical characterization. Kinetic parameters
of activity (Vo) and feedback inhibition (Ki) were determined
FIGURE 5. c-di-GMP product inhibition of DgcA. A, initial velocities of the
wild-typediguanylate cyclaseDgcA (squares) and thenon-feedback inhibited
I-site mutant DgcA0244 (circles) in the presence of increasing concentrations
of c-di-GMP. B, conversion of GTP into c-di-GMP by DgcA (dashed lines) and
accelerated GTP consumption, c-di-GMP synthesis, and cleavage into pGpG
by a diguanylate cyclase-phosphodiesterase tandem reaction (plain lines).
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individually using an in vitro diguanylate cyclase activity assay
(16). Consistent with their rdar-like in vivo phenotype, only
class 2 and class 3 mutants showed detectable diguanylate
cyclase activity with an initial velocity between 1.93 and 14.21
mol of c-di-GMP mol protein1 min1 (Table 2). Only
mutant proteins from the IPTG tolerant class 3 showedproduct
inhibition with Ki values close to 1M (Table 2). In contrast, all
proteins from class 2mutants showed no feedback inhibition in
vitro, arguing that their in vivo toxicity is the result of uncon-
trolled run-off DGC activity (Fig. 5A and Table 2). Support for
this hypothesis comes from experiments determining the cel-
lular concentration of c-di-GMP and DgcA protein expression
levels in E. coli BL21 carrying selected dgcA alleles on plasmid
pET42b (see “Materials and Methods”). Alleles dgcA0244,
dgcA1229, and dgcA1250were chosen, because the DGC activ-
ity of these enzymes is similar towild typeDgcA (Table 2). Basal
level expression (no IPTG) of dgcA0244, the allele coding for a
DGC that completely lacks feedback inhibition, resulted in a
more than 100-fold increased cellular level of c-di-GMP as
compared with cells expressing wild-type dgcA (Table 3). This
was due to an almost 100-fold higher overall turnover of the
mutant enzyme as compared with wild type (Table 3). In con-
trast, enzymatic turnover and cellular concentration of c-di-
GMP was increased only marginally in E. coli cells expressing
alleles dgcA1229, and dgcA1250 with restored feedback inhibi-
tion control (Table 3).
Sequence analysis of the tetrapeptide insertions of class 2 and
class 3 mutants revealed several important characteristics of a
functional allosteric I-site binding pocket. All catalytically
active and feedback inhibition competent mutants restored the
wild-type Arg and Asp residues at positions one and four of the
RXXDmotive (Table 2).Whereas most of themutants that had
lost feedback inhibition had altered either one or both of these
charged residues (Table 2) only two feedback inhibition
mutants had retained both charges with changes in the inter-
vening residues (Table 2). Obviously, Arg and Asp, while being
strictly required for feedback inhibition, need to be placed in
the appropriate sequence context of the I-site loop. These
experiments define the minimal requirements of the I-site core
region and demonstrate that the Arg and Asp residues that
make direct contacts to the c-di-GMP ligand in the crystal
structure are of critical functional importance for DGC feed-
back inhibition in vivo and in vitro. This provides a plausible
FIGURE 6. Phenotypic characterization of ectopically expressed diguanylate cyclase dgcA in E. coli and S. enterica. Behavior of E. coli strain BL21 with
empty pET42b plasmid (A) and pET42b::dgcA (B) on motility plates. Colony morphology of E. coli strain BL21 with empty pET42b plasmid (C ) and with
pET42b::dgcA (D) on Congo Red plates. Biofilm formation of S. enterica serovar Typhimurium trp::T7RNAP with empty pET42b (E ) and pET42b::dgcA (F ) grown
in liquid culture and stained with crystal violet. E. coli BL21 transformed with PCR-restored dgcA wild type on pET42b::dgcA (G), with the inactive allele
dgcARESD (pET42b::dgcARESD) (H), andwith a library of random tetrapeptide insertions in the I-site (pET42b::dgcAXXXX) (I) andplatedonCongoRedplates.
E. coliBL21 expressing different I-sitemutant alleleswere spotted ontoCongoRedplateswithout (J and K ) andwith 1mM IPTG (L andM) to screen for feedback
inhibition dgcA alleles.
TABLE 1
Kinetic analysis of PleD mutants
Protein Vo Vo Ki Ki
mol c-di-GMP/
(mol protein*min)
M
PleD wild type 0.202  0.023 5.8  1.0
PleDR359A 0.005 NDa 100 ND
PleDR359V 0.0 ND
PleD359362 0.0 ND
PleDD362A 0.0 ND
PleDR390A 0.076  0.007 115.0  18.1
PleDR148A 0.822  0.020 2.8  1.2
PleDR178A 0.918  0.292 3.6  0.1
PleDR148AR178A 3.75  0.43 2.9  0.6
PleDG194W 0.161  0.005 6.3  1.9
PleDEE370GG 0.0 ND
PleDE370Q 0.0 ND
PleDE371Q 0.0 ND
a ND, not determined.
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explanation for the strong conservation of the RXXD motif in
GGDEF domains.
The molecular mechanism of product inhibition through
I-site binding remains unclear. To assist the interpretation of
the present data and provide information on binding induced
mobility, atomistically detailed simulations were carried out.
Normal mode calculations on ligated and unligated PleD were
used to analyze the structural transitions that occur during
I-site binding of c-di-GMP. Normal mode calculations on the
optimized structures yielded no imaginary frequencies, and
translational and rotational frequencies were close to zero (
 0.02 cm1). This indicated that the minimized structures
correspond to real minima on the potential energy surface. The
displacements calculated for the ligated and the unligated pro-
tein showed a significant decrease in mobility for both I- and
A-site residues upon complexation (supplemental Figs. S2 and
S3). Whereas motion in the I-site is suppressed due to steric
interactions upon ligand insertion, quenching of the A-site res-
idues suggested that the two sitesmight be dynamically coupled
via the short connecting -strand (2). Backbone C-atoms
and side chains of the I-site and A-site loops were displaced by
an average of 1–4 Å in opposite directions, arguing that a bal-
ance-like movement centered around 2 could be responsible
for direct information transfer between the two sites (Fig. 7).
The cumulated displacements per residue over all 147 modes
(supplemental Fig. S3) showed differentmobilities in additional
regions of the protein. The C atoms of residues exhibiting
large changes in flexibility upon ligand binding are depicted as
spheres in supplemental Fig. S3. Reduced flexibility (yellow
spheres) is found at the I-site, A-site, phosphorylation site, and
the dimer interface, whereas the flexibility is enhanced (black
spheres) at the REC1/REC2 interface. In summary, these simu-
lations show that I-site binding of c-di-GMP not only reduced
the mobility around the RXXDmotif but also of the residues of
the A-site loop.
DISCUSSION
Feedback Inhibition Is a General Control Mechanism of
Diguanylate Cyclases—The data presented here propose a gen-
eral mechanism to regulate the activity of diguanylate cyclases
(DGCs), key enzymes of c-di-GMP-based signal transduction
in bacteria. High affinity binding of c-di-GMP to a site distant
from the catalytic pocket (I-site) efficiently blocks enzymatic
activity in a non-competitive manner. Mutational analysis of
multi- and single-domain DGC proteins has provided convinc-
ing evidence for the role of several charged amino acids in c-di-
GMP binding and allosteric regulation. Furthermore, these
experiments indicated that the allosteric binding site is func-
tionally contained within the GGDEF domain. An in vivo selec-
tion experiment using a random tetrapeptide library, and
TABLE 2
Diguanylate cyclase activity and inhibition constant of DgcA I-site mutant proteins
Protein Motif Vo Vo Ki Ki
mol c-di-GMP/
(mol proteinmin)
M
DgcA wt RESD 2.79  0.01 0.96  0.09
DgcA1406 RQGD 5.35  0.05 7.02  2.92
DgcA1040 RLVD 4.92  0.19 4.52  1.81
DgcA1229 RGAD 2.03  0.01 1.84  0.26
DgcA1524 RSAD 3.70  0.13 7.36  2.69
DgcA1529 RLAD 2.79  0.04 1.01  0.23
DgcA0751 RCAD 3.65  0.10 3.51  0.52
DgcA1250 RGGD 2.07  0.02 2.24  0.49
DgcARESD 0.14  0.06 NDa
DgcA0207 GMGG 14.21  0.54 No inhibition
DgcA0244 VMGG 2.57  0.05 No inhibition
DgcA0613 GGVA 4.29  0.06 No inhibition
DgcA0646 GRDC 8.90  0.10 No inhibition
DgcA0913 GVGD 3.81  0.04 No inhibition
DgcA1300 MEGD 0.87  0.02 No inhibition
DgcA1733 GGNH 11.47  0.17 No inhibition
DgcA3018 RESE 11.1  0.11 No inhibition
DgcA0230 RNRD 3.02  0.06 No inhibition
DgcA0642 RVDS 4.17  0.08 No inhibition
DgcA1007 RAGG 6.06  0.05 No inhibition
DgcA2006 RGQD 1.93  0.01 No inhibition
a ND, not determined.
TABLE 3
DgcA protein levels and cellular c-di-GMP concentrations in the absence or presence of IPTG induction at 1 mM
Protein conc.a c-di-GMP conc. Turnoverb
No induction 1 mM IPTG No induction 1 mM IPTG No induction 1 mM IPTG
pmol protein/mg dry weight pmol c-di-GMP/mg dry weight pmol c-di-GMP per pmol protein
DgcA0244 4.1 22 1466.3 1570.7 357.6 71.4
DgcA1229 3.5 31 87.6 139.5 25.0 4.5
DgcA1250 2.7 43 24.2 305.4 9.0 7.1
DgcA wt 2.9 33 13.75 189.4 4.7 5.7
DgcARESD 3.5 23 NDc ND NAd NA
a See “Materials and Methods.”
b As derived from the cellular c-di-GMP concentration divided by the cellular protein concentration.
c ND, not detectable.
d NA, not applicable.
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designed to re-engineer the I-site has led to the definition of a
highly conserved RXXD core motif of the c-di-GMP binding
pocket. The RXXD motif forms a turn at the end of a short
five-amino acid -sheet that directly connects the I-site with
the conserved catalytic A-site motif, GG(D/E)EF (Fig. 7). This
raised the question of how I-site ligand bindingmodulatesDGC
enzyme activity. In the multidomain protein PleD, c-di-GMP
bound to the I-site physically connects the GGDEF domain
with the REC1-REC2 dimerization stem. It was speculated that
product inhibition occurs by domain immobilization, which
would prevent the encounter of the twoDGC substrate binding
sites (8). Several observations argue in favor of a more direct
communication between I- and A-sites. First, with a large vari-
ety of domains found to be associated with GGDEF domains, it
seems unlikely that functional I-sites are generally formed by
the interface of a GGDEF with its neighboring domain (2). In
agreement with this, residues of the PleD REC2 domain are
not required for c-di-GMP binding and feedback inhibition.
Second, the single domain DGC protein, DgcA, shows I-site-
dependent allosteric control with aKi of 1M. Third, the intro-
duction of a bulky tryptophan residue (G194W) at the GGDEF-
REC2 interface did not affect activity, I-site binding, or
feedback inhibition of PleD (Fig. 2 and Table 1). Fourth, atom-
istic simulations of ligated and unligated PleD predicted a
marked drop in flexibility of C-atoms both in the I- and A-site
upon ligand binding. Simultaneous with motion quenching, 2
and its flanking I- and A-loops undergo a balance-like move-
ment that repositions A-site residues in the catalytic active site
(Fig. 7). This is consistent with the idea that structural changes
within the GGDEF domain upon binding of c-di-GMP at the
I-site lead to repositioning of active site residues and possibly
altered kinetic parameters. Thus, we propose that c-di-GMP
binding and allosteric control represents an intrinsic regulatory
property of DGCs that contain an RXXDmotif.
Like guanylate and adenylate cyclases (GCs and ACs) and
DNApolymerases,DGCs catalyze the nucleophilic attack of the
3-hydroxyl group on the -phosphate of a nucleoside triphos-
phate. Despite the lack of obvious sequence similarities, the
PleD x-ray structure revealed that DGCs possess a similar
domain architecture like ACs and GCs (8, 30). Based on muta-
tional analysis (8, 14, 16) and on structural comparisons
between DGC, AC, GC, and DNA polymerases (31–34), a
model for DGC catalysis can be proposed. In contrast to the
heterodimeric ACs and GCs, DGCs form homodimers, with a
GTP molecule bound within the catalytic core of each DGC
monomer (8). Two Mg2 ions are coordinated by the highly
conserved glutamic acid residue Glu-371, which is part of the
GGDEF motif, and possibly by Asp-327 on the opposing
-sheet. The divalent Mg2 carboxyl complex coordinates the
triphosphate moiety of GTP and activates the 3-hydroxyl
group for intermolecular nucleophilic attack. Substrate speci-
ficity of AC and GC can be interchanged by converting a few
key residues involved in purine recognition (31, 34, 35). This
includes an arginine residue, which in PleD corresponds to the
highly conservedArg-366 located in the-sheet connecting the
I- and A-sites. Based on the active site model, two alternative
inhibition mechanisms can be envisaged. In a first scenario,
binding of c-di-GMP to the I-site would change the orientation
of Arg-366 and would thereby disturb the guanine binding
pocket resulting in an increased Km for GTP. Alternatively,
inhibitor binding could rearrange the Mg2 carboxyl complex
and thus destabilize the active state.
In Silico Analysis of the GGDEF Protein Family Indicates
That Product Inhibition Is a General Regulatory Mechanism—
DGC activity of GGDEF domain proteins seems to strictly
depend on conserved GGDEF or GGEEF motifs in the active
site (10, 16, 18, 36–38). Consistent with this, 	90% of the
GGDEF and 62% of the GGDEF/EAL composite proteins show
a conserved GG(D/E)EF A-site motif. Of the GGDEF proteins
with a highly conserved A-site motif, 60% have conserved
RXXD I-site residues and a conserved spacer length between I-
and A-site, arguing that the three-dimensional arrangement of
catalytic and allosteric pocket is likely to be similar in all DGCs.
From a total of 19 GGDEF proteins, for which convincing evi-
dence for a DGC activity exists, 14 have a conserved I-site (sup-
plemental Fig. S4). Ryjenkov and coworkers (10) reported
severe toxicity problems when expressing diguanylate cyclases
lacking I-site residues inE. coliBL21. This is consistentwith the
growth defect observed upon expression of dgcA feedback inhi-
bitionmutants inE. coliBL21 and argues that these proteins are
not feedback-controlled. The molecular basis of growth inter-
ference under these conditions is unclear. It is possible that
depletion of the GTP pool or adverse effects of unphysiologi-
cally high levels of c-di-GMP are responsible for this effect.
Although the experiments presented here define a role for the
I-site in DGC feedback inhibition, the c-di-GMP binding
pocket could also be exploited for other roles in c-di-GMP sig-
naling. It has been proposed recently that non-catalyticGGDEF
FIGURE 7. Comparison of the energy-minimized structures of the PleD
GGDEFdomainwithandwithout ligandbound to the I-site. For improved
clarity, the domain is sliced through the I-site loop/2/A-site loop plane. The
unligated protein is shown in gray and the I-site loop (green), 2 (black), and
A-site loop (gold ) of the bound structure are shown as an overlay. GTP bound
to the active site is modeled according to the orientation of c-di-GMP bound
to the A-site in the crystal structure. The PleD amino acid sequence of I-site,
2, and A-site is indicated below.
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domains with variant A-site motifs can fulfill regulatory func-
tions (14). It is attractive to speculate that a subgroupofGGDEF
proteins that has degenerate catalytic A-sites but conserved
c-di-GMP binding pockets, represents a novel class of c-di-
GMP effector proteins that regulate cellular functions in
response to c-di-GMP binding.
Regulatory Significance of DGC Feedback Control—GGDEF
domains are often associated with sensory domains in one- or
two-component signaling systems (39, 40). Thus it is reasona-
ble to assume that in most cases DGC activity is controlled by
direct signal input through these domains. But why then would
a substantial portion of these enzymes also be subject to feed-
back inhibition? There are several possibilities, which among
themselves are not mutually exclusive. Given the anticipated
regulatory complexity of the c-di-GMP signaling network (2,
39) and the potentially dramatic changes in cellular physiology
and behavior caused by fluctuating levels of c-di-GMP, it is in
the cell’s best interest to rigorously control the production of
the second messenger. Product inhibition of DGCs allows the
establishment of precise threshold concentrations of the sec-
ond messenger, or, in combination with counteracting PDEs,
could produce short spikes or even generate oscillations of c-di-
GMP. In addition, negative feedback loops have been impli-
cated in neutralizing noise and providing robustness in genetic
networks by limiting the range over which the concentrations
of the network components fluctuate (41, 42). Similarly, prod-
uct inhibition of DGCs could contribute to the reduction of
stochastic perturbations and increase the stability of the c-di-
GMP circuitry by keeping c-di-GMP levels in defined concen-
tration windows. Alternatively, DGC autoregulationmay influ-
ence the kinetics of c-di-GMP signaling. Mathematical
modeling and experimental evidence suggested that negative
autoregulation in combination with strong promoters substan-
tially shortens the rise-time of transcription responses (43–45).
In analogy, a desired steady-state concentration of c-di-GMP
can in principle be achieved by two regulatory designs: (a) a low
activity DGCwith no product inhibition, and (b) a high activity
DGC with built-in negative autoregulation. In cases where cir-
cuits have been optimized for fast up-kinetics, design B will be
superior. It is plausible that DGCs with or without I-site motifs
can be divided into these two kinetically different classes.
This study contributes to the emerging understanding of the
c-di-GMP regulatory network in bacteria. The current empha-
sis lies on the identification of effector molecules, regulatory
mechanisms, and processes controlled by c-di-GMP. With the
long term goal in mind of approaching a detailed systems-level
understanding of c-di-GMP signaling, kinetic parameters of
signalingmechanismswill require our particular attention.Our
experiments provide an entry point into the kinetic analysis of
individual DGCs and the quantitative assessment of the c-di-
GMP circuitry.
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 1
SUPPLEMENTAL MATERIAL: 
MATERIALS AND METHODS: 
Purification of His-tagged proteins - E. coli BL21 cells carrying the respective expression 
plasmid were grown in LB medium with ampicillin (100?g/ml) or kanamycin (30?g/ml) and 
expression was induced by adding IPTG at OD600 0.4 to a final concentration of 0.4 mM. After 
harvesting by centrifugation, cells were resuspended in buffer containing 50 mM Tris-HCl, pH 
8.0, 250 mM NaCl, 5 mM ?-mercaptoethanol, lysed by passage through a French pressure cell, 
and the suspension was clarified by centrifugation for 10 min at 5,000 x g. Soluble and insoluble 
protein fractions were separated by a high-spin centrifugation step (100,000 x g, 1 h). The 
supernatant was loaded onto Ni-NTA affinity resin (Qiagen), washed with buffer, and eluted with 
an imidazol-gradient as recommended by the manufacturer. Protein preparations were examined 
for purity by SDS-PAGE and fractions containing pure protein were pooled and dialyzed for 12 h 
at 4°C. 
Molecular modeling of PleD  
All-atom simulations were carried out using the CHARMM (25) program and the 
CHARMM22/27 force field (26). The A chain of the X-ray dimer structure (PDB entry: 1W25 
(17)) was used. All titratable side chains were generated in their standard protonation state at pH 
7. Parameters and partial charges for the non-standard residue c-di-GMP were adopted from the 
extended CHARMM parameter sets for nucleic acids. The structure of the ligated (intercalated c-
di-GMP bound to the I-site) and the unligated protein, to which hydrogen atoms were added, 
were minimized using a distance-dependent dielectric with ?=4 and a cutoff of 12 Å for non-
bonded interactions. 5000 steps of steepest descent minimization were followed by adopted 
Newton Raphson minimization until a RMS gradient of 10-7 kcal/mol·Å was reached. Such a 
threshold is found to be sufficient for normal mode calculations (49). Normal modes were 
calculated with the diagonalization in a mixed basis (DIMB) method, as implemented in 
CHARMM. The DIMB method is an approximate scheme retaining the full atomistic description 
of the protein, where the Hessian is approximated iteratively. The total number of basis functions 
was 153 and cumulated displacements were calculated for T = 300 K.  
For ligated PleD motion is suppressed at L(?1,?1) (res.10-12), L(?3,?3) domain REC1, the C-
terminal end of ?3 (res. 220-224) of domain REC2, the unstructured linker between REC2 and 
GGDEF domain (res. 282-284), the residues forming the A-site (res. 352), L(?2,?2) (res. 357-
 2
360, I-site), L(?2,?3) (res. 367-373, A-site) and at the C-terminal end of ?3 (res. 396-398) of  the 
GGDEF domain. By contrast upon ligand binding mobility increases for ?1 (res. 24), ?4 (res. 96-
99) of domain REC1, residues (res. 149, 175), L(?2,?2) (res. 205-207), L(?5,?5) (res. 254-257) 
of domain REC2 and residues L(?3',?3'') (res. 404-407) and L(?4,?4) (res. 422-424) of the 
GGDEF domain. 
Primer list 
The following primers were used: #1006, ACA CGC TAC ATA TGA AAA TCT CAG GCG 
CCC GGA C; #1007, ACT CTC GAG AGC GCT CCT GCG CTT; #1129, CAA GCG GCT 
GCA GGC CAA TGT GAT CGT CGG CCG CAT GGG TGG TGA; #670, TGC TAG TTA TTG 
CTC AGC GG; #1006 ACA CGC TAC ATA TGA AAA TCT CAG GCG CCC GGA C; #1130, 
CAA GCG GCT GCA GGC CAA TGT GCG CGA AAG CGA CAT CGT CGG CCG CAT 
GGG TGG TGA; #1132, CAC ATT GGC CTG CAG CCG CTT GGC GAC; #1131, CAA GCG 
GCT GCA GGC CAA TGT GNN NNN NNN NNN NAT CGT CGG CCG CAT GGG TGG 
TGA. 
 3
FIGURE LEGENDS: 
Figure S1: Separation of peptides yielded from tryptic digest of PleD in the presence (red 
chromatogram) or absence of c-di-GMP (black chromatogram) on a C18 column. Peaks 
identified by ESI-MS: c-di-GMP m/z 691, tR 7.70 min, T47 (amino acids 354-359) m/z 659.3 tR
25.64 min. T49 (amino acids 367-386) m/z 2167.7 tR 47.73 min.
Figure S2: Normal modes of PleD I-site and A-site residues. The displacements for each mode 
of the ligated and unligated structures are shown in Å for the residues of the REC2 domain 
(green) and the GGDEF domain (red). Insertion of intercalated c-di-GMP in the I-site quenches 
motion in both the I-site (R359-D362, R390) and the A-site (G368-E371), suggesting that the two 
sites are dynamically coupled. 
Figure S3: Representation of the PleD protein (blue: REC1, green: REC2, red: DGC) with c-
di-GMP bound to the I-site. C?-atoms at positions of considerable changes in flexibility upon 
ligand binding are shown as spheres; reduced flexibility (yellow) and enhanced flexibility (black). 
Note that binding of c-di-GMP at the I-site (I) affects mobility not only in the I-site, but also in 
other regions of the protein, e.g. A-site (A), phosphorylation site (P) and dimer interface. 
Figure S4: Alignment of I- and A-site sequence of biochemically characterized diguanylate 
cyclases.  I-site residues (RXXD) are underlined in green and A-site residues (GGDEF) are 
underlined in yellow. 
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Summary
In this publication we enlighten the signal transduction mechanism of the bacterial second
messenger c-di-GMP and demonstrate the existence of diguanylate receptor proteins. We report
the biochemical purification of c-di-GMP receptor proteins from C. crescentus crude extract and
describe their physiological role in c-di-GMP dependent repression of cell motility. A multitude of
biochemical, genetic and NMR experiments was used to characterize these effector proteins and
homologs from S. enterica and P. aeruginosa down to molecular level. In particular we used [33P] c-
di-GMP UV cross linking studies to demonstrate that these receptors specifically bind c-di-GMP in
the sub micro molar range and, in combination with NMR spectrometry, to elicit determinants for c-
di-GMP binding. Further more, we performed genetic suppressor analysis and epitasis
experiments with receptor deletion and point mutants, to corroborate that the identified diguanlyate
receptors from C. crescentus act in vivo downstream of the second messenger c-di-GMP.
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2Abstract
Bacteria are able to switch between two mutually exclusive lifestyles, motile single cells and sedentary
multicellular communities that colonize surfaces. These behavioral changes contribute to an increased fitness in
structured environments and are controlled by the ubiquitous bacterial second messenger cyclic di-GMP. In
response to changing environments, fluctuating levels of c-di-GMP inversely regulate cell motility and cell
surface adhesins. Whereas the synthesis and breakdown of c-di-GMP has been studied in detail, little is known
about the downstream effector mechanisms. Using affinity chromatography we have isolated several c-di-GMP
binding proteins from Caulobacter crescentus. One of these proteins, DgrA, is a PilZ homolog involved in
mediating c-di-GMP-dependent control of C. crescentus cell motility. Biochemical and structural analysis of
DgrA and homologs from C. crescentus, Salmonella typhimurium and Pseudomonas aeruginosa demonstrated
that this protein family represents a class of specific diguanylate receptors and suggested a general mechanism
for c-di-GMP binding and signal transduction. Increased concentrations of c-di-GMP or DgrA blocked motility
in C. crescentus by interfering with motor function rather than flagellar assembly. We present preliminary
evidence implicating the flagellar motor protein FliL in DgrA-dependent cell motility control.
3Cyclic purine nucleotides are ubiquitous second messengers involved in cell signaling. They are produced
through the action of growth factors, hormones or neurotransmitters and elicit their response by acting on a range
of downstream effector proteins like protein kinases, transcription regulators, gated ion channels, or GTPase
nucleotide exchange factors. Whereas cAMP is widespread through all kingdoms of life, cGMP seems to be
restricted to signaling in eukaryotes. Recently, a third major cyclic nucleotide messenger, cyclic di-guanosine-
monophosphate (c-di-GMP) has emerged as a ubiquitous signaling molecule in prokaryotes, where it
antagonistically controls motility and virulence of planktonic cells on one hand and cell adhesion and persistence
of multicellular communities on the other (1, 2) (supplemental Fig. 7). C-di-GMP is synthesized from two
molecules of GTP and degraded into the linear dinucleotide pGpG by the opposing activities of diguanylate
cyclases (DGC) and c-di-GMP-specific phosphodiesterases (PDE). DGC and PDE activities are comprised in
GGDEF and EAL domains, respectively (3-8), which represent two large families of output domains found in
bacterial one- and two-component signal transduction systems (9, 10).
The molecular principles of c-di-GMP signaling have been studied in the model organism Caulobacter
crescentus, where c-di-GMP coordinates the developmental transition from a motile swarmer cell to a surface
attached, replication competent stalked cell. Both acquisition of flagellar motility in the predivisional cell and its
replacement by an adhesive organelle later in development are controlled by c-di-GMP. TipF, an EAL domain
protein, is required for an early step of flagellum assembly in the predivisional cell (11), whereas the diguanylate
cyclase PleD is involved in flagellum ejection and subsequent steps in pole remodeling (3, 12-15). Similarly, the
second messenger c-di-GMP regulates motility, adhesion factors and biofilm formation in a wide variety of
bacterial pathogens including Yersinia, Pseudomonas, Vibrio and Salmonella (1, 2). C-di-GMP influences
flagellar motility as a function of growth (16) or adaptation to surfaces (17), affects pili assembly (18), and
controls the production of surface structures like fimbriae and exopolysaccaride matrices (19). The wide variety
of cellular functions that are affected by c-di-GMP calls for multiple receptors and signaling mechanisms.
However, little information is available on specific targets of c-di-GMP action. With the exception of a
component of the cellulose synthase complex from Gluconacetobacter (20, 21) and the recent prediction of a
candidate c-di-GMP binding domain (22, 23), no c-di-GMP effector proteins have been reported. We have
4designed a biochemical approach to purify and characterize c-di-GMP effector molecules from Caulobacter
crescentus crude cell extracts.
5Results:
Purification of c-di-GMP binding proteins from C. crescentus. Based on the assumption that c-di-GMP signal
transduction depends on specific receptor proteins, we designed a biochemical purification strategy to identify
such components. C-di-GMP binding proteins from C. crescentus were purified by two consecutive
chromatography steps using BlueSepharose® CL-6B and affinity chromatography with GTP immobilized on
Epoxy activated Sepharose 4B (Pharmacia). UV crosslinking with [33P]c-di-GMP was used to identify proteins
with specific binding activity for c-di-GMP (see Materials and Methods and supplemental Table II). Two
binding proteins with apparent molecular weights of 47 kDa and 36 kDa were detected in the 0.4 – 0.7 M NaCl
eluate of the BlueSepharose® column (Fig. 1A, B, lane 3) and the 0.7 – 0.9 M NaCl fraction contained several
small c-di-GMP binding proteins with apparent molecular weights of 8-12 kDa (Fig. 1A, B, lanes 4-5; Fig. 1C).
The latter fraction was dialyzed, concentrated and separated on a GTP Epoxy-Sepharose 4B affinity column
(Fig. 1A,B lane 4 and Fig. C). One of these (labeled c in Fig. 1C) was identified by MS/MS as the product of
gene CC1599, a conserved hypothetical 12.5 kDa protein that we consequently renamed as diguanylate receptor
A (DgrA). Sequence comparison disclosed DgrA as a member of the PilZ protein family, members of which
have recently been proposed by bioinformatics to be c-di-GMP effector proteins (22).
DgrA is a diguanylate receptor protein. In order to confirm that the identified protein is a c-di-GMP receptor,
dgrA was subcloned into the expression vector pET-42b and the recombinant hexahistidine-tagged protein was
purified by Ni-NTA-affinity chromatography. Like the semi-purified protein from C. crescentus (Fig. 1C), the
recombinant protein showed strong labeling upon UV crosslinking with [33P]c-di-GMP (Fig. 2A), confirming
that DgrA is a c-di-GMP receptor protein. UV crosslinking experiments with DgrA in the presence of 60 nM 33P
labeled c-di-GMP and increasing concentrations of cold c-di-GMP, GTP (200 μM), or pGpG (200 μM) indicated
that DgrA binds c-di-GMP with high affinity and specificity (Fig. 2B). Furthermore, c-di-GMP seems to bind to
DgrA in a non-covalent manner since no radiolabeled c-di-GMP was incorporated without UV irradiation (Fig.
2B). The dissociation constant for c-di-GMP of the recombinant DgrA was determined using the UV
6crosslinking assay (Table I). Saturated incorporation of radiolabeled c-di-GMP was already observed at 50 nM,
indicating that the KD of DgrA for c-di-GMP is below 50 nM.
To test if other members of the PilZ protein family also bind c-di-GMP we analyzed several ortho- or
paralogs of DgrA, including CC3165 (renamed as DgrB), YcgR from S. thyphimurium (24) and PA4608 from P.
aeruginosa (Fig. 6). As shown in Fig. 2A all four proteins were efficiently labeled with 33P c-di-GMP upon UV
crosslinking, whereas the control protein BSA did not incorporate c-di-GMP. The c-di-GMP binding constants
of DgrB, YcgR and PA4608 were determined by performing UV crosslinking experiments with 50 nM receptor
protein in the presence of increasing concentrations of 33P labeled c-di-GMP (50 - 1000 nM). All wild type
diguanylate receptor proteins exhibit a binding affinity in the nanomolar range (Table I). Taken together, these
data demonstrate that DgrA and its homologs containing a PilZ domain are members of a class of small
diguanylate receptor proteins, which bind c-di-GMP, but not other guanine nucleotides, with high affinity. Thus,
these proteins represent bona fide diguanylate receptor proteins and may be involved in the response of specific
cell functions to fluctuating concentrations of c-di-GMP (2).
DgrA and DgrB mediate c-di-GMP-dependent motility control in C. crescentus. Low concentrations of c-di-
GMP are generally associated with flagella or pili based motility of single planktonic cells, whereas increased
concentrations of c-di-GMP promote multicellular traits and efficiently block cell motility (2). In agreement with
this, C. crescentus cells are non-motile in the presence of a plasmid-borne copy of dgcA, which encodes a highly
active, soluble diguanylate cyclase (15) (Fig. 3A). Electron micrographs and immunoblot experiments showed
that these cells were flagellated and expressed similar level of flagellins (data not shown), arguing that increased
c-di-GMP concentrations interfere with flagellar function rather than with the expression or assembly of flagellar
components. To test if motility control by c-di-GMP involves dgrA or dgrB, single and double in frame deletion
mutants were generated using a two-step homologous recombination procedure (see supplemental materials). In
contrast to C. crescentus wild type, ?dgrA and ?dgrB mutants were motile even in the presence of the dgcA
plasmid (Fig. 3A strains). This was not due to a reduction of the c-di-GMP concentration, as cellular levels of c-
di-GMP in these mutants were indistinguishably high (data not shown). At low cellular concentrations of c-di-
GMP, motility phenotypes were not significantly altered in the deletion mutants (data not shown), indicating that
7DgrA and DgrB interact with cell motility primarily at conditions where the level of c-di-GMP is elevated.
Together, these data suggested that the c-di-GMP binding proteins DgrA and DgrB are part of a signal
transduction pathway that interferes with flagellar function in response to increasing concentrations of c-di-
GMP. In agreement with this, overexpression of dgrA or dgrB from a plasmid efficiently blocked motility on
swarmer plates (Fig. 3B) and in liquid media as observed microscopically (data not shown).
Analysis of c-di-GMP binding to the diguanylate receptor by NMR spectroscopy. The available NMR
structure and resonance assignments of the DgrA homolog PA4608 from P. aeruginosa (25) (PDB 1YWU;
BMRB 6514) provided an opportunity to characterize the ligand binding site on a molecular level and to
investigate the structural consequences of ligand binding. PA4608 carrying an N-terminal hexahistidine tag was
produced in uniformly 15N- and 13C-labeled form for NMR spectroscopy. The 1H and 15N chemical shifts
observed for pure PA4608 were in good agreement with those reported in BMRB entry 6514. When c-di-GMP
was added to the protein, 1H-15N-HSQC spectra changed dramatically (supplemental Fig. 8). Free and ligand-
bound PA4608 were in slow exchange on the NMR chemical shift time scale, and titration curves were in
agreement with a KD in the sub-μM range (data not shown). In order to assign resonances of the PA4608*c-di-
GMP complex, exchange (EXSY) spectra were recorded on a roughly 3:1 mixture of free and c-di-GMP-bound
PA4608; exchange within a mixing time of 800 ms was only observed after heating to 313 K. Standard triple-
resonance NMR spectra recorded on PA4608 saturated with c-di-GMP were used to complete the backbone
resonance assignments. No resonances were observed for residues M3-H12 (hexahistidine tag), H22, F33-I36,
G73, I91, E125, L128, and D130-L1381. Probably, these residues are flexible on a μs to ms time scale, and peaks
are broadened beyond detection due to intermediate chemical exchange. Secondary 13C? and 13C? shifts (26)
showed that the secondary structure of PA4608 remained essentially unchanged after ligand binding
(supplemental Fig. 9).
In order to localize the ligand binding site on the protein surface, backbone amide 1H and 15N chemical shifts
of the PA4608*c-di-GMP complex were compared to those of the free protein, and the differences were mapped
1 Residue numbering for PA4608 as in BMRB entry 6514, which differs from that in PDB structure 1YWU by +22, is used
throughout this text.
8on the structure of the free protein (Figs. 5, 8). Large shift differences are found on one face of the ? barrel
(around V58, I63), in the C-terminus (V142, A144), and in the N-terminus (R30-D39). We conclude that c-di-
GMP binds to the outside of the ? barrel close to V58, and that the termini, which are partially flexible in the apo
form, fold around the bound ligand. Presumably the side chain N-H group of W99 forms a hydrogen bond with
the ligand, since the 15N?1 and 1H?1 resonances strongly shift towards higher chemical shifts by 8.24 and 1.66
ppm, respectively.
Due to their distinct chemical shifts (>10.7 ppm), the H1 imino hydrogens of guanine in c-di-GMP could be
identified once the assignment of protein backbone 1HN and tryptophan 1H?1 resonances had been completed.
Since four separate H1 resonances of about equal intensity are observed for c-di-GMP in complex with PA4608,
and each molecule of c-di-GMP contains two guanine bases, c-di-GMP binds to PA4608 as a dimer. Consistent
with the ligand-binding site outlined above, two of these H1 imino resonances show intermolecular NOEs to L64
and W99 (supplemental Fig. 10).
Amide 15N T1 and T2 relaxation times and heteronuclear {
1H}-15N NOEs were measured at 20°C for free and
c-di-GMP-bound PA4608 (data not shown). Isotropic rotational correlation times (?c) were determined from
these data with the program TENSOR (27) as 11.3 and 12.3 ns for free and ligand-bound protein, respectively.
These ?c are in reasonable agreement with values expected for monomeric apo-PA4608 (16.7 kDa, 9.8 ns) and c-
di-GMP-bound PA4608 (18.1 kDa, 10.6 ns). Thus, PA4608 is a monomer before and after ligand binding.
C-di-GMP binding mutants of DgrA are unable to control motility. Alignments of the amino acid sequences
of PA4608, DgrA, DgrB, and YcgR revealed that the key residues that, based on NMR data, were postulated to
be involved in c-di-GMP binding to PA4608, are conserved among other diguanylate receptor proteins (Fig. 6).
To probe the c-di-GMP binding site of DgrA and to define the minimal requirements for c-di-GMP binding,
residues R11, R12, D38, and W75 were replaced with Ala and the mutant proteins were analyzed for c-di-GMP
binding. Mutants R11AR12A and W75A strongly reduce c-di-GMP binding, whereas mutant D38A is still able
to bind c-di-GMP (Fig. 5A). In agreement with this, the binding constant for the D38A mutant was marginally
increased to 740 nM, whereas the KD for the W75A mutant (6.4 μM) was increased 100-1000 fold as compared
to wild type (Table I). Binding of c-di-GMP was completely abolished in the R11AR12A mutant. To analyze the
9importance of c-di-GMP binding for DgrA mediated signaling, the dgrA mutant alleles were tested for
functionality in vivo. As indicated above, overexpression of wild type dgrA renders cells non-motile (Figs. 4B,
6B). In contrast, overexpression of dgrAD38A, dgrAR11AR12A, or dgrAW75A only partially affected motility
(Fig. 5B). In particular, changing W75 to Ala almost completely abolished the ability of DgrA to block motility
under these conditions (Fig. 5B). Similarly, when the dgrAW75A mutant allele was expressed in single copy
from its original chromosomal locus, cells were fully motile even in the presence of the dgcA plasmid, arguing
that DgrAW75A can no longer control motility in response to increased c-di-GMP levels (Fig. 3). We isolated
suppressors that alleviated the dgrA-mediated motility block (see Materials and Methods). One of the intragenic
dms (diguanylate receptor motility suppressors) mutations mapped to V74, in the immediate vicinity of the Trp
residue critical for c-di-GMP binding (Fig. 5B, Fig. 6). Other intragenic dms mutations (D62, G82) mapped to
conserved residues of DgrA, emphasizing the functional importance of these residues (Fig. 6). In conclusion,
these results support the view that ligand binding is essential for the regulatory function of the diguanylate
receptor and suggest that DgrA blocks motility in its c-di-GMP bound state.
Motility control by DgrA correlates with cellular levels of the FliL motor protein. Immunoblot analysis
revealed that overexpression of dgrA or dgrB blocks motility without interfering with the expression of known
class II, class III or class IV components of the flagellar hierarchy (Fig. 3C). Because the expression of each
class of genes depends on the successful expression and assembly of components of the preceding class of the
hierarchy (28), this result suggested that flagella are assembled normally in cells overexpressing dgrA or dgrB.
In agreement with this, flagella were readily observed by electron microscopy in these non-motile cells (data not
shown). The only flagellar protein whose concentration was severely affected in cells overexpressing dgrA was
FliL (Fig. 3C). The C. crescentus fliL gene is not part of the flagellar hierarchy and its product is not assembled
into the flagellar structure (29). However, fliL is required for flagellar rotation (29). To examine if reduced FliL
levels are linked to motility we screened the pool of dms mutants (see above) for extragenic suppressors (see
Materials and Methods). From a total of 120 independently isolated motile suppressors, only one mapped to the
chromosome. This suppressor mutation (dms0541), which mapped to gene CC3587 coding for the ribosomal
protein S1, not only restored motility but also re-established normal levels of FliL (Fig. 3C).
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Discussion:
Motility control by c-di-GMP is implemented through gene expression, organelle assembly, or motor function
(2). In C. crescentus, increased cellular concentrations of c-di-GMP block motility by interfering with motor
function rather than by altering expression or assembly of structural components of the flagellum (13). How are
increased levels of c-di-GMP sensed and how is this information transmitted to the flagellar motor? The data
presented here suggest that DgrA and DgrB are high affinity receptors for c-di-GMP that, in a ligand-bound
form, interfere with the flagellar motor either directly or indirectly. Motor control by DgrA-like proteins is not
unique to Caulobacter. E. coli H-NS mutants lack flagella because the expression of the flagellar master control
operon flhCD is reduced. Ectopic expression of flhCD restores flagellation but leaves the motors partially
paralyzed (24). Under these conditions flagellar function can be restored either by a mutation in ycgR, coding for
the E. coli DgrA homolog, or by providing multiple copies of yhjH, which encodes a presumable c-di-GMP
specific phosphodiesterase (24). Together with our data demonstrating that the Salmonella YcgR protein
specifically binds c-di-GMP, this suggests that in C. crescentus and in enteric bacteria flagellar motor function
might be controlled by c-di-GMP via similar mechanisms.
But how would DgrA or YcgR interfere with the function of the flagellum? Our data propose the FliL
protein as a candidate for such a role. FliL was the only flagellar protein that showed significantly reduced levels
in non-motile cells overexpressing dgrA. In C. crescentus the FliL protein is not part of the flagellar structure but
is required for flagellar rotation (29). Intriguingly, fliL mutant strains exhibit an identical motility phenotype like
cells that have high levels of c-di-GMP or overexpress dgrA (29). Because the expression of fliM, the gene
located immediately downstream of fliL in the same operon (30), was not affected by DgrA, FliL changes must
be the result of altered translation or protein stability. An extragenic suppressor mutation that restored motility
under these conditions also re-established normal FliL concentrations, indicating that the two phenotypes are
linked. The simplest model that is in agreement with these results predicts that DgrA, upon binding of c-di-
GMP, represses FliL by a so far unknown mechanism and through this blocks motor function. The extragenic
suppressor mutation restoring FliL levels was mapped to the coding region of rpsA (ribosomal protein S1). RpsA
enhances translation initiation by binding to mRNA regions upstream of the Shine-Dalgarno sequence and by
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tethering the mRNAs on the 30S subunit of the ribosome (31-33). We are currently investigating how DgrA and
its ligand c-di-GMP modulate FliL levels. Recently, FliL was reported to be involved in surface sensing and
virulence gene expression in the urinary tract pathogen Proteus mirabilis (34). Thus, it is possible that FliL has a
more general role in controlling the switch between a planktonic and a surface-associated lifestyle.
A bioinformatics study originally proposed that the PilZ domain is a specific c-di-GMP binding module
(22). This was recently substantiated by the demonstration that YcgR, a PilZ protein from E. coli, is able to bind
c-di-GMP (23). Here we presented genetic, biochemical, and structural evidence that further validate this
hypothesis and propose a model for ligand binding and activation of proteins containing a PilZ domain. NMR
studies with the DgrA homolog PA4608 showed that a dimer of c-di-GMP binds to a well-defined binding site
on the surface of the ?-barrel (Fig. 4). Large chemical shift differences between free and ligand-bound PA4608,
which indicate changes in the local environment, were also observed in both termini of the protein, with the
largest differences observed for residues R30-R32, V142, and A144. These regions are structurally ill defined in
the absence of ligand (25) and are probably flexible. The observed chemical shift differences indicate that these
regions come in direct contact with the ligand after complex formation. The N-terminal part of PA4608 contains
three consecutive Arg residues, which are conserved in most PilZ domains (22) (Fig. 6). Arg side chains are
likely to be involved in hydrogen bonds or in electrostatic or ? stacking interactions with c-di-GMP, as has been
shown for the allosteric binding site of the diguanylate cyclases PleD and DgcA (15, 35). Furthermore, it is
conceivable that the positively charged head groups of Arg are sufficient for transient binding to the phosphate
groups of c-di-GMP and that their position on the flexible N-terminus increases the ligand capture radius of the
protein, as in the “fly-casting mechanism” proposed in (36). Alternatively, the observed folding of previously
flexible parts of the protein may be responsible for communication of the c-di-GMP signal to downstream
elements, either by forming new interaction surfaces or by determining the relative position of neighboring
domains. Similarly, the chemical shift differences of the C-terminal part of PA4608 could be explained by a
specific role in ligand binding. However, the fact that residues V142 and A144, which showed the largest
chemical shift differences are not conserved, argues against this possibility. Several of the motile dgrA loss of
function suppressors that were isolated had frameshift mutations in the very C-terminus of DgrA (Fig. 6),
suggesting that this part of the protein is critical for its in vivo function. One possibility is that the C-terminus
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contributes to the specific readout mechanism of this protein family. Upon c-di-GMP binding to the ?-barrel
surface, the C-terminus could be untied to interact with downstream components. In accordance with such a
view, the very C-terminus of the P. aeruginosa PilZ protein has recently been proposed to interact with the PilF
protein required for type 4-pilus assembly (37). To complement our picture of the c-di-GMP circuitry, future
studies will have to focus on interaction partners of DgrA and related PilZ domain proteins.
It is intriguing that genetic and biochemical studies of the C. crescentus DgrA protein and structural analysis
of PA4608 from P. aeruginosa identified the same set of key amino acids involved in c-di-GMP binding (Fig.
6). This finding is a strong indication that these proteins bind c-di-GMP in a similar way and suggests that they
may share a common signaling mechanism. Based on these results we postulate that most or all PilZ domain
proteins function as diguanylate receptor proteins.
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Materials and Methods:
Strains, plasmids and media. E. coli strains were grown in Luria Broth (LB). C. crescentus strains were grown
in complex peptone yeast extract (PYE) (38) supplemented with antibiotics, where necessary. For the exact
procedure of strain and plasmid construction see supplemental material.
UV cross-linking with [33P]c-di-GMP, and isolation of DgrA. Procedures for enzymatic production of [33P]c-
di-GMP and, UV cross-linking with [33P]c-di-GMP were published earlier (6, 39). For a detailed protocol used
for the isolation of DgrA see supplemental material.
Preparation of isotope-labeled protein, NMR samples and NMR spectroscopy. The detailed procedures for
overexpression and 13C, 15N- double-labeling of PA4608 are described in supplemental material. NMR samples
(Shigemi microtubes) were prepared as 0.8 mM U-13C/15N-labeled protein in 300 μl 95 % H2O/5% D2O, 250 mM
NaCl, 10 mM DTT, 1 mM sodium azide, 10 mM Tris at pH 7.1. C-di-GMP was added at suitable molar ratios
from a 7.7 mM stock solution. NMR spectra were recorded on Bruker DRX 600 and 800 MHz spectrometers at
293 K (20°C) with the exception of EXSY spectra that were recorded at 313 K for faster exchange. Standard 1D,
2D and 3D spectra were recorded and processed as described elsewhere (40).
Isolation and mapping of motile dgrA suppressors. A plasmid carrying dgrA (pBBR::dgrA) was conjugated
into a C. crescentus recA mutant strain and 150 individual transconjugants were patched onto PYE swarmer
plates. Motile dms (diguanylate receptor motility suppressors) mutants were isolated and analyzed by
immunoblot using an ?-DgrA antibody. Mutants with reduced DgrA levels were discarded. The rest was
analyzed by retransforming plasmids into the recA mutant strain in order to distinguish between intra- and
extragenic suppressors. Intragenic mutations were identified by sequencing.. The extragenic suppressor
(dms0541) was mapped by Tn5 linkage (41) and co-transduction with phage ?CR30, and identified by
sequencing.
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Fig. 1. Isolation of c-di-GMP binding proteins from C. crescentus. A) Coomassie stained SDS-PAGE gel with
protein fractions used for UV-crosslinking with [33P]c-di-GMP. Lane 1: 100.000 ? g supernatant, lane 2: 60%
ammonium sulfate precipitation, lane 3: 0.4 - 0.7 M NaCl eluate from Blue Sepharose®, lane 4: 0.7 - 0.9 M NaCl
eluate from Blue Sepharose® and lane 5: 125 mM NaCl eluate from GTP-sepharose column. B) Autoradiograph
of SDS-PAGE gel shown in A. C-di-GMP binding proteins a, b, and c were identified by MS/MS and their role
in c-di-GMP signaling is under investigation. Protein c was identified by MS/MS as hypothetical protein
CC1599 and was renamed DgrA (Diguanylate receptor protein A).
Fig. 2. DgrA is a member of a novel family of c-di-GMP binding proteins. A) UV crosslinking of purified
hexahistidine-tagged diguanylate receptor proteins with [33P]c-di-GMP. The following proteins were used: DgrA
(CC1599; C. crescentus), DgrB (CC3165; C. crescentus), PA4608 (P. aeruginosa), YcgR (S. typhimurium), and
BSA (control). The Coomassie-stained gel (left) and the autoradiograph (right) are shown. B) UV crosslinking of
10 μM DgrA in the presence of 60 nM of 33P labeled c-di-GMP. Samples were supplemented with increasing
concentrations of non-labeled nucleotides as indicated. Controls carried out in the absence of UV irradiation or
with BSA are shown on the right.
Fig. 3. DgrA and DgrB are involved in motility control by c-di-GMP. Motility behavior of C. crescentus wild
type strain CB15 and mutants are shown on semisolid agar plates. Three different colonies from independent
conjugation experiment are shown. A) The following strains containing plasmid pUJ142::dgcA or control
plasmid pUJ142 were analyzed: CB15/pUJ142::dgcA (a), CB15?dgrA/pUJ142::dgcA (b),
CB15dgrAW75A/pUJ142::dgcA (c), CB15?dgrB/pUJ142::dgcA (d), CB15?dgrA?dgrB/pUJ142::dgcA (e),
CB15/pUJ142 (f). B) Overexpression of dgrA or dgrB from the lactose promoter (Plac) repressed C. crescentus
motility. CB15/pBBR (vector control) (a), CB15/pBBR::dgrA (b), CB15/pBBR::dgrB (c). C) Levels of class II,
class III, and class IV structural components of the C. crescentus flagellum were determined by immunoblot
analysis for the following strains: CB15/pBBR (wild-type), CB15/pBBR::dgrA (DgrA), CB15/pBBR::dgrB
(DgrB) and the extragenic diguanylate receptor motility suppressors CB15dms0541 pBBR::dgrA (dms0541).
The motility behavior of each strain is shown on top of the graph.
18
Fig. 4. Combined amide 1H and 15N shift differences (??) between PA4608 in its free and ligand-bound form.
Shift differences are color-coded on the structure of free PA4608 (PDB 1YWU, model 12). Combined chemical
shift differences were calculated as ?? = sqrt( [ ( ??H )2 + ( ??N / 5)2 ] / 2). These data are also shown in
supplemental Fig. 8. Residue W99 is shown as sticks, and N?1 and H?1 are shown in red to highlight the large ??
value (1.67 ppm) for these atoms.
Fig. 5. C-di-GMP binding and motility control of DgrA mutants. A) UV crosslinking of different DgrA mutant
proteins with [33P]c-di-GMP. Coomassie stained SDS-PAGE (top) and autoradiograph (bottom) with purified
wild-type and mutant DgrA proteins (10 μM). B) Motility behavior of C. crescentus wild type CB15
overexpressing different dgrA alleles. CB15/pBBR::dgrA (a), CB15/pBBR::dgrAR11AR12A (b),
CB15/pBBR::dgrAD38A (c), CB15/pBBR::dgrAV74A (d), CB15/pBBR::dgrAR11AR12AV74A (e),
CB15/pBBR::dgrAW75A (f), CB15/pBBR (vector control) (g). Three different colonies from independent
conjugation experiment are shown.
Fig. 6. Sequence alignment of the c-di-GMP binding proteins DgrA, DgrB, YcgR and PA4608 according to the
PilZ PFAM entry PF07238. The PilZ domain is highlighted in green. DgrA residues shown to be important for
c-di-GMP binding and in vivo function (red) and the positions of intragenic dms suppressor mutations (black) are
highlighted above the alignment. Residues of PA4608 with large chemical shift differences upon c-di-GMP
binding (blue) are indicated below the alignment.
Table I:
Binding constants of diguanylate receptor proteins determined by UV crosslinking with
33P c-di-GMP
Organism Protein KD in nM ?KD
C. crescentus DgrB 132 36
DgrA wt* < 50 14
RR11AA N. D. ** -
D38A 761 149
W75A 6200 496
S. typhimurium YcgR 182 29
P. aeruginosa PA4608 < 50 27
protein concentrations used for binding assay: 50 nM
* wt, wild type
** N.D. not detectable
Table II:
Purification of c-di-GMP binding proteins from C. crescentus CB15 crude extracts
Sample Total yield of protein Total yield of
binding activity
Purification
μg % % fold
100.000 x g supernatant 680.000 100 100 1
60 % (NH4)2SO4 precipitation 323,000 47.5 95 2
BlueSepharose 0.4 - 0.7 M NaCl 10.800 1.59 40 26
BlueSepharose 0.7 - 0.9 M NaCl 7.800 1.15 41 35
GTP Sepharose 125 mM NaCl 24 0.0035 11 3200
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Summary
The GGDEF response regulator WspR couples the chemosensory Wsp pathway to the
overproduction of acetylated cellulose and cell attachment in the niche-specialist Pseudomonas
fluorescens SBW25 wrinkly spreader (WS) genotype. This paper demonstrates biochemical that
WspR is a diguanylate cyclase (DGC), and that DGC activity is elevated in the WS genotype
compared to the ancestral smooth (SM) genotype. The work described uses two distinct
mutagenesis strategies to probe in detail the structure-function relationship of WspR. In the first of
these, short, in-frame stretches of DNA were introduced at positions throughout wspR. In the
second, the amino-acid residues of the RYGGEEF active site motif (A-site) were substituted via
extensive site-specific mutagenesis. The resulting library of wspR mutant alleles was analyzed with
perspective to surface attachment, cellulose production and colony morphology.
Statement of my work
This paper has been developed within a scientific collaboration with the laboratories of P. Rainey
and U. Jenal. Whereas most of the scientific work was done within the scope of the PhD thesis of
J. Malone, I contributed to this paper by synthesizing and providing [33P] labeled c-di-GMP as
reference compound and by performing and teaching the procedure of DGC activity assays with
His-tag purified WspR and various Pseudomonas fluorescens mutant strains (see figure 1).
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Summary  1
The GGDEF response regulator WspR couples the chemosensory Wsp pathway to the 2
overproduction of acetylated cellulose and cell attachment in the niche-specialist 3
Pseudomonas fluorescens SBW25 wrinkly spreader (WS) genotype. Here we show that 4
WspR is a diguanylate cyclase (DGC), and that DGC activity is elevated in the WS genotype 5
compared to the ancestral smooth (SM) genotype. A structure-function analysis of 120 wspR6
mutant alleles was employed to gain insight into the regulation and activity of WspR. Firstly, 7
44 random and defined pentapeptide insertions were produced in WspR, and the effects 8
determined using assays based on colony morphology, attachment to surfaces and cellulose 9
production. The effects of mutations within WspR were interpreted using a homology model, 10
based on the crystal structure of Caulobacter crescentus PleD. Mutational analyses indicate 11
that WspR activation occurs as a result of disruption of the interdomain interface, leading to 12
the release of effector domain repression by the N-terminal receiver domain. Quantification of 13
WspR variant function suggests that regulation of cellulose production and surface attachment 14
proceed via two separate pathways. The conserved RYGGEEF motif of WspR was also 15
subjected to mutational analysis and the effects of 76 single amino acid residue substitutions 16
tested for their effects on WspR function. The RYGGEEF motif of WspR is functionally 17
conserved, with almost every mutation abolishing function. 18
19
20
21
22
23
24
25
26
27
28
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Introduction 1
Investigations into the regulation of surface colonization and aggregative behaviour in 2
prokaryotes have established the central role of the second messenger cyclic-di-GMP (c-di-3
GMP) (Jenal, 2004; D’Argenio & Miller, 2004; Römling et al., 2005). Though the biological 4
pathways through which c-di-GMP regulates persistence, cell aggregation and the switch to 5
the commensal lifestyle are currently poorly understood, the proteins responsible for c-di-6
GMP synthesis and degradation have been determined, and at least partially characterised. 7
Bacterial di-guanylate cyclase (DGC) activity is found in GGDEF domain-containing proteins 8
(Paul et al., 2004; Ryjenkov et al., 2005; Hickman et al., 2005; Kulesekara et al., 2006), 9
whilst EAL domains have been shown to have c-di-GMP-specific phosphodiesterase (PDE) 10
activity (Bobrov et al., 2005; Christen et al., 2005; Schmidt et al., 2005; Kulesekara et al.,11
2006).  12
13
Despite the publication of much biological data concerning GGDEF domains, biochemical 14
demonstration of DGC activity (Paul et al., 2004; Ryjenkov et al., 2005), and the solution of 15
the crystal structure of the GGDEF response regulator PleD (Chan et al., 2004), detailed 16
structure-function analyses of GGDEF proteins are scarce. Site-specific mutagenesis studies 17
to date have focussed on single residues of interest (Kirillina et al., 2004; Garcia et al., 2004; 18
Goymer et al., 2006), and systematic mutagenesis has yet to be described. Such analyses 19
stand to contribute insights into various issues, including the role of the GGDEF motif, the 20
mode of activation of individual GGDEF proteins, and potential alternative mechanisms of 21
downstream signal transduction.  22
23
The GGDEF domain was first recognised in PleD, a response regulator responsible for 24
mediating the swarmer-to-stalked cell transition in Caulobacter crescentus (Hecht & Newton, 25
1995), and has since been identified in large numbers in many bacterial species (Galperin et26
al., 1999; 2001; Galperin, 2005). GGDEF domains are often associated with receiver, PAS 27
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and GAF sensor domains, and are frequently paired with EAL domains (Galperin et al.,1
2001).  2
3
Numerous studies in diverse species have linked GGDEF domain proteins to processes 4
involved in biofilm formation and aggregative behaviour (reviewed in Römling, 2005; 5
Römling et al., 2005). The effects of GGDEF proteins on exopolysaccharide levels have been 6
probed via genetic studies in numerous species, including Pseudomonas putida (Gjermansen 7
et al., 2005; Ude et al., 2006), P. fluorescens SBW25 (Spiers et al., 2002; 2003; Goymer et8
al., 2006; Ude et al., 2006), Salmonella typhimurium (Simm et al., 2004; Garcia et al., 2004; 9
Simm et al., 2005), Thermotoga maritima (Johnson et al., 2005), and Vibrio cholerae 10
(Bomchil et al., 2003; Rashid et al., 2003; Kovacikova et al., 2005). 11
12
In addition, GGDEF-containing proteins have been repeatedly implicated in the regulation of 13
cell motility, attachment and virulence (reviewed in Jenal, 2004; D’Argenio & Miller, 2004; 14
Römling, 2005). For example, PleD controls the onset of motility during the C. crescentus15
cell cycle (Aldridge et al., 2003; Paul et al., 2004). In Pseudomonas aeruginosa, auto-16
aggregation is controlled by the GGDEF response regulator WspR (D’Argenio et al., 2002; 17
Hickman et al., 2005), and twitching motility by FimX, which contains GGDEF and EAL 18
domains (Huang et al., 2003; Kazmierczak et al., 2006). Additional examples of the effects of 19
GGDEF domains on cell attachment and motility include ScrC regulation of attachment 20
factors in Vibrio parahaemolyticus (Boles & McCarter, 2002), control of curli fimbriae by 21
AdrA in S. typhimurium (Simm et al., 2004), and RocS effects on V. cholerae motility 22
(Rashid et al., 2003). A recent survey of all GGDEF-containing genes in P. aeruginosa PA14 23
showed that in several cases over-expression or inactivation had profound effects on cell 24
attachment to surfaces and virulence (Kulesekara et al., 2006).25
26
The GGDEF response regulator WspR was initially discovered as a consequence of 27
investigation into the genetic causes of adaptive radiation in experimental populations of P.28
Malone et al. 2006 
5
fluorescens SBW25 (Rainey & Travisano, 1998; Spiers et al., 2002). One class of derived 1
genotype colonises the air-liquid interface of static broth microcosms: these genotypes 2
produce distinctive wrinkled colonies on agar plates and are termed wrinkly spreaders (WS). 3
Transposon mutagenesis was used to identify genes that determine WS phenotype, focussing 4
initially on a single WS genotype, the LSWS genotype. Two major gene clusters were 5
identified: the wrinkly spreader structural (wss) and wrinkly spreader phenotype (wsp)6
operons (Spiers et al., 2002; Goymer et al., 2006). The wss operon encodes proteins involved 7
in cellulose synthesis and acetylation (Spiers et al., 2002; 2003), whilst the wsp operon 8
encodes a chemosensory system with homology to the chemotaxis system of Escherichia coli9
(P.B. Rainey, E. Bantinaki, R. Kassen, C.G. Knight, Z. Robinson & A.J. Spiers, unpublished).  10
11
WspR is the final gene product, and primary output component of the Wsp pathway, and is 12
activated by a currently unknown signal processed by the rest of the Wsp complex (Spiers et 13
al. 2002). A wspR::mini-Tn5 WS mutant displays a smooth colony morphology (Spiers et al.14
2002), and does not produce cellulose or attach to surfaces (Spiers et al. 2003). Expression of 15
wspR in trans stimulates attachment and exopolysaccharide synthesis in various species 16
(Aldridge et al., 2003; Goymer et al., 2006; Ude et al., 2006). The evolutionary cause of 17
LSWS is a single point mutation in the gene encoding the WspF methylesterase which results 18
in over-activation of the WspE kinase and constitutive activation of the primary output 19
component of the Wsp pathway, WspR (P.B. Rainey, E. Bantinaki, R. Kassen, C.G. Knight, 20
Z. Robinson & A.J. Spiers, unpublished). 21
22
P. fluorescens SBW25 WspR is a 333 residue protein comprising an N-terminal response 23
regulator receiver domain and a C-terminal GGDEF domain separated by a linker region 24
(Spiers et al., 2002; 2003). Recently, a combination of random and site-specific mutagenesis 25
was used to outline basic physical characteristics of WspR (Goymer et al., 2006). Asp 67 was 26
established as the site of WspR phosphorylation, and WspR activation was shown to be 27
dependant upon phosphorylation. In addition, constitutively-active (e.g. WspR 19 (R129C), 28
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D’Argenio et al., 2002; Aldridge et al., 2003) and dominant-negative (e.g. WspR 9 (G296R)) 1
wspR alleles were identified. A model was proposed to explain the dominant-negative effect 2
seen upon the production of certain WspR variants. In this model, N-terminal receiver 3
domains without functional C-termini competitively inhibited the interaction of 4
chromosomally-expressed WspR with the Wsp kinase machinery, and hence ameliorated the 5
downstream signal (Goymer et al., 2006).  6
7
The work described here expands on the findings of Goymer et al. (2006), employing two 8
distinct mutagenesis strategies to probe in detail the structure-function relationship of WspR. 9
In the first of these, short, in-frame stretches of DNA were introduced at positions throughout 10
wspR. In the second, the amino-acid residues of the RYGGEEF motif were substituted via11
site-specific mutagenesis. Following mutagenesis, phenotypic assays were applied to the 12
libraries of wspR mutant alleles. Morphological analysis and assays for surface attachment 13
and cellulose production were carried out on SBW25 strains expressing the wspR insert and 14
substitution libraries in trans, allowing for qualitative, quantitative and in silico analysis of 15
WspR. These data, combined with biochemical analyses of cell extracts and purified protein, 16
were used to revise and expand upon models for the structure-function relationship of WspR. 17
More broadly, these models were applied to our understanding of both response regulators 18
and GGDEF domain-containing proteins. 19
20
21
22
23
24
25
26
27
28
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Methods 1
Strains and growth conditions 2
Bacterial strains used in this work are listed in Table 3. Bacteria were grown in either KB or 3
LB media (King et al., 1954; Miller 1972) at 28 °C (P. fluorescens) or 37 °C (E. coli) with 4
shaking. KB microcosms contained 6ml KB in 35ml universal glass vials and were used for 5
attachment and growth assays. Kanamycin was used at a final concentration of 50 μg ml-1,6
Streptomycin at 100 μg ml-1 and Tetracycline at 12.5 μg ml-1. Oligonucleotide primers used in 7
this work are listed in Table S3. 8
9
Molecular biology procedures 10
Cloning was carried out in accordance with standard molecular biology techniques 11
(Sambrook et al., 1989). The plasmid pME6010-wspR was constructed by ligation of wspR12
excised as a BamHI/EcoRI fragment from pWspR12 (Aldridge et al., 2003) between the BglII13
and EcoRI sites of pME6010 (Heeb et al., 2000), destroying the BglII site in the process. The 14
plasmid pET42b-wspR was constructed by ligation of the relevant wspR PCR fragment 15
(amplified with primers WspRPurFor and WspRPurRev from pME6010-wspR), between the 16
XhoI and NdeI sites of pET42b (Novagen). 17
18
Over-expression and purification of His6-WspR 19
Overnight cell cultures of E. coli BL21-(DE3) containing pET14b-wspR and pET42b-wspR20
were used to inoculate LB medium plus ampicillin, to an initial OD600 of 0.1. Cell cultures 21
were incubated for 150 min at 37 °C with shaking before protein expression was induced with 22
IPTG (Sigma) solution at a final concentration of 100 μM for pET14b-wspR, 1 mM for 23
pET42b-wspR. Cell cultures were then incubated for an additional 150 min at 30 °C. Cells 24
were harvested by centrifugation and re-suspended in running buffer (25 mM Tris-HCl pH 25
8.0, 250 mM NaCl, 1 % ?-mercaptoethanol), before lysis by sonication and French press. 26
Following lysis, the samples were centrifuged (30,000 x g, 15 min, 4 °C) and His6-WspR 27
purified from the supernatant via NTA-nickel chromatography according to the 28
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manufacturer’s protocol (Qiagen). Both His6-WspR samples eluted in the 200 mM imidazole 1
fraction, and N-terminal His6-WspR was verified by mass spectrometry. The protein 2
concentration of samples was determined after Bradford (1976) [N-terminal His6-WspR 1.6 3
mg ml-1, C-terminal His6-WspR 5.0 mg ml-1].4
5
Western blotting 6
Overnight cell cultures were lysed by incubation (95 °C, 5 min) with 1 volume SDS loading 7
buffer (10 mM Tris-HCl pH 6.8, 0.005 % bromophenol blue, 10 % glycerol, 2 % SDS). 8
Proteins from the resulting cell extracts were separated on pre-poured 12 % Tris-HCl gels 9
(BioRad) and blotted onto polyvinylidene difluoride (PVDF) membranes (Millipore). After 10
overnight incubation in blocking solution (15 mM Tris-HCl pH 7.0, 10 mM KCl, 10 mM 11
NaCl, 0.01 % Tween20, 10 % glycerol, 5 % milk powder), WspR was detected with a 1/2,500 12
dilution of WspR-specific polyclonal antiserum (Harlan Seralabs) and a 1/3,000 dilution of 13
anti-rabbit secondary antibody (Invitrogen). Bound antibodies were visualized with ECL 14
Chemiluminescent detection reagent (Amersham Biosciences) and photographic film. 15
16
Assay for DGC activity 17
Di-guanylate cyclase activity was assayed after Paul et al. (2004). Overnight cultures were 18
grown of SBW25 strains, cells were harvested, re-suspended in running buffer and partially 19
lysed by gentle sonication. Assays were run in 50 μl (final volume) of running buffer 20
containing 10 μl cell extract or purified WspR and started by the addition of (final 21
concentration) 100 μM GTP [18.5 kBq ?32P-GTP] (Amersham Biosciences). Retardation 22
Factor (RF) values were recorded as the ratio of spot migration distance to the distance 23
migrated by the solvent front. 24
25
Polymerase chain reaction (PCR) 26
A standard reaction contained 5 μl 2 mM dNTP mix, 2.5 μl 10x polymerase buffer, 1 U Pfu27
turbo polymerase (Stratagene), 0.4 pmol of each primer, and 10-20 ng template DNA, made 28
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up to 25 μl with deionised water. Following an initial template denaturation step of 3 min at 1
94 °C, amplification was performed by 25 cycles of denaturation for 30 sec at 94 °C, 2
annealing for 30 sec at the appropriate temperature (56 °C – 62 °C depending on the reaction) 3
and strand extension for 1 min 30 sec at 72 °C. A final extension step for 5 min at 72 °C was 4
performed before samples were kept at 4 °C. 5
6
Pentapeptide scanning mutagenesis (PSM) 7
PSM was used to insert 15 base-pair sections of DNA into pME6010-wspR after the method 8
of Hallet et al. (1997), except that a morphological screen was used for transposon insertions 9
in wspR. P. fluorescens WS-4 (WS wspR::miniTn5) was transformed with pooled pME6010-10
wspR::Tn4430 DNA and transformant colonies exhibiting a smooth morphology were 11
selected. These colonies contained constructs unable to complement WS-4; hence they 12
contained transposon insertions in wspR. Following mutagenesis, the site of insertion in each 13
case was verified by sequencing. 14
15
Strand overlap extension PCR (SOE-PCR) 16
SOE-PCR (Ho et al., 1989) was used during the systematic mutagenesis of wspR. DNA on 17
either side of the point of mutation was amplified by a standard PCR reaction with primers 18
SOEFor/Rev 1-25 that complemented at the site for joining (and containing the altered 19
nucleotide sequence). PCR products were purified and 1 μl of each used as templates in the 20
subsequent SOE-PCR reaction. The SOE-PCR reaction was carried out with primers 21
SOEFOR and SOEREV in a final volume 25 μl. Following an initial template denaturation 22
step of 3 min 30 sec at 94 °C, strand extension was carried out in two steps; primer annealing 23
for 30 sec at 56 °C followed by extension for 2 min at 72 °C. DNA was then amplified under 24
the conditions described for the standard PCR protocol, with annealing at 56 °C for 30 sec. 25
SOE-PCR fragments were confirmed by sequencing and ligated between the XhoI and EcoRI 26
sites of pME6010. 27
28
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Degenerate PCR-based mutagenesis 1
In order to efficiently mutagenise the GGEEF motif of wspR, an upstream restriction site was 2
required. This allowed mutagenesis to proceed via PCR with degenerate primers, and reduced 3
the size of the inserts produced from 1 kb to approximately 300 bps (the region of wspR DNA 4
between the introduced site and the downstream EcoRI site). A SacI restriction site 5
(GAGCTC, coding for E-L) was introduced at positions 339/240 of wspR via SOE-PCR with 6
primers SacIFor and SacIRev. PCR was carried out using the degenerate primers DEG1-14 7
with the primer SOEREV, and pME6010-wspR-SacI as a template. PCR products were 8
ligated as a pool between the SacI and EcoRI sites of pME6010-wspR-SacI. SM cells were 9
transformed with the pooled constructs and colony morphology on LB agar determined. 10
Individual colonies were selected on the basis of morphology and the substituted codon in 11
each case verified by sequencing. 12
13
DNA sequencing 14
A 50-100 ng aliquot of plasmid DNA was mixed with 1 pmol of primer SeqFor or SeqRev 15
and 4 μl Big-Dye ready reaction mix version 3.0 (ABI), in a final volume of 10 μl. Samples 16
were thermocycled for 25 cycles of 10 sec at 96 °C, 5 sec at 50 °C, and 4 min at 60 °C before 17
cooling to 4 °C. Following the reaction, samples were ethanol precipitated and submitted for 18
sequence analysis on an ABI 3100 sequencer.  19
20
Measurement of overnight culture cell density  21
Assays for attachment and cellulose production described below were inoculated with 24 hour 22
cell cultures. Accordingly, the effects of WspR variants on SM culture growth were 23
measured. KB microcosms inoculated with 60 μl aliquots of overnight cultures, and with the 24
lids loosely taped in place were incubated at 28 °C with shaking. All cultures displayed 25
similar optical densities (OD600) after 24 hours growth. A Spectronic-20 spectrometer 26
(Genesys) was used throughout. 27
28
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Attachment assay 1
Bacterial attachment was determined quantitatively using Crystal Violet (CV) after Spiers et2
al. (2003). KB microcosms were inoculated with 60 μl aliquots of overnight cultures and 3
incubated statically at 28 °C for 48 h. Vials were emptied and washed vigorously with 4
deionised water. 1 ml of 0.05% (w/v) CV (Sigma) was added and mixed for two minutes. The 5
vials were then emptied and washed with deionised water. CV was eluted in 5 ml ethanol with 6
vigorous shaking for 1 h and the A570 determined. 7
8
Congo Red (CR) binding assay 9
Cellulose expression was measured using a CR binding assay adapted from Spiers et al.10
(2003). Ten μl drops of overnight cultures were grown on 25 ml KB agar plates for 24 hours 11
at 28°C. Colonies were re-suspended in 1 ml 0.005% (w/v) CR (Sigma) and incubated for 2 h 12
at 37°C. Colony material was then pelleted by centrifugation. The amount of CR remaining in 13
the supernatant was determined by measurement of A490 and comparison with appropriate CR 14
standards. CR binding was expressed as a fraction of the CR bound by the control strain.   15
16
Homology modelling 17
BLAST (Altschul et al., 1997) was used to align the primary sequence of WspR and the 18
monomeric structure of Caulobacter crescentus PleD (Chan et al., 2004, PDB code 1w25B). 19
Twenty-two residues were deleted from the sequence of WspR and gaps were added where 20
necessary to give the optimum alignment (Figure S1), which was then used as a template for 21
SwissModel analysis (Schwede et al., 2003). The resulting WspR homology model was 22
visualised and manipulated using DeepView / Swiss PDB Viewer v3.7 (Guex & Peitsch 23
1997). The reliability of the homology model was assessed by comparison of the predicted 24
secondary structures of WspR and PleD to the known secondary structure of PleD (Chan et25
al., 2004) using PROFsec from the Predict Protein database (Rost et al., 2004). 26
27
28
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Results 1
WspR functions as a diguanylate cyclase (DGC) in vitro and enzymatic activity is 2
increased in a WS background 3
N- and C-terminal His6-tagged WspR were over-expressed in E. coli BL21-(DE3) and 4
purified from cell extracts using NTA-Nickel affinity chromatography. For purification of N-5
terminal His6-WspR (molecular weight 39.1 kilo Daltons (kDa)), the major eluted band 6
corresponded unambiguously to WspR when tested by mass spectrometry (data not shown). 7
The smaller, minor band (35 kDa) seen in Figure 1(c) also corresponded to WspR and is 8
likely to be a degradation fragment of WspR. 9
10
N-terminal His6-WspR was supplied to Harlan Seralabs for generation of a WspR-specific 11
polyclonal antiserum. Western blotting with this antiserum was then used to provide a 12
qualitative comparison of relative WspR expression levels in the (wild type) SM and WS 13
genotypes. A sample of purified N-terminal His6-tagged WspR was included as a control (Fig. 14
1c). Approximately equal amounts of WspR were detected in SM and WS cell lysates, 15
supporting the hypothesis that the WS wrinkled phenotype does not arise primarily as the 16
result of WspR over-expression, in agreement with previous observations (Spiers et al.,17
2002). 18
19
Given the sequence homology (74 % identity) between SBW25 and P. aeruginosa PA01 20
WspR (recently shown to function as a DGC (Hickman et al., 2005)) and the fact that WspR 21
R129C complements PleD activity in C. crescentus (Aldridge et al., 2003), it was reasonable 22
to assume that WspR is a DGC, catalyzing the formation of c-di-GMP from two molecules of 23
GTP. Nevertheless, it was important to independently verify DGC activity for SBW25 WspR. 24
N- and C-terminal His6-WspR was assayed for DGC activity after the method of Paul et al.25
(2004). Radio-labelled GTP was incubated with purified His6-WspR, and samples removed at 26
regular intervals. When the nucleotide samples were separated by TLC, a spot corresponding 27
to c-di-GMP was generated over time by His6-WspR, determined by comparison with a c-di-28
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GMP control sample (Christen et al., 2005) (Fig. 1a). The low rate of c-di-GMP formation 1
suggests that conditions in this assay were sub-optimal for enzyme activity. No DGC activity 2
was detected for N-terminal His6-WspR (data not shown), possibly as a result of disruption of 3
the active state by the His6-tag, similar to that seen for N-terminal His6-PleD (R. Paul and U. 4
Jenal, personal communication). 5
6
To investigate the effects of the WS background on WspR DGC activity, cell extracts from 7
overnight cultures of SM, WS, and isogenic strains lacking WspR (SM ?wspR and WS 8
?wspR), and containing pME6010 and pME6010-wspR as indicated, were assayed for DGC 9
activity (Fig. 1b) in the same way as above. A slow running spot corresponding to c-di-GMP 10
was generated in WS cell lysates expressing wspR both from pME6010 and from the 11
chromosome. No c-di-GMP was seen in any other samples. Hence, the WS cell extract 12
activates WspR DGC activity, whereas the SM cell extract does not.  13
14
Mutagenesis of WspR 15
Nineteen wspR mutant alleles were produced by Pentapeptide Scanning Mutagenesis (PSM), 16
(Hallet et al., 1997), (see supplemental Table S1). The five amino acid residue insert resulting 17
from PSM differs among mutants depending on the specific site of Tn4430 insertion into 18
wspR. Hovever, the disruption to protein tertiary structure caused by the insertion of five 19
amino-acids into the protein was considered likely to outweigh any effects caused by 20
variation in the amino-acid sequence of the insert, and this latter difference was discounted 21
(Hayes & Hallet 2000).  22
23
To complement the PSM variants and fully mutagenise wspR, strand-overlap-extension PCR 24
(SOE-PCR), (Ho et al., 1989) was used to introduce 25 GVPTK insertions at specific 25
positions throughout wspR (supplemental Table S2). The resulting library (44 variants) 26
contained approximately one insert for every seven to eight amino-acid residues of WspR, 27
Malone et al. 2006 
14
ensuring a high probability of disrupting most elements of secondary structure present in the 1
protein. 2
3
To determine whether soluble protein was expressed from each pME6010-wspR mutant 4
allele, all alleles were expressed separately in SM ?wspR, to allow WspR produced from 5
pME6010 to be detected by Western blotting. Forty wspR mutant alleles produced detectable 6
amounts of protein, but no WspR was detected for variants with inserts at residue positions 7
99, 182, 246 and 264 (data not shown), suggesting either that an undetectably small amount 8
of WspR was present in each case, or that these variants produced highly unstable protein that 9
was rapidly degraded during sample preparation. However, when expressed in WS these four 10
variants ameliorated the wrinkled colony morphology (see below): given clear phenotypic 11
effects these alleles were included in subsequent analyses. 12
13
Phenotypic characterisation of WspR variants 14
The WspR variants may be divided into several functional classes; inactive, signal-dependent 15
(i.e. wild type), signal independent (i.e. dominant or constitutively-active) and dominant-16
negative. When wild-type wspR is expressed in trans in the ancestral SM genotype it causes 17
development of the WS phenotype. By extension, the activity states of different WspR 18
variants may be distinguished by their effects in different SBW25 backgrounds (Goymer et 19
al., 2006). Because WspR is activated by the WspE kinase, (P.B. Rainey, E. Bantinaki, R. 20
Kassen, C.G. Knight, Z. Robinson & A.J. Spiers, unpublished) development of WS 21
morphology in strains lacking the wsp operon (e.g. SM ?wspA-wspF) indicates the presence 22
of constitutively-active WspR. In cases where a WS morphology develops in the presence of 23
the Wsp machinery (e.g. in SM) but not in a wsp deletion background the protein is signal-24
dependent and behaves like wild-type WspR. Inactive proteins have no effect in any SBW25 25
genotype, whilst dominant-negative WspR variants produce a smooth morphology in the WS 26
genotype. Potential interactions between WspR variants and chromosomal WspR may be 27
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investigated by expanding the morphological analysis to include wspR deletion strains (e.g. 1
SM ?wspA-wspR and SM/WS ?wspR).2
3
To fully distinguish between all possible activity states, the wspR insert alleles were 4
expressed in several SBW25 backgrounds: SM, WS, SM ?wspA-wspF, SM ?wspA-wspR, SM 5
?wspR, and WS ?wspR and their effects on colony morphology were determined. In general, 6
changes in colony morphology conformed to predictions, and allowed one to assign one of the 7
four activity states described previously to every tested WspR variant (Table 1, and Figure 2). 8
Morphological analysis provided no evidence for interactions between WspR variants and 9
chromosomal WspR; little morphological difference was seen upon WspR production in SM 10
versus SM ?wspR, or SM ?wspA-wspF versus SM ?wspA-wspR.11
12
The activation states of the WspR variants correlated with the positions of the inserts 13
throughout WspR. N-terminal variants displayed all four states, whilst linker variants were all 14
constitutively-active, and C-terminal variants were either dominant-negative or inactive. 15
Several WspR variants (marked with an asterisk in Table 1) produced a wrinkled morphology 16
in WS ?wspR, but had no effect in other tested strains. Whilst these variants appeared to have 17
some residual activity, they were classed as inactive for the purposes of further analysis.  18
These variants suggested that recovery of the WS phenotype was significantly simpler than 19
generation of a wrinkled morphology in the SM genotype.  20
21
The emerging model of WspR function was refined through analysis of the effects of WspR 22
variants on different aspects of biofilm formation. WspR is known to be essential for the 23
enhanced levels of attachment seen in the WS (Spiers et al., 2003). Therefore, the effect of 24
wspR mutant allele expression on attachment in SBW25 strains was measured using a 25
quantitative Crystal Violet assay (Figure 3). To distinguish between the effects of 26
constitutively-active and signal-dependent variants on attachment, the assay was repeated in 27
SM and SM ?wspA-wspR backgrounds. 28
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1
Variations in bacterial attachment corresponded well with the changes seen in colony 2
morphology. Specifically, constitutively-active WspR variants (e.g. WspR138) produced 3
raised levels of cell attachment in both tested backgrounds, relative to the plasmid-only 4
control. Signal-dependent variants produced enhanced levels of attachment in SM only (e.g. 5
WspR6). Insertions in the N-terminus (residues 1-130) and in the linker region of WspR 6
(residues 131-163) produced active or constitutively-active proteins, with corresponding 7
increases in cell attachment. Insertions in the C-terminus (residues 164-333) eliminated WspR 8
function, and these variants did not affect cell attachment. Several variants produced greatly 9
enhanced levels of attachment compared with wild-type WspR. 10
11
To determine whether the close correlation between attachment and colony morphology also 12
applied to cellulose production, the effects of WspR variants on cellulose production in SM 13
were determined quantitatively using a Congo Red (CR) binding assay after Spiers et al.14
(2003) (Figure 4). [In addition, the presence or absence of cellulose in each sample was 15
determined qualitatively by staining with Calcofluor (CF)(Sigma). No major discrepancies 16
emerged between cellulose seen upon CF staining, and the results of the CR assay (data not 17
shown)]. In general, increased cellulose production relative to SM pME6010 was seen for 18
those strains displaying WS colony morphology in SM (Table 1). High levels of cellulose 19
production (relative to the SM pME6010-wspR control) were observed for several N-terminal 20
and linker region variants, whilst C-terminal variants did not affect cellulose production. The 21
CR assay results were then compared with the results for attachment in the SM genotype. 22
Several variants were identified that strongly up-regulated cell attachment, but did not effect a 23
corresponding large increase in cellulose production (e.g. WspR6), suggesting that WspR 24
may regulate these two systems via distinct and separable mechanisms. 25
26
The solution of the crystal structure of PleD from C. crescentus (Chan et al., 2004) made 27
possible the use of homology modelling software to produce a putative three-dimensional 28
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structure for WspR (Figure 5). The PleD structure contains two response regulator receiver 1
domains and a C-terminal GGDEF domain, which has a similar fold to the adenylyl cyclase 2
catalytic domain (Zhang et al., 1997), consistent with the earlier predictions of Pei & Grishin 3
(2001). WspR shares significant sequence homology with PleD across the second response 4
regulator receiver (R2) and GGDEF (DGC) domains, and the PleD and WspR DGC domains 5
are functionally interchangeable in C. crescentus (Aldridge et al., 2003). Therefore, the PleD 6
crystal structure represented the best candidate upon which to base the model. The completed 7
homology model was then used to refine the structure-function models of WspR. The 8
insertion positions of the N-terminal and linker region WspR variants were mapped onto the 9
WspR homology model (Figure 5), and the relationship between each insert’s position and its 10
effect on function was analysed.  11
12
The GGEEF motif of WspR is functionally conserved 13
As a final extension of the structure-function analysis of WspR, single amino-acid residue 14
substitutions throughout the GGEEF motif, and the preceding two residues RY (residues 246-15
252) were produced and analysed. To allow for simple, high throughput mutagenesis, a WspR 16
variant (WspR-SacI, containing the substitutions R239E and P240L) was selected for use in 17
the substitution mutagenesis. Analysis of colony morphology and biofilm formation indicated 18
that WspR-SacI activity was similar to that of wild-type WspR (Figure 6). Substitution 19
variants were produced as a random pME6010-wspR-SacI plasmid pool in which all residue 20
substitutions (except tryptophan) were possible throughout RYGGEEF. This pool was used to 21
transform SM, and WspR substitution variants were recovered and checked. In total, 76 22
different WspR substitution variants were isolated. Seventy-five of these were from colonies 23
displaying smooth colony morphology (i.e. those in which the WspR variant was no longer 24
active) (Table 2). One additional variant, WspRE250D, produced a wrinkled colony 25
phenotype in SM, suggesting that the protein was active in this case. 26
27
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Twenty-one WspR substitution variants were selected for further characterisation on the basis 1
of the side chain chemistry of the substituted residues. Firstly, the effects of WspR variant 2
production on WS colony morphology were analysed, and used to predict their activity states 3
as described previously. All but one of the WspR variants, WspRY247F, produced smooth 4
colony morphology in WS, indicating dominant-negative activity. WspRY247F was classed 5
as inactive. Given that most of the tested proteins produced a dominant negative phenotype, 6
quantitative analysis was used to investigate the properties of this phenotype. Therefore, 7
assays for cellulose production and attachment were undertaken in the WS genotype. 8
WspRY247F did not repress WS cellulose production, in contrast with the other substitution 9
variants. Finally, none of the WspR variants significantly reduced WS attachment levels 10
(Figure 6), providing additional support for the hypothesis that attachment and 11
exopolysaccharide production are regulated separately by WspR. 12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
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1
Discussion 2
A systematic biological and biochemical analysis was undertaken of the GGDEF domain-3
containing protein, WspR, in order to address several unanswered questions concerning 4
GGDEF proteins in general, and WspR in particular. Firstly, biochemical analysis was carried 5
out on purified WspR and on SBW25 cell extracts. WspR was shown to function as a DGC6
(Figure 1a, 1b), and the WS phenotype was shown to stimulate WspR DGC activity in cell 7
extracts, in proportion to the level of WspR present. This provided a definite mechanism for 8
WspR function, and indicates that the WS phenotype arises (at least in part) as the result of 9
increased levels of WspR activation and concomitant c-di-GMP production. 10
11
Secondly, to probe the mechanisms of WspR activation and regulation, systematic 12
mutagenesis was used to disrupt WspR at positions throughout its length. The effects of the 13
resulting WspR insert library on SBW25 colony morphology, attachment and cellulose 14
production were analysed, and used to determine the activity state of the various WspR 15
variants. Several distinct observations were made of the relationship between WspR activity 16
and insert position. Firstly, inserts in the C-terminus (residues 164-333) of WspR always 17
eliminated enzymatic activity. Whilst several insertions in the N-terminus also eliminated 18
enzymatic function, the same sensitivity to mutation was not seen in the domain as a whole. 19
Secondly, a number of constitutively-active WspR variants were found with insertions in the 20
N-terminus (residues 1-130), and insertions in the linker region (residues 131-163) produced 21
constitutively-active enzymes in every case (Figure 4). To our knowledge, WspR is the only 22
GGDEF protein for which a comprehensive structure-function analysis of this kind has been 23
undertaken. 24
25
Detailed structure-function analysis provides significant insight into the means of protein 26
regulation, and in this case allowed the construction of a model for WspR activation (Figure 27
7). In this model, the C-terminal effector domain is inhibited in the inactive state by the N-28
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terminal domain. Regulation through effector domain inhibition occurs in a number of 1
response regulators including E. coli NarL (Baikalov et al., 1996; Eldridge et al., 2002) and 2
S. typhimurium CheB (Djordjevic et al., 1998). Phosphorylation (Figure 7a), or mutation of 3
the N-terminal domain (Figure 7b) leads to the release of inhibition. This model expands on 4
the observations of Goymer et al. (2006), who noted that mutations in or near the linker 5
region of WspR mimicked the phosphorylated state of the protein. Biochemical (Ryjenkov et 6
al., 2005) and structural (Chan et al., 2004) evidence suggests that DGCs function as dimers. 7
Whilst this study provides no direct evidence for WspR dimerisation, it is reasonable to 8
assume that activation is accompanied by dimerisation. In this case, disruption of the inactive 9
form of the protein might lead to exposure of the dimer interface, and hence activation 10
(Figure 7b). These data do not rule out the possibility of an alternative activation mechanism, 11
where the phosphorylated N-terminal domain stabilizes the DGC activated conformation. 12
However, it is unlikely that the precise interactions required by such a mechanism would be 13
reproduced by every activating insertion tested, strongly suggesting that the mechanism of 14
WspR activation proceeds via release of effector domain repression. 15
16
A number of insertions produced a dominant-negative phenotype. In these cases, the activity 17
of either the Wsp or Wss machinery was adversely affected by trans-expressed wspR mutant 18
alleles. This dominant-negative phenotype could arise as a consequence of competitive 19
inhibition of the Wsp signalling machinery by inactive WspR variants, in agreement with the 20
model proposed by Goymer et al. (2006) for suppression of the WS wrinkled morphology by 21
the isolated WspR N-terminus. Alternatively, inactive heterodimers, formed between inactive 22
WspR variants and chromosomal wild-type WspR could interrupt Wsp signalling at the level 23
of WspR. Neither model for inhibition may be ruled out at this stage. However, the fact that 24
chromosomal wspR appears to have little influence on the behaviour of trans-expressed 25
WspR variants lends support to the competitive model for Wsp inhibition. 26
27
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When the positions of the five amino-acid residue inserts were plotted onto the N-terminus 1
and linker region of the homology model (Figure 5), they clustered according to their effects 2
on WspR activity, suggesting that each group affected WspR function via a common 3
mechanism. N-terminus insertions producing constitutively-active proteins were found at the 4
interface between the N- and C-terminal domains and in adjoining loops and helices. These 5
insertions presumably activated WspR via disruption of the interface between the two 6
domains, a mechanism common to many response regulator activation mechanisms (Eldridge 7
et al., 2002; Park et al., 2002; Muchova et al., 2004). A comparison of the domain interaction 8
surfaces of four full-length, two-domain response regulator crystal structures (Robinson et al.,9
2003) suggested that the activation mechanisms of the different proteins; NarL (Baikalov et10
al., 1996), CheB (Djordjevic et al., 1998), DrrD (Buckler et al., 2002), and DrrB (Robinson et 11
al., 2003) varied with the extent of their interdomain interfaces.  12
13
Several activating insertions were clustered in the ?-helical section of the linker region 14
(Figure 5). Mutational analysis of the linker region between the receiver and effector domains 15
of OmpR by Mattison et al. (2002) showed that the composition of the linker region affected 16
the interplay of the two domains, and hence played a role in transducing the receiver signal to 17
the effector. In addition, the importance of interdomain linkers in the determination of the 18
response regulator activation mechanism was shown using OmpR-PhoB hybrid proteins 19
(Walthers et al., 2003). The linker region appears to play an important role in regulation of 20
WspR activation. However, studies with NarL assigned little functional significance to the 21
linker region (Eldridge et al., 2002), suggesting that linker-mediated regulation is not a 22
universal feature of response regulators.  23
24
Insertions producing inactive and dominant-negative WspR variants were spread over the 25
surface of the model furthest from the domain interface, surrounding the predicted 26
phosphorylation site (Figure 5). N-terminal dominant-negative insertions may have disrupted 27
protein folding without affecting the domain interface or promoting dimerisation in the same 28
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manner as was seen for the activating insertions. Alternatively, these insertions could have 1
affected WspR interaction with the Wsp chemosensory kinase.  2
3
Quantitative analysis of the effects of WspR variants showed that generation of the wrinkled 4
phenotype in SM strains was associated with increases in levels of both cell attachment and 5
cellulose production (Figures 2, 3 and 4). An important exception however, was the discovery 6
of several WspR variants whose expression produced little effect on cellulose production, but 7
greatly stimulated cell attachment, relative to the other tested WspR variants (e.g. WspR6, 8
WspR120). In addition, greatly decreased levels of cellulose production in WS were observed 9
upon expression of the 20 dominant-negative wspR substitution mutant alleles. However, cell 10
attachment to glass in WS strains expressing these wspR mutant alleles was not repressed, 11
relative to results seen with the wild-type control (Figure 6). These findings suggest that 12
cellulose production and cell attachment are regulated by WspR through two distinct and 13
separable pathways. 14
15
[For several wspR insert variants (e.g. SOEwspR130) higher levels of attachment were 16
observed upon expression in SM ?wspA-wspR than in SM (Figure 3). This may be related to 17
the loss of pellicle structure in SM ?wspA-wspR compared to SM, allowing more cells to 18
attach at the meniscus than would be possible for strains producing a structured biofilm. 19
Similarly, repression of cellulose production, and hence loss of pellicle structure, may explain 20
why several dominant-negative WspR substitution variants (e.g. SUBwspRR246F) produced 21
increased WS attachment levels compared to wild-type WspR (Figure 6).] 22
23
There are two possible alternative explanations for the quantitative data described above. In 24
both scenarios, WspR functions exclusively as a DGC. In the first, up-regulation of 25
attachment requires considerably lower levels of c-di-GMP than cellulose production. In this 26
case, WspR insert variants that up-regulate attachment only (e.g. WspR6) would not produce 27
enough c-di-GMP to trigger cellulose production. Likewise, inhibition of DGC activity by 28
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dominant-negative WspR substitution variants (e.g. WspRR246L) would reduce c-di-GMP 1
levels to the point where cellulose production, but not attachment is repressed. While further 2
research is required to fully exclude this possibility, the fact that WspR variants were able to 3
completely repress cellulose production while having no discernable effect on attachment 4
(Figure 6) seems more consistent with separate activation pathways than with a graded 5
response to a single signal.  6
7
In the second case, the Wsp kinase modulates c-di-GMP levels through WspR, but activates 8
attachment through a second, as yet undiscovered response regulator. An example of a similar 9
system is the Ple/Div system in C. crescentus, where the response regulators PleD and DivK 10
are jointly controlled by the kinases PleC and DivJ (Paul et al., 2004). Repression of cellulose 11
production in WS by dominant-negative WspR variants would have no effect on attachment 12
in this scenario. If a second Wsp-controlled response regulator existed, we would expect to 13
see high levels of attachment for WS ?wspR relative to SM ?wspR. In fact, attachment levels 14
in this strain are comparable to SM ?wspR (Figure S2), strongly arguing against this model.  15
16
The separation of WspR regulatory activities is consistent with recent data obtained for the C.17
crescentus protein CC3396 (Christen et al., 2005), in which a domain with a degenerate 18
GGDEF motif regulates protein function by binding GTP. A similar regulatory function has 19
also been proposed for P. aeruginosa FimX (Kazmierczak et al., 2006). The existence of 20
additional, non-enzymatic regulatory functions for GGDEF domains provides an explanation 21
for why many species contain such large numbers of GGDEF containing proteins (Galperin, 22
2005), a fact that is difficult to reconcile with enzymatic activity alone.  23
24
Finally, the RYGGEEF motif of WspR was investigated using site-specific mutagenesis, and 25
was shown to be highly sensitive to mutation. Substitution of residues 246-252 (RYGGEEF), 26
led to a loss of protein function in almost every tested case. Of the 76 wspR substitution 27
alleles produced, only one produced an active protein (wrinkled morphology in SM). As 28
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WspR functions as a DGC, it is reasonable to suggest that the level of functional conservation 1
seen for the WspR RYGGEEF motif may also apply to other DGCs; that this motif 2
(GGD/EEF) is absolutely required for DGC activity. [The GGD/EEF motif is not 3
always required for protein function, however (Christen et al., 2005; Kazmierczak et al.,4
2006)]. Mutagenesis of single residues in RYGGD/EEF has eliminated protein function in 5
numerous species (Paul et al., 2004; Simm et al., 2004; Kirillina et al., 2004; Garcia et al.,6
2004; Goymer et al., 2006), and the crystal structure of PleD places the RYGGEEF motif 7
close to the ribose group and alpha-phosphate of bound c-di-GMP, suggesting a critical role 8
in nucleotide binding or catalysis (Chan et al., 2004).  9
10
The single active WspR variant, WspRE250D contained the motif RYGGDEF, rather than 11
RYGGEEF. An analysis of sequence conservation among GGDEF domains (Galperin et al.,12
2001) indicated that aspartate and glutamate were found with similar frequency at position 13
250. It is possible that the conformational constraints on the first glutamate in the RYGGEEF 14
motif are not so pronounced as for the second, allowing either residue to be present. 15
Interestingly, tyrosine 247 was absolutely conserved in this study, despite the residue at this 16
position showing substantial variation across different GGDEF domains (Galperin et al.,17
2001). When three WspR substitution variants were chosen to represent each position of the 18
RYGGEEF motif and analysed in more depth, almost every tested variant produced a 19
dominant-negative effect on WS morphology (Table 5). The only exception was 20
WspRY247F, which produced an inactive protein. The structural similarity between tyrosine 21
and phenylalanine suggested that an undefined protein mis-folding event, avoided in the case 22
of a structurally conserved substitution such as that in WspRY247F, effected the observed 23
dominant-negative effect of the tested residue substitutions on WspR activity. 24
25
This work sheds light on several previously unanswered aspects of the WspR structure-26
function relationship. WspR functions as a DGC, whose enzyme activity is stimulated in the 27
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WS genotype compared with the (wild-type) SM genotype. Upon phosphorylation, or 1
disruption of the linker region or the interdomain interface, activation proceeds via release of 2
effector domain repression by the receiver domain. Quantitative analysis of aspects of biofilm 3
formation suggested a dual regulatory mechanism for WspR. Finally, the RYGGEEF motif of 4
WspR is highly functionally conserved, with almost every tested substitution abolishing 5
function in a dominant-negative fashion. As the time and effort required to produce high-6
quality structural models of proteins continues to decrease, this study underlines the 7
continued utility of systematic mutagenesis to structure-function analyses. 8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
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Figure 1: Biochemical analysis of WspR. (a): WspR was shown to function as a DGC in vitro.
C-di-GMP production was observed over time against control lanes (Ctrl) containing ?-33P c-di-
GMP (Christen et al., 2005). 1(b): DGC activity assays were carried out with whole cell extracts.
The furthest migrating spot, thought to correspond to GMP, (retardation factor [RF] value 0.54)
predominated in the cell extracts. The second furthest migrating spot (Rf 0.47) was thought to
correspond to GDP. These molecules may have been formed through breakdown of GTP (Rf
0.37) by enzymes in the cell lysate. The slowest running spot (Rf 0.25) was present in WS cell
lysates expressing wspR either from a plasmid or from the chromosome (Lanes 2 and 6). This
spot corresponded to c-di-GMP. 1(c): Protein expression levels were measured for SM and WS
cell extracts by Western blotting. WspR expression levels were similar in SM and WS cultures.
SBW25 SM ?wspR cell extract, and N-terminal His6-tagged WspR were included as controls.
The small, minor band seen in the control lane was shown to correspond to a degradation
fragment of WspR by mass spectroscopy.
Figure 2: The effects of five amino-acid residue insertions on WspR activity. Morphology
data was used to assign activity states to WspR insert variants. The arrows represent the positions
of amino-acid inserts, and indicate the resultant activity of the insert as shown. Insertions in the
linker region and sections of the N-terminus produced constitutively-active variants, whilst
insertions in the C-terminus abolished WspR activity and usually led to suppression of the
wrinkled phenotype in WS.
Figure 3: The effects of wspR mutant allele expression on SM and SM ?wspA-wspR
attachment to glass microcosms Data show mean A570 ± standard error for eight replicates.
The grey bars represent SM ?wspA-wspR, and the white bars SM strains, both containing WspR
variants with inserts at the residue positions noted. The bar below the graph represents the domain
structure of WspR. The grey section represents the N-terminus, the black section the linker
region, and the white section the C-terminus. A two-way ANOVA showed that the effect of the
mutation was dependent on whether is was in the N-terminal domain, the linker region, or the C-
terminal domain [F2,698 = 118.84, P < 0.0001]. The effect of strain background was not
significant [F1,698 = 0.32, P = 0.571], but the interaction effect was highly significant [F2,698 =
12.76, P < 0.0001].
Figure 4: The effects of wspR mutant allele expression on SM and WS binding to Congo Red
dye. Data show mean Congo Red absorbed relative to WS pME6010 ± standard error for five
replicates. The bar below the graph represents the domain structure of WspR. The grey section
represents the N-terminus, the black section the linker region, and the white section the C-
terminus. One-way ANOVA revealed a highly significant difference among means [F47,192 =
238.00, P < 0.0001]. Dunnet’s test was used to identify alleles that gave effects that were
significantly greater than the plasmid controls and are indicated by an asterisk.
Figure 5: Insert positions in the N-terminus and linker region of WspR. The figure shows the
WspR homology model visualised from four different angles. The GGDEF domain is coloured
grey. The N-terminal receiver domain and the linker region are coloured green, with the sites of
five amino-acid residue insertions highlighted according to their resultant activity state.
Constitutively-active = red, signal-dependent = orange, inactive = light blue, dominant-negative =
dark blue. Areas of ribbon coloured grey in the N-terminus represent sections with no
corresponding WspR sequence.
Figure 6: Effects of WspR substitution variants on WS behaviour. The effects of 21 WspR
substitution variants on (a) cellulose production and (b) attachment in WS were measured. Data
show (a) mean A490 ± standard error for five replicates and (b) mean A570 ± standard error for
eight replicates respectively. Constructs are named based on the WspR substitution in each case.
Wrinkled morphology and cellulose production were repressed in WS upon production of all but
one variant protein; WspRY247F. Attachment was not repressed by any WspR variant. A nested
ANOVA revealed a significant effect due to substitutions at different positions in the RYGGEEF
motif [F9,168 = 26.96, P < 0.0001] and a significant effect of the particular residue at each
position [F14,168 = 4.50, P < 0.0001]. Analysis of a priori contrasts in least-squared-means
derived from the nested ANOVA model showed highly significant effects of substitutions at
positions 246, 247 and 248 (P < 0.0001 in each case), but no significant effect of substitutions at
positions 250-252.
Figure 7: A model for WspR function. For wild-type WspR (a), inhibition of the C-terminal
effector domain (oval) by the N-terminal receiver domain (square) is relieved upon
phosphorylation, allowing WspR to produce a signal, possibly via dimerisation in a similar
manner to other GGDEF proteins (Chan et al., 2004, Ryjenkov et al., 2005). Mutation of the N-
terminus or linker region (b) may remove this inhibition, as exemplified by constitutively-active
WspR variants. Mutation of the C-terminus (c) knocks out function irrespective of the
phosphorylation state of WspR, resulting in the inactive or dominant negative state.
??
?
?
? ?
?
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Table 1: Colony morphologies of SBW25 strains expressing the pME6010-wspR insert 1
library 2
Colony morphology bConstruct a
SM WS SM 
?wspA-F
SM
?wspA-R
WS
?wspR
SM 
?wspR
Activity 
state c
pME6010 SM WS SM SM SM SM I 
pME6010-wspR WS WS SM SM WS WS D 
PSM wspR6 WS WS SM SM WS WS D 
PSM wspR10 WS WS WS WS WS WS C 
SOE wspR17 WS WS WS WS WS WS C 
SOE wspR24 SM SM SM SM SM SM N 
SOE wspR31 SM WS SM SM WS Int. I* 
PSM wspR38 SM WS SM SM WS SM I* 
PSM wspR45 SM WS SM SM SM Int. I 
SOE wspR58 WS WS WS WS WS WS C 
SOE wspR79 WS WS WS WS WS WS C 
PSM wspR89 WS WS WS WS WS WS C 
PSM wspR99 SM SM SM SM SM SM N 
PSM wspR105 SM SM SM SM SM SM N 
SOE wspR113 WS WS WS WS WS Int. C 
PSM wspR120 WS WS SM SM WS WS D 
PSM wspR124 SM SM SM SM SM SM N 
SOE wspR130 WS WS WS WS WS WS C 
PSM wspR138 WS WS WS WS WS WS C 
SOE wspR144 WS WS WS WS WS WS C 
SOE wspR150 WS WS WS WS WS WS C 
SOE wspR157 WS WS WS WS WS WS C 
SOE wspR169 SM SM SM SM SM SM N 
PSM wspR175 SM SM SM SM SM SM N 
SOE wspR182 SM SM SM SM SM SM N 
PSM wspR189 SM SM SM SM SM SM N 
SOE wspR200 SM SM SM SM SM SM N 
PSM wspR211 SM SM SM SM SM SM N 
PSM wspR213 SM SM SM SM SM SM N 
SOE wspR221 SM SM SM SM SM SM N 
SOE wspR228 SM SM SM SM SM SM N 
SOE wspR239 SM WS SM SM WS SM I* 
SOE wspR246 SM SM SM SM SM SM N 
PSM wspR249 SM SM SM SM SM SM N 
PSM wspR250 SM SM SM SM SM SM N 
SOE wspR253 SM SM SM SM SM SM N 
PSM wspR258 SM SM SM SM SM SM N 
SOE wspR264 SM SM SM SM SM SM N 
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SOE wspR270 SM SM SM SM SM SM N 
SOE wspR276 SM SM SM SM SM SM N 
SOE wspR289 SM WS SM SM WS SM I* 
PSM wspR296 SM SM SM SM SM SM N 
SOE wspR303 SM Int. SM SM SM SM I 
SOE wspR310 SM SM SM SM SM SM N 
SOE wspR317 SM SM SM SM SM SM N 
PSM wspR326 SM SM SM SM SM SM N 
1
a Each construct name contains the amino-acid position of the insert.  2
b Colony morphology on LB agar plates; designated as smooth (SM), wrinkled (WS) or intermediate 3
(Int.). Strains containing pME6010 and pME6010-wspR (wild-type) are included as controls. 4
c The deduced activity state of each WspR variant is given as either constitutively-active (C), signal-5
dependent (D), inactive (I) or dominant-negative (N) (see Figure 2). 6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
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Table 2: Amino-acid residue substitutions that knock out WspR-SacI activity a1
Substituted residues cAltered
residue
No. of 
substitutionsb Aliphatic 
residues 
Aromatic
residues 
Charged or 
polar 
Aliphatic hydroxyl/ 
sulphur-containing 
246 R 11 L, I, V, A F K, Q T, S, C, M 
247 Y 11 L, I, V, P F, H D, E T, S, C 
248 G 9 L, I, V F, Y K, R, Q T 
249 G 10 L, I, V, A F, Y K, N S, C 
250 E 11 G, L, I, A, P F, Y Q T, S, C 
251 E 13 G, L, I, V, P F, Y K, R, N T, S, C 
252 F 10 G, L, I, V  R, D, E, N S, C 
2
a In every example shown, the ability of the variant protein to produce a wrinkled phenotype in SM 3
cells grown on LB agar plates was abolished.  4
b The number of substitutions is out of a possible 18 residue substitutions at each position.  5
c WspR variants are grouped according to the chemistry of the substituted residue side-chain. Standard 6
amino-acid definitions are used. 7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
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Table 3: Bacterial strains and plasmids 1
Strain or Plasmid Description Reference a
P. fluorescens SBW25   
SM Environmental isolate, wild-type ancestral smooth genotype 42 
WS (also LSWS) Biofilm former, evolved from SBW25 SM  56 
SM ?wspA-wspF SM with wspA-wspF deleted Rainey et al. (unpublished)
SM ?wspA-wspR SM with wspA-wspR deleted Bantinaki, E. (unpublished) 
SM ?wspR SM with wspR deleted Gehrig, S.M. (unpublished)  
WS ?wspR WS with wspR deleted 20 
WS-4 WS wspR::miniTn5, KmR 56 
E. coli   
BL21-(DE3) SmR, K12 recF143 lacIq lacZ?.M15, xylA Novagen 
DH5? endA1, hsdR17(rK-mK+), supE44, recA1, gyrA (Nalr), relA1, 
?(lacIZYA-argF)U169, deoR, ?80dlac?(lacZ)M15
60 
DS941 K12 recF143 lacIq lacZ?.M15, xylA, SmR 57 
FH395  DH5? containing pFH395, a KmR, conjugative F derivative 
(pOX38Km) containing transposon Tn4430 - inserted in vivo
Hayes, F. (unpublished) 
Plasmids   
pET14b-wspR pET14b with wspR as NdeI-BamHI fragment Goymer, P.J. (unpublished)  
pET42b-wspR pET42b with wspR as XhoI-NdeI fragment this study 
pME6010 TetR, PK, 8.3 kb pVS1 derived shuttle vector 25 
pME6010-wspR pME6010 with wspR BamHI-EcoRI fragment ligated between BglII
and EcoRI - BglII site destroyed 
this study 
PSM wspR alleles pME6010-wspR with 19 separate 15 bp inserts produced by transposon 
mutagenesis - see Table S1 
this study 
SOE wspR alleles 25 wspR-SOE alleles produced by SOE PCR using pME6010-wspR.
PCR products ligated between XhoI and EcoRI of pME6010 - see 
Table S2 
this study 
pME6010-wspR-SacI wspR-SacI produced by SOE PCR using pME6010-wspR. PCR 
product ligated between XhoI and EcoRI of pME6010 
this study 
SUB-wspR alleles 76 wspR fragments containing substitutions between codons 246 and 
252, produced by PCR with degenerate primers using pME6010-
wspR-SacI, and ligated between SacI and EcoRI of pME6010-wspR-
SacI - see Table 2 
this study 
2
a SM ?wspA-wspR, SM ?wspR, FH395 and pET14b-wspR were the kind gifts of E. Bantinaki, S.M. 3
Gehrig, F. Hayes and P.J. Goymer respectively.  4
5
6
7
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3.5 Unpublished results
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3.5.1 Cyclic di-GMP regulates adenylosuccinate synthetase - a key enzyme in purine
biosynthesis pathway
Marc Folcher, Matthias Christen, Beat Christen, Suzette Moes, Paul Jeno? and Urs Jenal
Biozentrum, University of Basel, Klingelbergstrasse 70, CH-4056 Basel, Switzerland
Abstract:
C-di-GMP is a bacterial second messenger implicated in biofilm formation, antibiotic resistance,
and persistence of pathogenic bacteria in their animal host. The enzymes responsible for the
regulation of cellular levels of c-di-GMP, diguanylate cyclases (DGC) and phosphodiesterases
(PDE), have been identified and characterized. So far little information is available regarding c-di-
GMP effector mechanisms and binding proteins. Using affinity chromatography and a specific
assay for c-di-GMP binding, we have identified in Caulobacter crescentus extract an
adenylosuccinate synthetase (PurA, CC3103) that binds c-di-GMP with high affinity. Using purified
recombinant PurA for kinetic analysis and binding studies, we show that c-di-GMP is a potent
inhibitor of PurA activity. Initial rate kinetics revealed that c-di-GMP inhibition is competitive with
respect to GTP and noncompetitive with respect to IMP. These findings suggest a central role for
c-di-GMP as regulator of nucleotide pool. We propose that inhibition of the first step of de novo
biosynthesis of AMP by c-di-GMP directs IMP towards guanine biosynthesis and thereby prevent
the drainage of the guanine pool under conditions of elevated c-di-GMP leves.
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Results
Purification of c-di-GMP binding proteins from C. crescentus. Based on the assumption that c-
di-GMP signal transduction depends on specific receptor proteins, we designed a biochemical
purification strategy to identify such components. C-di-GMP binding proteins from C. crescentus
were purified by two consecutive chromatography steps using BlueSepharose® CL-6B and affinity
chromatography with GTP immobilized on Epoxy activated Sepharose 4B (Pharmacia). UV cross-
linking with [33P]c-di-GMP was used to identify proteins with specific binding activity for c-di-GMP
(see Materials and Methods). After ammonium sulfate precipitation of 100.000 ? g C. crescentus
supernatant, 323 mg resolubilized protein was applied to a BlueSepharose® CL-GB column
(Pharmacia). Most of the protein was eluted during the first wash step with 0.4 M NaCl. Fractions
eluted in subsequent washing steps (0.4 - 0.7 M and 0.7 – 0.9 M NaCl) included most of the
specific binding activity. Two binding proteins with apparent molecular weights of 47 kDa and 36
kDa were detected in the 0.4 – 0.7 M NaCl eluate (Figure 3A, B, lane 3) and the 0.7 – 0.9 M NaCl
fraction contained several small c-di-GMP binding proteins with apparent molecular weights of 8-12
kDa (Figure 3A, B, lane 4). The 0.4 – 0.7 M NaCl eluate was dialyzed, concentrated and applied to
a MiniQ anion exchange column (Amersham Pharmacia Biotech). The column was washed with
PBS Buffer, and bound material was eluted with a 0 – 500 mM linear gradient of NaCl in PBS
Buffer. Fractions were analyzed by UV cross linking with [33P]c-di-GMP, separated by tricine
gradient gel and stained with coomassie colloidal blue. The 47 kD c-di-GMP binding protein was
eluted in fraction 9 (162-185 mM NaCl) (Figure 3C,D lane 9) and identified by MS/MS analysis as
the product of the gene CC3103, the C. crescentus homologue of the adenylosuccinate synthetase
PurA (EC 6.3.4.4) (Figure 3E).
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Figure 3 Isolation of c-di-GMP binding proteins from C. crescentus.
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A) Coomassie stained SDS-PAGE gel with protein fractions used for UV cross linking with [33P]c-di-GMP. Lane 1:
100.000 ? g supernatant of total protein extracts, lane 2: 60% ammonium sulfate precipitation, lane 3: 0.4 - 0.7 M NaCl
eluate from Blue Sepharose®, lane 4: 0.7 - 0.9 M NaCl eluate from Blue Sepharose® and lane 5: 125 mM NaCl eluate
from GTP-sepharose column. B) Autoradiograph of SDS-PAGE gel shown in A. Due to weak incorporation, lanes 1 and 2
were exposed on a phosphoimager screen, whereas lane 3–5 were exposed on X-ray film. Protein a was identified by
MS/MS as the C. crescentus adenylosuccinate synthetase PurA (CC3103), protein b as translation elongation factor EF-
Tu (CC1240, CC3199), protein c as DgrA (Diguanylate receptor protein A, CC1599) the nature of protein d is under
investigation. C) Coomassie stained tricine gradient gel with protein fractions from the miniQ column used for UV-cross
linking with [33P]c-di-GMP. The arrow indicates the c-di-GMP binding protein PurA identified by MS/MS analysis. D)
Autoradiograph of SDS-PAGE gel shown in C. E) Coomassie stained tricine gradient gel with protein fraction 9 from the
miniQ column labeled with [33P]c-di-GMP. left lane: marker, middle lane: coomassie colloidal staining, right lane:
radiography. By MS/MS identified proteins: CC3103 adenlylosuccinate synthetase, CC3248 gylceraldehyde-3-phosphate
dehydrogenase, CC0279 methionyl tRNA formyltransferase, CC1681 guanylate kinase, CC1581 glycosamine 1-
phosphate N-acetyltransferase. F) UV cross linking of purified hexahistidine-tagged PurA with [33P]c-di-GMP. left lane:
marker, middle lane: recombinant PurA protein containing a C-terminal His-tag, right lane: tryptic digest of the
recombinant PurA protein after UV cross-linking with [33P]-c-di-GMP. The arrow indicates the 5 kD N-terminal fragment of
PurA which has been identified by MS/MS the peptide fragments AA18-27 K.LALLPSGVVQGK.LMH+= 1181.72 and
AA51-68 K.IVDWLSNR.A MH+= 1002.52.
PurA is a c-di-GMP binding protein. In order to confirm that the identified protein is c-di-GMP
binding, purA was sub cloned into the expression vector pET-21b and the recombinant
hexahistidine-tagged protein was purified by Ni-NTA-affinity chromatography. Like the semi-purified
protein from C. crescentus (Figure 3E), the recombinant protein showed strong labeling upon UV
cross linking with [33P]c-di-GMP (Figure 3F), confirming that PurA is a c-di-GMP binding protein.
C-di-GMP is a competitive inhibitor towards GTP. PurA plays an important role in the de novo
pathway of purine nucleotide biosynthesis. It catalyzes the committed step of the AMP de novo
biosynthesis, the generation of 6-phosphoryl-IMP from GTP and IMP followed by the formation of
adenylosuccinate from 6-phosphoryl-IMP and L-aspartate. It has been shown, that PurA is
inhibited by a vide variety of nucleotides as by the product adenylosuccinate (34), by AMP (35), the
end product of the pathway, but also by different guanine nucleotides. GMP exhibits competitive
inhibition towards both GTP and IMP, and GDP and ppGpp are competitive inhibitors toward GTP
(36-43). Based on these diverse inhibition properties and based on the finding that PurA binds
specific c-di-GMP, we assumed that binding of the guanine nucleotide c-di-GMP might affect PurA
activity as well. Therefore, initial rate kinetic studies with the recombinant C. crescentus
adenylosuccinate synthethase were undertaken, to investigate the role of c-di-GMP binding for
PurA activity. The experimental protocol involves varying the concentration of one of the substrate
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at several fixed levels of c-di-GMP. The concentrations of the other two substrates are held
constant at values above their respective Michaelis-Menten constant but below saturation (39).
Figure 4 Lineweaver-Burk plots of inhibited adenylosuccinate synthetase.
A) Plot of the reciprocal initial velocity (ODU280nm / min) versus the reciprocal molecular concentration of IMP (in μM-1).
AMP concentrations are 0 and 250 μM, GTP and aspartate concentrations are 125 μM and 2.5 mM. IMP was varied in
the range 12.5 to 200 μM. Other experimental details are described in “Experimental procedures”. B) Plot of the
reciprocal initial velocity (ODU280nm / min) versus the reciprocal molecular concentration of IMP (in μM-1). C-di-GMP
concentrations are 0, 18.5 and 25 μM, GTP and aspartate concentrations are 125 μM and 2.5 mM. IMP was varied in the
range 12.5 to 200 μM. Other experimental details are described in experimental procedures. C) Plot of the reciprocal
initial velocity (ODU280nm / min) versus the reciprocal molecular concentration of GTP (in μM-1). C-di-GMP
concentrations are 0, 15 and 24 μM, GTP and aspartate concentrations are 125 μM and 2.5 mM. GTP was varied in the
range 25 to 200 μM. Other experimental details are described in experimental procedures.
AMP was found to be a competitive inhibitor towards IMP, as previously reported for the E. coli
adenylosuccinate synthetase (Figure 4A, (44, 45)), whereas c-di-GMP was found to be a
noncompetitive inhibitor towards IMP (Figure 4B) and a competitive inhibitor towards GTP,
indicating that c-di-GMP acts as a substrate analog binding at the GTP site. This hypothesis is
supported by UV cross-linking experiments with PurA in the presence of 1 μM [33P] labeled c-di-
GMP (see material and methods). After trypsin digestion of [33P]c-di-GMP labeled PurA, a [33P]c-di-
GMP labeled 5 kD N-terminal trypsin digested fragment including the GTP binding site G12-K18 of
PurA was isolated and identified by MS/MS (Figure 3F and Figure 7F), peptide fragments AA18-27
K.IVDWLSNR.A MH+= 1002.52 and AA51-68 K.LALLPSGVVQGK.L MH+= 1181.72.).
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Figure 5 UV cross linking of PurA with [33P]c-di-GMP in presence of GTP, IMP or AMP.
A) Radiography of UV cross linking of 500 nM PurA in the presence of 1 μM of 33P labeled c-di-GMP and GTP (0, 10, 50,
100, 200, 350, 500, 750 and 1000 μM, upper lane), IMP (0, 1, 2, 5, 10, 20, 50, 100 and 200 μM middle lane), or AMP (0,
10, 50, 100, 200, 350, 500, 750, 1000 μM lower lane). B-E) Binding constants for IMP, AMP and GTP derived from the
33P c-di-GMP-IMP, GTP or AMP competition experiment.
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Competition of C-di-GMP binding by GTP, IMP and AMP. Competition of C-di-GMP binding by
GTP, IMP and AMP was monitored upon UV cross linking PurA in presence of 1μM [33P]c-di-GMP
and increasing concentration of cold GTP, IMP or AMP. IMP shows a mixed inhibition profile. At
low concentration, IMP competes with a Ki of 0,4 μM for one third of the c-di-GMP binding capacity
(Figure 5B) at higher concentration of IMP a second Ki of 94 μM can be observed where IMP is
competing with two third of the c-di-GMP binding capacity (Figure 5C). In a similar experiment the
indirect binding constants for GTP and AMP were determined to 690 μM for AMP and 130 μM for
GTP. These values are in agreement with the dissociation constants determined by initial rate
kinetics (Ki >500μM for AMP, a Km of 120 μM for GTP and 6.7μM for IMP).
Figure 6 The de novo AMP synthesis from IMP by PurA (EC 6.3.4.4) and PurB (EC 4.3.2.2).
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Discussion
Using affinity chromatography and a specific assay for c-di-GMP binding (46, 47), we have purified
and identified in C. crescentus extract an adenylosuccinate synthetase (PurA, CC3103) that has
high affinity for the bacterial second messenger c-di-GMP. Binding studies and initial rate kinetic
studies with purified recombinant were undertaken to clarify the inhibition mechanism of the second
messenger c-di-GMP on PurA activity. Enzyme kinetics revealed that c-di-GMP potently inhibits
PurA activity and that c-di-GMP inhibition is competitive with respect to GTP and noncompetitive
towards IMP. Beside activation of the cellulose synthase complex from Gluconacetobacter by c-di-
GMP (48, 49) and allosteric product inhibition of diguanylate cyclases, (47) the c-di-GMP mediated
regulation of PurA activity represents a novel example of enzyme regulation by this bacterial
second messenger.
The catalytic mechanism of the adenylosuccinate synthetase has been investigated intensively by
kinetic studies and X-ray crystallographic analysis of various PurA substrate and inhibitor
complexes (34, 40, 50-57). Isotope exchange studies at equilibrium by Cooper and Bass (58, 59)
support the formation of 6-phosphoryl IMP prior to the nucleophilic attack of aspartate. Based on
these investigations a two-step catalytic reaction mechanism, as suggested 60 years ago by
Liebermann et al. (60), including the formation of the 6-phosphoryl IMP as an intermediate of the
reaction pathway seems to be a valuable model (Figure 7B-D). In detail the catalytic process starts
with the proton abstraction from N1 of IMP by Asp13 and generation of the 6-oxoanion, which is
stabilized by a hydrogen bond to Gln222. The 6-oxoanion then displaces GDP from the ?-
phosphate of GTP (Figure 7B), yielding the 6-phosphoryl IMP intermediate (Figure 7C). In the
transition state, His41 and Mg2+ presumably stabilize the charge development on the ?-and ?-
phosphate of GTP. The second reaction catalyzed by the enzyme involves the nucleophilic
substitution of the phosphate from 6-phosphoryl-IMP by the amino group of L-aspartate generating
adenylosuccinate and phosphate. The hydrogen bond between the ?-carboxylate and ?-amino
group of L-aspartate enhances the nucleophilicity of the amino group, meanwhile enhances the
hydrogen bond between N1 and Asp13 the electrophilicity of C6 and the hydrogen bond between
His41 and the 6-phosphoryl group stabilizes the developing charge on the leaving group.
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Figure 7 Reaction mechanism of the adenylosuccinate sythetase PurA
B-D) Homology model of the nucleotide binding site of the C. crescentus adenylosuccinate synthetase (CC3103)
generated by Swissmodel with PDB entries 1CH8.pdb, 1CG0.pdb and 1SON.pdb as templates. A model of the reaction
mechanism of the adenylosuccinate synthetase is shown according to (Bradley Poland JBC1997, Bradley Poland JMB
1996, Liebermann I JBC 1956). B) Proton abstraction at N1 of IMP by the carboxyl moiety of Asp13 is generating the 6-
oxoanion of IMP, which then displaces GDP from the g-phosphate of the bound GTP. C) Nucleophilic displacement of 6-
phosphate from the 6-phosphoryl intermediate by the amino group of Asp and subsequent protonation of N1 via Asp13
D) Reaction products adenylosuccinate, GDP and phosphate. E) Model for the inhibition of PurA by c-di-GMP (red) and
AMP (blue). Our initial rate kinetic studies indicate, that the c-di-GMP inhibition of PurA is competitive with respect to
GTP and non-competitive with respect to IMP, suggesting that c-di-GMP binds to the GTP binding site of the enzyme. F)
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Homology model of the C. crescentus PurA with c-di-GMP placed into the GTP binding pocket. Peptides AA18-27 and
AA51-68, which have been identified by MS/MS are highlighted in yellow.
It is well known, that the adenylosuccinate synthetase is regulated by a wide variety of guanine
nucleotides. For GDP, ppGpp, pppGpp and ppG3?:2?p it has been demonstrated that they act as
competitive inhibitors towards the GTP binding site of the enzyme (61-63), whereas guanosine
monophosphate has been shown to compete with both, GTP and IMP (63, 64). Our results suggest
that the cyclic dimeric form of guanosine monophosphate, c-di-GMP, interacts mainly with the GTP
binding site and functions as a competitive GTPase inhibitor as shown for the stringent response
ppGpp (37, 65).
The cellular function of PurA inhibition by c-di-GMP is unclear. A possible physiological function
might be the negative regulation of the de novo purine nucleotide synthesis upon induction of c-di-
GMP. To maintain cellular homeostasis, nucleotide biosynthesis pathways are subject to tight
allosteric control. Because AMP and GMP biosynthesis pathways compete for the same precursor
IMP, feedback inhibition of their first enzymatic step (PurA for AMP and GuaB for GMP) not only
controls the flux of metabolites but also contributes to balanced purine pools. Increasing c-di-GMP
levels upon induction of enzymatic production of c-di-GMP from two molecules of GTP by
diguanylate cyclases (DGC?s) results in an accelerated consumption of the cellular guanosine pool.
However nucleotide analysis by HPLC revealed that under such conditions the intracellular
concentration of ATP and GTP are not affected (Figure 15A). A possible physiological function of
PurA inhibition by c-di-GMP might be to shift the de novo purine biosynthesis towards the
guanosine synthesis to maintain the GTP level and counteract the GTP consumption of DGCs. It
has been reported, that the synthesis of the second messenger c-di-GMP as well as its
degradation are under multiple control by guanine nucleotides (46, 47, 66). The synthesis of c-di-
GMP is allosterically inhibited by c-di-GMP itself and it has been reported that the c-di-GMP
specific phosphodiesterases PdeA from C. crescentus and FimX from P. aeruginosa are
allosterically activated by GTP (46, 66). In such a context inhibition of PurA by c-di-GMP might be
part of a cellular regulation network designated to maintain cellular homeostasis of the guanine
pool under conditions of elevated c-di-GMP level.
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Material and methods:
Strains, plasmids and media. E. coli strains were grown in Luria Broth (LB). C. crescentus strains
were grown in complex peptone yeast extract (PYE) (67) supplemented with antibiotics, where
necessary. Motility phenotypes were determined using PYE motility plates containing 0.3% Difco-
Agar. For the exact procedure of strain and plasmid construction see supplemental material.
BlueSepharose® CL-6B column. 50 ml of resuspended and dialyzed 60% (NH4)2SO4 precipitate
containing 323 mg protein (6.63 mg/ml) were loaded on a BlueSepharose® CL-6B column
(Pharmacia) (flow 2 ml/min, 30 ml resin) with buffer A as loading buffer (1x PBS buffer containing
10 % (v/v) glycerol, 1 mM DTT). 151 mg protein was collected in the flow through and additional
160 mg was eluted during washing with 200 ml of buffer A. Bound proteins were eluted with a
gradient of 50 - 1000 mM NaCl at a flow rate of 3 ml/min. The following fractions were pooled,
dialyzed over night in buffer A and concentrated to a final protein concentration of 1 mg/ml using a
50 ml Amicon ultra filtration cell and regenerated cellulose ultra filtration membrane NMWL 10,000
(Millipore Corporation): weak binders (3.3 mg protein, fractions 7-11), medium binders (10.8 mg
protein, fraction 12-20) and tight binders (7.8 mg protein, fractions 21-29).
UV cross-linking with [33P]c-di-GMP, DGC and PDE activity assays. Procedures for enzymatic
production of [33P]c-di-GMP and UV cross-linking with [33P]c-di-GMP, as well as for diguanylate
cyclase and phosphodiesterase reactions were published earlier (46, 47). Nucleotides were
analyzed by PEI-Cellulose chromatography as described in (46, 47). The cellular concentration of
c-di-GMP was determined by anionic exchange chromatography as described in (47).
Adenylosuccinate synthetase enzyme assay. The enzyme activity was determined at 25 °C by
measuring the increase in absorbance at 280 nm which results from the conversion of IMP to
adenylosuccinate (?280=1.17x104 M-1 cm-1) (39). The standard assay solution used to monitor
enzyme activity contained 10 mM MgCl2, 2.5 mM aspartate, 200 μM IMP, and 150 μM GTP in 20
mM Hepes, pH 7.7, in a total volume of 1 mL. Purified recombinant PurA enzyme was used at a
final concentration of 0.04 mg/ml.
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3.5.2 The substrate specificity of diguanylate cyclases
Mechanism of c-di-GMP synthesis. Like guanylate and adenylate cyclases (GC, AC) and DNA
polymerases, diguanylate cyclases (DGCs) catalyze the nucleophilic attack of the 3? hydroxyl group
on the ?-phosphate of a nucleoside triphosphate. Despite the lack of obvious sequence similarities,
the PleD X-ray structure confirmed that DGCs possess a similar Palm-domain architecture like AC
and GC (24, 47, 68) (Figure 8). Based on mutational analysis (24, 25, 46) and on structural
comparisons between DGC, AC, GC and DNA polymerases (69), a model for DGC catalysis can
be proposed.
Figure 8: Comparison between adenylate cyclase and diguanylate cyclase
Upper lane: homology model between AC and DGC according to (68). Lower lane: X-ray structure of PleD (24) with
modeled GTP bound to the active site (A-site) and a dimer of c-di-GMP bound at the allosteric inhibition site (I-site).
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Figure 9: Model for the catalytic mechanism of c-di-GMP formation.
A) Model of the GGDEF domain arrangement of an enzymatically active DGC dimer with a GTP molecule bound at each
active site. B) Monomeric GGDEF domain with bound GTP in the A-site. C) Zoom into the substrate-binding site of the
GGDEF domain with one GTP molecule bound at the active site homology modeled according to the X-ray structure of
the activated adenylate cyclase. Negatively charged amino acids, which are proposed to coordinate metal ions, are
indicated. D-F) Schematic of the reaction mechanism for c-di-GMP synthesis through the linear intermediate pppGpG.
We assume that the intermolecular nucleophilic attack of the 3?-hydroxyl group occurs under inversion of the
stereochemistry at the ?-phosphate as it was shown for many DNA and RNA polymerases.
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In contrast to the heterodimeric ACs and GCs, DGCs form homodimers, with a GTP molecule
bound within the catalytic core of each DGC monomer (Figure 9A) (24). Two Mg2+ ions are
coordinated by the highly conserved glutamic acid residue E3711, which is part of the GGDEF
motif, and possibly by D327 on the opposing ?-sheet (Figure 9B,C). Both residues are strictly
required for DGC activity of WspR. The divalent Mg2+ carboxyl complex coordinates the
triphosphate moiety of GTP and activates the 3? hydroxyl group for an intermolecular nucleophilic
attack (1st SN2 at P?) of the ?-phosphate of the neighboring GTP substrate (Figure 9C,D). In the
transition state the entering hydroxyl oxygen and the leaving pyrophosphate oxygen are in line
(Figure 9D). In the transition state, the negative charge of the pentagonal-bipyramidal hybridized ?-
phosphate is stabilized via the positively charged Mg2+ complex and presumably by a hydrogen
bond between E370. After electron transfer and protonation pyrophosphate is released and the
intermediate linear dinucleotide pppGpG is formed (Figure 9E). By a sequential similar reaction
performed at the opposing active site of the second DGC subunit the 3? hydroxyl moiety of the
linear intermediate pppGpG undergoes an intramolecular nucleophilic substitution of the 5? ?-
phosphate (2nd SN2 at P?) resulting in the release of pyrophosphate and the formation of the
second messenger c-di-GMP (Figure 9E,F).
By using a combination of structural, genetic, biochemical and modeling techniques it has been
shown, that a distinct allosteric binding site for c-di-GMP (I-site) is responsible for non-competitive
product inhibition of DGCs (47) (Figure 10). The I-site was mapped in both multi- and single
domain DGC proteins and is fully contained within the GGDEF domain itself (47). In vivo selection
experiments and kinetic analysis of the evolved I-site mutants led to the definition of an RXXD motif
as the core c-di-GMP binding site. Based on these results and based on the observation that the I-
site is conserved in a majority of known and potential DGC proteins, we have been proposed that
product inhibition of DGCs is of fundamental importance for c-di-GMP signaling and cellular
homeostasis. According to the proposed active site model, two alternative allosteric product
inhibition mechanisms can be envisaged. In a first scenario, binding of c-di-GMP to the I-site would
change the orientation of R366 and would thereby disturb the guanine-binding pocket resulting in
an increased Km for GTP. Alternatively, c-di-GMP binding to the I-site could rearrange the Mg2+
carboxyl complex and thus destabilize the active state.
1 For the nomenclature of DGC key residues, we refer to the amino acid sequence of the diguanylate cyclase
PleD from caulobacter crescentus for which an X-ray structure has been published (PDB entry 1w25.pdb).
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Figure 10: Crystal structure of the diguanylate cyclase PleD
A) 1W25.pdb according to (24, 47). B) Zoom into the allosteric product inhibition site of PleD.
3.5.3 Diguanylate cyclase Inhibition studies
Both I- and A-site of DGC represent potential interaction sites for targeted drug design. The I-site
has been examined by extensive biochemical studies on different diguanylate cyclases. It has
been proposed that the I-site binding pocket provides an entry point into unraveling the molecular
mechanisms of ligand-protein interactions involved in c-di-GMP signaling. I-site mediated feedback
inhibition makes DGCs a valuable target for drug design to develop new strategies against biofilm-
related diseases (47). But DGC inhibition by I-site ligands might also harbor some disadvantages.
Since c-di-GMP is binding to this allosteric inhibition site, potential I-site DGC inhibitors might
exhibit similar chemical properties as the second messenger itself. Therefore unwanted cross
reactivity with components of the c-di-GMP signaling pathways like activation of downstream c-di-
GMP receptors or inactivation of c-di-GMP specific phosphodiesterases have to be considered.
DGC inhibition using A-site inhibitors represents an alternative, so far not investigated approach.
Therefore, we decided to examine the substrate-binding site of DgcA, a single GGDEF domain
model DGC with A and I-site from Caulobacter crescentus, and to define crucial residues (so called
chemophores) required for substrate binding affinity as well as enzymatic catalysis. Previous
diguanylate cyclase activity assays revealed that DgcA is specific for the substrate GTP and has
very low affinities for ATP, UTP, CTP or the guanosine mono- and diphosphates (M. Christen,
unpublished data), indicating that the base and the triphosphate moiety are crucial for ligand
binding.
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Figure 11: Analogs of substrate and reaction intermediates and their inhibition activity on DgcA.
A) Overview of the substrate modifications used to examine the substrate specificity of DgcA. B) Structure of the linear
dinucleotide pGpG, the enzymatic product of c-di-GMP specific phosphodiesterases. C-D) Structures of reaction
intermediate analogs. F) PEI-cellulose thin layer chromatogram of the reaction products obtained after incorporation of
DgcA with a mixture of GTP and different substrate analogs as substrate.
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Table 1: Diguanylate cyclase inhibition constants of different guanosine nucleotide derivatives
Inhibitor Ki
a in μM ?Ki a Kib in μM ?Ki b Intermediate c
dGTP 231.2 ±28.2 19 ±12 pppGp(dG)
ppCH2pG 30 ±16 2.5 ± 5.6 ppCH2pGpG
GTP?S Sa 108 ±11 3.7 ± 4.1 pppS?(S)GpG
GTP?S Ra 41.6 ± 23 19 ±1.4 pppS?(R)GpG
pGpG 124 ±12.5 123 ±12.7 no intermediate
pppGpp 52.9 ± 3.5 40 ± 2.7 no intermediate
Br-GTP 28.0 ± 3.3 28.2 ± 3.5 no intermediate
Mant-GTP 20.6 ± 2.5 20.6 ± 2.2 no intermediate
di-bu-cGMP - - - - no intermediate
a: Inhibition constant with respect to GTP consumption
b: Inhibition constant with respect to c-di-GMP production
c: observed intermediate of the diguanylate cyclase reaction
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A total of seven substrate analogs (Br-GTP, Mant-GTP, GTP?S, ?-?CH2GTP, dGTP, pppGpp,
Figure 11A) have been used to characterize chemophores required for ligand binding and
substrate conversion. In addition analogs of the reaction intermediate pppGpG were produced
(pGpG, Figure 11A A and B) enzymatically in a DGC-PDE tandem reaction and were purified as
TEAC salt by PEI and RP18-HPLC (M. Christen, unpublished) and tested with respect to their
inhibition potential.
All GTP derivatives were tested with respect to their ability to interfere with the DGC reaction. The
assay was performed in the presence of 100 μM inhibitor, 0.5 μM DgcA and 25 μM 33P labeled
GTP. Reaction samples were taken at regular time intervals and reactions were stopped by adding
equal volumes of 0.5 M EDTA. The nucleotide composition was analyzed by PEI cellulose thin
layer chromatography. After exposure on a phosphoimager screen and scanning, the intensity of
the nucleotide species was quantified with the software ImageJ1.3. GTP consumption,
intermediate formation and c-di-GMP production was compared for each individual inhibitor (Figure
11). The respective Ki was determined with the software ProFit 4.6 by calculating the initial velocity
V0 of each reaction and determine the relative decrease in GTP consumption and c-di-GMP
formation, respectively. For a more detailed description see Materials and Methods in (47).
The measured inhibitors could be divided in two classes: compounds that form a reaction
intermediate with GTP and compounds that don?t accumulate an intermediate inhibitor (Table 1A).
GTP?S, ?-?CH2GTP and dGTP were enzymatically condensed with a substrate GTP and formed
non reactive linear heteromeric dinucleotide intermediates (Figure 11C-F). Adding these
compounds to the reaction resulted in inhibition constants between 2.5 and 19μM for c-di-GMP
production (Table 1). Due to the fact that the heterodimeric intermediate analogs were synthesized
in situ from the corresponding non hydrolysable GTP derivatives, the Ki values only represent a
tendency of the DGC inhibition. To determine the exact inhibition constant the formed
heterodimeric intermediates have to be purified by HPLC and have to be added to a DGC assay as
such. Additional experiments in the presence of increasing substrate concentration have to be
done to distinguish, whether the inhibition is competitive or uncompetitive.
Mant-GTP, Br-GTP, pppGpp and pGpG did not form an intermediate with a substrate GTP and
blocked the GTP consumption with Ki values of 20 to 124 μM. Based on these results we suggest a
different inhibition strategies for Mant-GTP, Br-GTP, pppGpp and pGpG: these GTP analogs
occupy the A-site of the diguanylate cyclase, block the binding of GTP and in this way inhibit c-di-
GMP formation with inhibition constants from 20.6μM to 123μM.
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3.5.4 The enzymatic synthesis of c-di-GMP
Introduction
Ross et al reported the first chemical synthesis of the second messenger c-di-GMP and its
derivatives. In their study, a serie of 13 analogs of c-di-GMP was synthesized, employing a
modified hydroxybenzotriazol phosphotriester approach (4, 48, 70). Hayakawa and coworkers (71)
published a synthesis, which includes two strategies different from those reported by Ross et al
(48). They use the phosphoramidit method for the preparation of a linear guanylyl(3'-->5')guanylic
acid intermediate and allyl protection for guanine bases and internucleotide linkages. Although
these distinctive strategies resulted in a 51 % yield of c-di-GMP, the chemical synthesis of the
second messenger is, due to the complex synthesis of the two required building blocks, of no
significant commercial value. Moreover, biochemically useful modifications like the generation of
33P and 32P radiolabeled c-di-GMP, or 13C and 15N labeled c-di-GMP for NMR studies are not easily
accessible by a conventional chemical synthesis. For these applications, the enzymatic production
of c-di-GMP using an appropriate diguanylate cyclase and GTP as the reaction substrate
represents a convincing strategy. However, allosteric product inhibition of diguanylate cylcases
(47) and the fact, that only the activated dimeric DGC performs the cyclisation reaction, have to be
considered.
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Results and Discussion
Figure 12 Optimization of the reaction conditions for various DGCs
A) Comparison of the temperature dependence of the diguanylate cyclase reaction of PleDwt (10 μM) and PleD* (1 μM).
Substrate concentration was 0.5 mM and the reaction time 1h. B) Dimerisation constant of PleD*. The Substrate
concentration was 0.5 mM GTP, the reaction time 1h and the reaction temperature 30°C. C, D) Effect of 50 μM of various
M2+ metals on the diguanylate cyclase activity in absence of 20 mM Mg2+ (C) and in presence of 20 mM Mg2+ (D).
Reaction time was 1h, 30°C, protein concentration 5 μM PleD*.
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Optimization of the diguanylate cyclase reaction. The second messenger c-di-GMP is formed
by the condensation of two GTP molecules (4, 24, 72) upon the action of the dimeric diguanylate
cyclase enzymes. A starting point for the optimization of the enzymatic synthesis was given by the
diguanylate cyclase reaction condition reported by Ross et al. (48). His tag fusions of the C.
crescentus diguanylate cyclases PleD and the constitutive active allele PleD* were used to
determine the optimal reaction conditions (24, 25, 47).
Figure 13 Effect of c-di-GMP binding on the enzymatic DGC activity
E) c-di-GMP product inhibition of DgcA. Initial velocities of the wild type diguanylate cyclase DgcA (blue graph) and the
non-feedback inhibited I-site mutant DgcA0244 (red graph) in presence of increasing concentrations of c-di-GMP. F) Km
for GTP of PleD*in absence of c-di-GMP (blue line) and increasing Km for GTP upon addition of 10 μM c-di-GMP (red
graph). Kinetics were measured at 30°C in presence of 5 μM PleD*. Initial velocities were measured for the non-inhibited
reaction in nmol c-di-GMP / (mg protein * min) and for the inhibited reaction, due to the lower activity, in μM c-di-GMP /
μM Protein*h. G) comparison of the reaction yield of various diguanylate cyclases mutants. Reaction time was 1h, 30°C,
protein concentration 5 μM PleD*. H) Overview of reaction yield and c-di-GMP production per mg protein.
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In a first approach, the constitutive active allele PleD* has been investigated in order to optimize
the reaction conditions for semi-preparative synthesis of c-di-GMP. The temperature dependence
of the PleD DGC reaction revealed an optimal enzymatic turnover for both wild type and PleD* at
47 °C (Figure 12A). However, at this temperature, the half live of the enzymatic activity dramatically
decreases to 10 min for PleDwt and 24 min for PleD* compared to 36 min for PleDwt and 140 min
for PleD* at 37°C. For reasons of protein stability, a reaction temperature of 30 °C is
recommended. In addition, the experimentally determined dimerization constant of 1.34 μM for
PleD*, demands for a minimal enzyme concentration of 1-2 μM (Figure 12B). The diguanylate
cyclase reaction requires Mg2+ or Mn2+ as cofactor and is inhibited by Ca2+ and Zn2+, the addition of
50 μM Ni2+ seems to stimulate the DGC activity, presumably upon dimerisation of the C-terminal
His-tag fusions (Figure 12C,D).
PleD, like other diguanylate cyclases, is subjected to allosteric product inhibition with an
experimental Ki of 1 μM (47) (Figure 12E). Allosteric product inhibition is the reason, why
enzymatic c-di-GMP synthesis using PleD*, does not exceed a maximal yield of more than 20%.
The observed product inhibition operates mainly by increasing the Km for GTP (from 8.3 μM in
absence of c-di-GMP to 465 μM in presence of 10 μM c-di-GMP), (Figure 12F). To overcome this
product inhibition, a genetic screen has been performed with the constitutive active diguanylate
cyclase DgcA from C. crescentus (CC3285), a single GGDEF domain protein with no obvious
signal input domain (47).
Out of this screen, a set of mutants have been isolated, which had lost product inhibition: Dgc0207
and Dgc0646 in which the RESD I-site motive 5 AA upstream of the highly conserved GGDEF
active site motive is replaced by GMGG and GRDC, respectively, exhibited massive increased
DGC activity: 1 μM Dgr0207 synthesize in 1 h at 30°C in presence of 1 mM GTP 480 μM c-di-GMP
with an overall yield of 96%. Per mg purified Dgr0207, 14.5 mg second messenger can be
synthesized compared to 0.7 mg for PleD* (Table G). In the following part a detailed description of
the enzymatic production of c-di-GMP by Dgc0207 is given:
Synthesis and Purification of [33P]c-di-GMP. [33P] labeled c-di-GMP was produced enzymatically
using ??labeled [33P] GTP (3000 Ci/mmol Amersham Bioscience) and purified hexahistidine-
tagged Dgc0207 a non feedback inhibited, constitutive active form of the DgrA diguanylate cyclase
(25). To a mixture of 87.5 μl reaction buffer (250 mM NaCl, 25 mM Tris-HCl, pH 8.0, 10 mM MgCl2,
5 mM ?-mercaptoethanol and 1 μM Dgc0207-H6), 12.5 μl ??labeled [33P] GTP (125 μCi, 41.66
pmol, 3000 Ci/mmol) were added. After 5 min at 30°C, the reaction was stopped by adding an
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equal volume of 0.5 M EDTA, pH 8.0. The protein was precipitated by heating for 5 min at 95°C
followed by centrifugation for 2 min at 10,000xg. The supernatant was loaded on a batch RP-18
column, salt was removed by washing 5 times with 200 μl 25 mM TEAC buffer
(triethylenammonium carbonat) pH 7.0 containing 1% (vol/vol) MeOH. c-di-GMP was eluted with
two times 200 μl TEAC containing 5% (vol/vol) MeOH. The buffer was subsequently removed in
the speed-vac and the purity of the compound was tested by separation on PEI-cellulose plates
(1:1.5 vol/vol saturated NH4SO4 and 1.5 M KH2PO4, pH 3.6).
Synthesis and Purification of 13C,15N labeled c-di-GMP for NMR studies. 13C,15N labeled c-di-
GMP was produced enzymatically using 13C,15N labeled GTP (>98% 13C,15N, >95% GTP, Division
of spectra Gases, Columbia, USA) and purified hexahistidine-tagged Dgc0207 a non feedback
inhibited, constitutive active form of the diguanylate cyclase DgrA (47).To a mixture of 2 ml reaction
buffer (100 mM triethylammonium carbonate pH 7.0, 20 mM MgCl2, and 1 mM
13C,15N labeled
GTP). Dgr0207 was added to a final concentration of 1 mM. After 1 h at 30°C, the enzymatic
reaction was stopped and protein was precipitated by heating for 5 min at 95°C followed by
centrifugation for 2 min at 10,000xg. The supernatant was filtered through a 0.45 μM pore size
syringe filter (Milipore) and lyophilized. The resulting powder was resuspended in 1 ml H2O
containing 6 mM formic acid, loaded on a VP 250/10 NUCLEOSIL 4000-7 PEI column (Macherey-
Nagel) and separated with the following methode: Buffer A; 6 mM KH2PO4 pH 3.6, Buffer B; 1 M
Na2SO4, 0.5M KH2PO4 pH 5.5, program; wavelength 254 nm, flow 1 ml/min, 0 min 0% B, 2.5 min
17% B, 3.5 min 33% B, 13 min 100 % B, 31 min 0% B, 50 min 0% B end method. The time of
migration for the solvent was 16 min and c-di-GMP was eluted after 24.7 min. Fraction 24-26 were
collected and loaded on a 250/10 NUCLEOSIL 100-7 C18 column (Macherey-Nagel). Buffer A; 250
mM triethylammonium carbonate pH7.0, Buffer B; MeOH, program; wavelength 254 nm, flow 1
ml/min, 0 min 0% B, 2.5 min 1% B, 5 min 5% B, 10 min 30 % B, 20 min 0% B, 40 min 0% B end
method. Fractions containing the c-di-GMP TEAC salt were collected and the triethylammonium
carbonat buffer was removed by lyophilizing over night. The remaining white powder was collected,
resolved in H20 and c-di-GMP concentration was determined by measuring UV absorbance at 254
nm.
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Figure 14 Synthesis of MANT c-di-GMP
left panel fluorescence emission spectra of MANT-c-cdi-GMP, right panel ESI-MS spectra of MANT-c-di-GMP
Synthesis of mono-2?-MANT c-di-GMP - a florescent c-di-GMP derivative. In a PCR tube, 2.18
mg of enzymatically synthesized c-di-GMP-TEAC salt solved in 100 μl H20 (2.34 nmol 1 eq.) were
added to 4.5 mg MANT anhydride (3.51 nmol, 15 eq.). The pH was adjusted to 9.6 by adding 15 μl
1M NaOH and the reaction was performed at 38°C for 4h in a PCR heating block. The reaction
product was separated on a 12/3 NUCLEOSIL 100-7 C18 RP18 column; flow 0.3 ml/min,
wavelengths 254 and 350 nm, 250 mM triethylammonium carbonate, 7.5 % MeOH 0-30 min,
followed by a linear gradient to 100% MeOH within 20 min, tR c-di-GMP = 10 min, tR MANT-c-di-
GMP = 14 min tR MANT-anhydride = 19 min. TLC analysis on RP18 TLC plates; Solvent 20%
MeOH, 250 mM TEAC in H2O pH 7.0, Rf MANT c-di-GMP 0.15 blue fluorescent compound. MS
analysis M/Z 821.9 H+ adduct of MANT-c-di-GMP, 859.8 Na+ adduct and 898 K+ adduct.
Fluorescence spectrum; absorption at 260, 280 and 350 nm Emission (350nm) at 444.5 nm.
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3.5.5 Analysis of in vivo c-di-GMP levels
Introduction
It has been suggested that pole development in C. crescentus is regulated by a novel bacterial
signal transduction mechanism, which relies on the controlled synthesis and breakdown of the
second messenger cyclic di-guanosine monophosphate (c-di-GMP)(23, 25). These and other
studies have proposed that c-di-GMP is a general modulator of the transition from a motile, single
cell state to a sessile, multi cellular form of growth, which is often associated with biofilm formation
and persistence in pathogenic bacteria. Whereas biochemical in vitro studies with purified DGCs
and PDEs are suitable for investigating catalytic, structural and regulatory aspects of the synthesis
and degradation of c-di-GMP, an appropriate in vivo assay for investigate intracellular c-di-GMP
levels was still missing.
Such an in vivo assay would allow to correlate altered levels of the second messenger c-di-GMP
with a particular observed phenotype, such as congo red straining, motility, attachment or biofilm
formation and allows to exclude that changes in other nucleotide pools, e.g. a decrease in GTP
concentration or an increased of the pGpG level, are responsible for these cellular effects. In
addition, investigating c-di-GMP pools in different bacterial species, different phenotypes, under
various growth conditions, during the cell cycle or biofilm formation, or in mutants lacking specific
DGC and PDEs enzymes will become accessible with an in vivo assay.
Nucleotide extraction and analysis. In order to address these questions, the intracellular
concentrations of nucleotides, including c-di-GMP level, were assayed by high-performance liquid
chromatography on a polyethylenimine column after extraction with 0.5 M formic acid. To normalize
the amounts of nucleotides found in different cultures, the amounts were expressed relative to the
dry cell weight measured at the time of harvesting, i.e., picomoles per milligram (dry weight) of
cells. The following procedure was applied to cell cultures of C. crescentus, E. coli, P. aeruginosa,
Salmonella Thyphimurium, Yesinia enterocolitica, Streptomyces coelicolor, and Synechocystis
PCC6803. The HPLC method is based on nucleotide separation on a PEI column, using a linear
gradient of high-ionic-strength buffer (0.5 M KH2PO4 plus 0.5 M Na2SO4). In order to enhance the
signal of the second messenger c-di-GMP and to increase the separation between ADP (tR 7.21
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min) and c-di-GMP (tR 7.82 min), the UV detector wavelength was changed from 254 nm to 280
nm.
Procedure. 2.0 ml of C. crescentus cell cultures (OD600 0.4) were harvested by centrifugation for
30 s at 16?000 rpm and the supernatant was discarded. The cell pellet was dissolved in 200 μl 0.5
M formic acid and nucleotides were extracted for 10 min at 4°C. Insoluble cellular components
were then pelleted and the supernatant was directly analyzed by chromatography. Nucleotides
were extracted and separated according to (73) on a 125/4 Nucleosil 4000-1 PEI column
(Macherey-Nagel) using a SMART-System (Pharmacia). The nucleotide peak corresponding to c-
di-GMP was verified by co-elution with chemically synthesized c-di-GMP standard and by
incubating the nucleotide extract for 20 min with the c-di-GMP specific phosphodiesterase PdeA
(CC3396) from C. crescentus (46) (data not shown).
M. Christen 2007 Mechanisms of c-di-GMP signaling Results
143
Figure 15 Intracellular c-di-GMP levels in C. crescentus.
A) HPLC chromatogramm of total cell nucleotide extraction in wild type and PleD* overexpression strain indicating a
massif burst of c-di-GMP but unaffected GTP and ATP pools. B) Fluctuation of the c-di-GMP level over C. crescentus
cellcycle as measured by nucleotide extraction of synchronized cells. The data concerning the relative attachment over
cell cycle was kindly provided by A. Levi.
M. Christen 2007 Mechanisms of c-di-GMP signaling Results
144
Results and discussion. The analysis of the nucleotide pool of different mutants in C. crescentus,
E. coli and S. Thyphimurium for the first time allowed to demonstrate that the observed phenotype
caused by overexpression of diguanylate cyclase enzymes correlates with a massif increased
intracellular level of the second messenger c-di-GMP and is not correlated to a change in other
nuceotides, such as a drop in GTP pool or accumulation of pGpG. Overexpression of the
constitutive active diguanylate cyclase PleD* in C. crescentus only affected, the level of c-di-GMP
but not the level of GTP (Figure 15A).
In C. crescentus, obligate asymmetric cell division at each replicative cycle generates two
genetically identical but morphologically different daughter cells, which undergo different
developmental programs: The progeny sessile stalked cell equipped with an adhesive stalk
initiates a new replication cycle immediately after cell division has completed whereas the motile,
polar flagellated swarmer cell undergoes an obligate, planctonic life phase, during which cell
division programs and DNA replication are inhibited (19, 20). In order to become replication
competent and progress cell cycle, the swarmer cell has to differentiate and undergoes subsequent
remodeling of its polar organelles, which involves ejection of the flagellum, retraction of the pili, and
generation of a stalk and adhesive holdfast at the pole previously occupied by the flagellum.
Precise timing of assembly and loss of polar organelles is critical for optimal surface colonization.
Both acquisition of flagellar motility in the predivisional cell and its replacement by an adhesive
holdfast later in development are dependent on the polar localized diguanylate cyclase PleD (21-
26). The in vivo measurement of the c-di-GMP level during the C. crescentus cell cycle revealed
that a peak of c-di-GMP correlates with PleD dependent pole morphogenesis (Figure 15B). These
findings link the second messenger c-di-GMP to the developmental process of the swarmer-to-
stalk cell transition and suggest a general role for the second messenger c-di-GMP in coordinating
developmental processes in bacteria.
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4 Discussion
The pioneering work of the late Moshe Benziman and his collaborators has not only identified
cyclic diguanosine monophosphate as a signaling molecule involved in bacterial metabolism but
has also led to the recognition of proteins containing GGDEF and EAL domains as being involved
in the synthesis and breakdown of c-di-GMP (reviewed in (74)). Building on this foundation, an
increasing number of genetic studies have in recent years highlighted a global role for c-di-GMP as
signaling molecule in bacteria. Most of these studies have reported mutant and/or overexpression
phenotypes of proteins containing GGDEF or EAL domains (16, 23, 30, 31, 75-83). The common
finding appearing from these studies is that changes associated with an increase of the cellular
concentration of c-di-GMP negatively modulate cell motility and induce biofilm formation, while
modifications that led to a presumable decrease of c-di-GMP in the cell had the opposite effect.
However, limited information was available on the downstream activities and possible targets of c-
di-GMP and on the specific biochemical properties of enzymes involved in c-di-GMP turnover. The
present study contributes to the emerging understanding of the c-di-GMP regulatory network in
bacteria and provides new insights on the specific biochemical and regulatory properties of
enzymes involved in synthesis and hydrolysis of c-di-GMP. Furthermore, by using biochemical,
genetic and molecular biological approaches, we identified novel components of the c-di-GMP
signaling circuitry, report the biochemical purification of c-di-GMP receptor proteins from C.
crescentus crude extract and describe their physiological role in c-di-GMP dependent repression of
cell motility.
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Figure 16 Components of the c-di-GMP signaling network
A) Homology model of the DgcA GGDEF domain according to 1W25.pdb harboring, in its dimerized state, diguanylate
cyclase activity. The substrate GTP is bound to the active site (A-site) located 5 AA upstream of the identified allosteric
product inhibition site (I-site) (47). B) Homology model of the EAL domain from PdeA (CC3396) harboring c-di-GMP
specific phosphodiesterase activity (46) (based on X-ray structure of the B. subtilis EAL protein YkuI 1bas.pdb) The EAL
domain exhibits an eight-stranded ? /? barrel (TIM barrel) fold. Highly conserved charged key residues required for the
Mg dependent hydrolysis of c-di-GMP are located in the center of the TIM barrel structure. C) Domain structure of the
isloated diguanylate receptor protein. The c-di-GMP binding site, which has been mapped by genetic, biochemical and
NMR studies, is located on the surface of a split-barrel. Colors indicate the Combined amide 1H and 15N shift differences
(??) upon addition of c-di-GMP to PA4608 from P. aeruginosa. D) Schematic of c-di-GMP signaling involving synthesis,
hydrolysis and effector mechanism of c-di-GMP. The GGDEF domain harboring the diguanylate cyclase activity (red), the
EAL domain responsible for degradation of the second messenger into the linear dinucleotide pGpG (blue) and the newly
identified diguanylate receptor DGR (green) are indicated. Dashed lines symbolize product inhibition of diguanylate
cyclases by c-di-GMP (47) and allosteric activation of c-di-GMP specific Phosphodiesterases by GTP (46).
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Feedback inhibition is a general control mechanism of diguanylate cyclases
The data presented here propose a general mechanism to regulate the activity of diguanylate
cyclases (DGCs), key enzymes of c-di-GMP based signal transduction in bacteria. High affinity
binding of c-di-GMP to a site distant from the catalytic pocket (I-site) efficiently blocks enzymatic
activity in a non-competitive manner with an apparent Ki of 1μM. Mutational analysis of multi- and
single-domain DGC proteins has provided convincing evidence for the role of several charged
amino acids in c-di-GMP binding and allosteric regulation. An in vivo selection experiment using a
random tetrapeptide library, and designed to re-engineer the I-site has led to the definition of a
highly conserved RXXD core motif of the c-di-GMP binding pocket. The RXXD motif forms a turn at
the end of a short five amino acid ?-sheet that directly connects the I-site with the conserved
catalytic A-site motif, GG[D/E]EF (Figure 16A). This raised the question how I-site ligand binding
modulates DGC enzyme activity. In the multidomain protein PleD, c-di-GMP bound to the I-site
physically connects the GGDEF domain with the REC1-REC2 dimerization stem. It was speculated
that product inhibition occurs by domain immobilization, which would prevent the encounter of the
two DGC substrate-binding sites (24). Several observations argue in favor of a more direct
communication between I- and A-sites. First, with a large variety of domains found to be
associated with GGDEF domains it seems unlikely that functional I-sites are generally formed by
the interface of a GGDEF with its neighboring domain (84). In agreement with this, residues of the
PleD REC2 domain are not required for c-di-GMP binding and feedback inhibition. Second, the
single domain DGC protein, DgcA, shows I-site dependent allosteric control with a Ki of 1μM. Third,
atomistic simulations of ligated and unligated PleD predicted a marked drop in flexibility of C?-
atoms both in the I- and A-site upon ligand binding. Simultaneous with motion quenching, ?2 and
its flanking I- and A-loops undergo a balance-like movement that repositions A-site residues in the
catalytic active site (Figure 16A). This is consistent with the idea that structural changes within the
GGDEF domain upon binding of c-di-GMP at the I-site lead to repositioning of active site residues
and possibly altered kinetic parameters. Thus, we propose that c-di-GMP binding and allosteric
control represents an intrinsic regulatory property of DGCs that contain an RXXD motif. Based on
the enzymatic mechanism of the diguanylate cyclase reaction, two alternative inhibition
mechanisms can be envisaged. In a first scenario, binding of c-di-GMP to the I-site would change
the orientation of R366 and would thereby disturb the guanine binding site, resulting in an
increased Km for GTP. In addition, inhibitor binding could rearrange the Mg2+ carboxyl complex
and thus destabilize the active state. Our observations with the diguanylate cyclases PleD suggest,
that the observed product inhibition operates mainly by increasing the Km for GTP (from 8.3 μM in
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absence of c-di-GMP to 465 μM in presence of 10 μM c-di-GMP), (Figure 12F). However this
observation does not exclude a decrease in vmax upon c-di-GMP binding.
In silico analysis of the GGDEF protein family indicates that product inhibition is a general
regulatory mechanism
DGC activity of GGDEF domain proteins seems to strictly depend on conserved GGDEF or
GGEEF motifs in the active site (25, 30, 72, 82, 85, 86). Consistent with this, about 90% of the
GGDEF and 62% of the GGDEF/EAL composite proteins show a conserved GG[D/E]EF A-site
motif. Of the GGDEF proteins with a highly conserved A-site motif, more than 60% have conserved
RXXD I-site residues and a conserved spacer length between I- and A-site, arguing that the three-
dimensional arrangement of catalytic and allosteric pocket is likely to be similar in all DGCs. From
a total of 19 GGDEF proteins, for which convincing evidence for a DGC activity exists, 14 have a
conserved I-site. Ryjenkov and coworkers reported severe toxicity problems when expressing
diguanylate cyclases lacking I-site residues in E. coli BL21 (72). This is consistent with the growth
defect observed upon expression of dgcA feedback inhibition mutants in E. coli BL21, and argues
that these proteins are not feedback controlled. The molecular basis of growth interference under
these conditions is unclear. It is possible that depletion of the GTP pool, or adverse effects of
unphysiologically high levels of c-di-GMP are responsible for this effect.
Regulatory significance of DGC feedback control
GGDEF domains are often associated with sensory domains in one- or two-component signaling
systems (32, 87). Thus it is reasonable to assume that in most cases DGC activity is controlled by
direct signal input through these domains. But why then would a substantial portion of these
enzymes also be subject to feedback inhibition? There are several possibilities, which among them
are not mutually exclusive. Given the anticipated regulatory complexity of the c-di-GMP signaling
network (32, 84) and the potentially dramatic changes in cellular physiology and behavior caused
by fluctuating levels of c-di-GMP, it is in the cell's best interest to rigorously control the production
of the second messenger. Product inhibition of DGCs allows the establishment of precise threshold
concentrations of the second messenger, or, in combination with counteracting PDEs, could
produce short spikes, or even generate oscillations of c-di-GMP. In addition, negative feedback
loops have been implicated in neutralizing noise and providing robustness in genetic networks by
limiting the range over which the concentrations of the network components fluctuate (88, 89).
Similarly, product inhibition of DGCs could contribute to the reduction of stochastic perturbations
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and increase the stability of the c-di-GMP circuitry by keeping c-di-GMP levels in defined
concentration windows. Alternatively, DGC autoregulation may influence the kinetics of c-di-GMP
signaling. Mathematical modeling and experimental evidence suggested that negative
autoregulation in combination with strong promoters substantially shortens the rise-time of
transcription responses (90-92). In analogy, a desired steady-state concentration of c-di-GMP can
in principle be achieved by two regulatory designs: A) a low-activity DGC with no product inhibition,
and B) a high-activity DGC with built-in negative autoregulation. In cases where circuits have been
optimized for fast up-kinetics, design B will be superior. It is plausible that DGCs with or without I-
site motifs can be divided into these two kinetically different classes.
The c-di-GMP specific Phosphodiesterase activity resides in the EAL domain
Recent biochemical and structural studies have proposed a catalytic and regulatory mechanism for
the synthesis of c-di-GMP by the GGDEF protein PleD (24, 25). Here we show that CC3396, a
GGDEF-EAL protein of C. crescentus harbors c-di-GMP-specific PDE activity but lacks DGC
activity. Analysis of the catalyic activities of the individual domains strongly suggested that the PDE
activity of CC3396 is confined to the C-terminal EAL domain, and does not dependent on the
physical presence of the N-terminal GGDEF domain. To our knowledge, this is the first report that
directly links an isolated EAL domain with the ability to catalyze the hydrolysis of c-di-GMP in vitro.
Our data further propose a regulatory role for the N-terminal GGDEF domain of CC3396. The in
vitro PDE activity of CC3396 is increased about 40-fold upon addition of GTP. Activation of the
PDE activity seems to occur via the reduction of the KM for c-di-GMP from above 100 μM in the
absence of GTP to 420 nM when GTP was present. Several lines of evidence suggest that GGDEF
mediates this allosteric control through an interaction with the associated EAL domain. i) While the
basal level PDE activity of full-length CC3396 and the isolated EAL domain are comparable, GTP
activation could only be detected if the GGDEF domain was present. ii) Compared to the bona fide
DGC PleD (25), the GGDEF domain of CC3396 has a slightly altered consensus sequence A-site
motif (GEDEF). Consistent with this, CC3396 does not seem to possess diguanylate cyclase
activity in vitro (the activity measured is about corresponds to. iii) GTP specifically binds to the
GGDEF but not to the associated catalytic EAL domain. iv) A defined mutation in the A-site motif of
the GGDEF domain (GQNEF) abolished allosteric activation and resulted in a constitutive activity
of the associated EAL domain. This last observation implies that the GGDEF domain of CC3396 is
a GGDEF-like domain, which is still able to bind GTP in the A-site cavity with a relatively high
affinity (KD 4 μM) but does not catalyze the formation of c-di-GMP. If so, an original GGDEF
domain might have been recruited as sensory domain for GTP through the loss of its catalytic
function and the evolution of a regulatory interaction with EAL. If such a regulatory role of a
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GGDEF domain has indeed evolved from an enzymatically active GGDEF domain, two scenarios
are possible. Either the GGDEF domain has lost DGC activity because key catalytic residues are
missing, or because, in the context of the GGDEF-EAL composite protein, it is no longer able to
form a dimeric structure required to condense two GTP molecules into c-di-GMP.
Thus, we propose that GGDEF domains, depending on their sequence conservation or on their
oligomeric status, can have two alternative biological activities and can play different roles in the
controlled formation and hydrolysis of c-di-GMP. It is conceivable that at least a subgroup of the
large family of bacterial GGDEF-EAL composite proteins represents PDEs with an associated
regulatory GGDEF domain that can act as GTP sensor. This hypothesis has recently been
confirmed by the c-di-GMP specific PDE FimX from P. aeruginosa, which is also activated by GTP
(66). At the same time GGDEF-EAL proteins may exist that combine both a GGDEF-born DGC and
an EAL-associated PDE activity. As a direct consequence of our findings, each GGDEF or EAL
domain will first have to be carefully analyzed biochemically before a catalytic or regulatory role
can be assigned.
Why would phosphodiesterase activity be coupled to the cellular concentration of GTP?
Römling and colleagues have reported that upon expression of the DGC protein AdrA in
Salmonella typhimurium the cellular GTP to c-di-GMP ratio reverses from about 100:1 to 1:10 (30).
Thus, it is possible that when c-di-GMP synthesis is fully induced, uncontrolled hydrolysis of c-di-
GMP to pGpG and GMP would deplete the cellular GTP pool. A massive reduction of the cellular
GTP concentration has been reported as a consequence of the increased production of the
?alarmone? pppGpp upon amino acid starvation in Bacillus subtilis (93). Similarly, the GTP
concentration decreases considerably upon nitrogen starvation in C. crescentus (94). It is possible
that in order to prevent drainage of the cellular GTP pool, specific PDEs are quickly turned off
when the GTP concentration drops under a threshold level. Considering that the KD for GTP of
CC3396 is about 4 μM, one would expect such a threshold GTP concentration to be in the low
micromolar range. Together with the observation that DGCs can be subject to tight allosteric
feedback inhibition by their own product, this could be interpreted as a simple means for flux-
controlled sensitivity, which would allow breaching the threshold for signal transduction by either
increased production or decreased degradation of the second messenger. Alternatively, the
prevailing GTP level of the cell itself could be used as a physiological signal to control the internal
concentration of c-di-GMP through the controlled activity of PDEs. A drastic drop of the GTP
concentration to the low micromolar range could lead to a rapid and substantial increase of the
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cellular c-di-GMP concentration through the inhibition of one or several key PDEs, which respond
to GTP in a similar manner as observed for CC3396. While such a regulatory role for GTP remains
speculative, cellular GTP pools are known to affect developmental transitions in bacteria. A
decrease in the cellular GTP concentration, but not of other purine or pyrimidine nucleotides,
correlates with the initiation of morphological differentiation during nutrient starvation of B. subtilis
and Streptomyces griseus (95-97). The signal responsible for the induction of sporulation is the
reduced GTP pool, rather than pppGpp, which is formed under the same starvation conditions (96).
The cellular GTP concentration is sensed by CodY, a transcriptional repressor of several
sporulation and motility genes, whose repression activity depends on binding of GTP with a KD in
the physiologically relevant millimolar range (98, 99). It remains to be shown if the GTP
concentration plays a similar regulatory role in cellular c-di-GMP signaling.
How are increased levels of c-di-GMP sensed and how is this information transmitted to the
flagellar motor?
The data presented here suggest that two members of a novel family of c-di-GMP binding proteins,
DgrA and DgrB, mediate motor control in response to fluctuating concentrations of the second
messenger. We show that DgrA, DgrB, and its homologs in S. typhimurium (YcgR) and P.
aeruginosa (PA4608) bind c-di-GMP specifically and with high affinity (KD in the nM range).
Mutants that lack DgrA, DgrB, or both were motile in the presence of a plasmid-encoded copy of
the soluble diguanylate cyclase DgcA. These mutants no longer respond to c-di-GMP, implying that
DgrA and DgrB are part of the c-di-GMP-dependent pathway that controls flagellar rotation. The
observation that single dgrA or dgrB deletion mutants partially restored motility, whereas motility
was fully restored in a dgrAdgrB double mutant, suggested that both proteins contribute to c-di-
GMP mediated motility control. Consistent with this, overexpression of both dgrA and dgrB
produced an exact phenocopy of the motility block caused by DgcA; components of the flagellum
are expressed and assembled normally, but the resulting structure is not functional. Together this
suggested that DgrA and DgrB are high affinity receptors for c-di-GMP that, in a ligand-bound form,
interfere with the flagellar motor either directly or indirectly.
How does DgrA interfere with the function of the flagellum?
Motor control by DgrA-like proteins is not unique to Caulobacter. E. coli H-NS mutants lack flagella
because the expression of the flagellar master control operon flhCD is reduced. Ectopic expression
of flhCD restores flagellation but leaves the motors partially paralyzed (100). Under these
conditions flagellar function can be restored either by a mutation in ycgR, coding for the E. coli
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DgrA homolog, or by providing multiple copies of yhjH, which encodes a presumable c-di-GMP
specific phosphodiesterase (100). Together with our data demonstrating that the Salmonella YcgR
protein specifically binds c-di-GMP, this suggests that flagellar motor function might be controlled
by c-di-GMP in C. crescentus and in enteric bacteria via similar mechanisms. But how would DgrA
or YcgR interfere with the function of the flagellum? Several observations suggested the FliL
protein as a candidate for such a function. FliL was the only flagellar protein that showed
significantly reduced levels in non-motile cells overexpressing dgrA. In C. crescentus the FliL
protein is not part of the flagellar structure but is required for flagellar rotation (101). Intriguingly, fliL
mutant strains exhibit an identical motility phenotype like cells that have high levels of c-di-GMP or
overexpress dgrA (101). Because the expression of fliM, the gene located immediately
downstream of fliL in the same operon (102), was not affected by DgrA, FliL changes must be the
result of altered translation or protein stability. An intergenic suppressor mutation that restored
motility under these conditions also re-established normal FliL concentrations, indicating that the
two phenotypes are linked. The simplest model that is in agreement with these results predicts that
DgrA, upon binding of c-di-GMP, represses FliL by a so far unknown mechanism and through this
blocks motor function. We are currently investigating how DgrA and its ligand c-di-GMP modulate
FliL levels. Recently, FliL was reported to be involved in surface sensing and virulence gene
expression in the urinary tract pathogen Proteus mirabilis (103). Thus, it is possible that FliL has a
more general role in controlling the switch between a planktonic and a surface-associated lifestyle.
Which key residues define the c-di-GMP binding pocket of the diguanylate receptor?
A bioinformatics study recently proposed that the PilZ domain is a specific c-di-GMP binding
module (104). Here we presented genetic, biochemical, and structural evidence that validate this
hypothesis. Based on our data we propose a model for ligand binding and activation of proteins
containing a PilZ domain. NMR studies with the DgrA homolog PA4608 showed that a dimer of c-
di-GMP binds to a well-defined binding site on the surface of the ?-barrel (Figure 16C). Large
chemical shift differences between free and ligand-bound PA4608, which indicate changes in the
local environment, were also observed in both termini of the protein, with the largest differences
observed for residues R30-R32, V142, and A144. These regions are structurally ill defined in the
absence of ligand (PDB 1YWU) and are probably flexible. The observed chemical shift differences
indicate that these regions come in direct contact with the ligand after complex formation. The N-
terminal part of PA4608 contains three consecutive Arg residues, which are conserved in most PilZ
domains (104). One of these highly conserved Arg residue, R35, could not be observed in the
NMR spectra of PA4608 but might well be of equal importance. Arg side chains are likely involved
in hydrogen bonds or in electrostatic or ? stacking interactions with c-di-GMP, as has been shown
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for the allosteric binding site of the PleD diguanylate cyclase (24, 47). Furthermore, it is
conceivable that the positively charged head groups of Arg are sufficient for transient binding to
phosphate groups of c-di-GMP and that their position on the flexible N-terminus increases the
ligand capture radius of the protein, as in the “fly-casting mechanism” proposed in (105).
Alternatively, the observed folding of previously flexible parts of the protein may be responsible for
communication of the c-di-GMP signal to downstream elements, either by forming new interaction
surfaces or, in proteins like YcgR, where other domains connect to the N-terminus of a PilZ
domain, by determining the relative position of neighboring domains. Similarly, the chemical shift
differences of the C-terminal part of PA4608 could be explained by a specific role in ligand binding.
However, the fact that residues V142 and A144, which showed the largest chemical shift
differences are not conserved, argues against this possibility. Several of the motile dgrA loss of
function suppressors that were isolated had frameshift mutations in the very C-terminus of DgrA,
suggesting that this part of the protein is critical for its in vivo function. One possibility is that the C-
terminus contributes to the specific readout mechanism of this protein family. Upon c-di-GMP
binding to the ?-barrel surface, the C-terminus could be untied to interact with downstream
components. In accordance with such a view, the very C-terminus of the P. aeruginosa PilZ protein
has recently been proposed to interact with the PilF protein required for type 4-pilus assembly
(106). To complement our picture of the c-di-GMP circuitry, future studies will have to focus on
interaction partners of DgrA and related PilZ domain proteins. It is intriguing that genetic and
biochemical studies of the C. crescentus DgrA protein and structural analysis of the PA4608 from
P. aeruginosa identified the same set of key amino acid residues involved in c-di-GMP binding.
This finding is a strong indication that these proteins bind c-di-GMP in a similarly way and argues
that they may share a common signaling mechanism. Based on these results we postulate that
most or all PilZ domain proteins function as c-di-GMP receptors.
Although the molecular components regulating the c-di-GMP signaling cascade have been
identified and general regulatory principles for the synthesis and degradation of the second
messenger have been defined, it is evident that there are more questions than answers regarding
the c-di-GMP signaling system in bacteria. However, since the molecular key players involved in c-
di-GMP signaling have now been characterized, the current emphasis for the next generation of
PhD students on the c-di-GMP signaling research field, lies on the investigation of further
downstream regulatory mechanisms, and processes controlled by c-di-GMP with the long-term
goal of approaching a detailed systems-level understanding of c-di-GMP signaling.
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5 Outlooks
Further effort has to focus on the investigation of downstream regulatory mechanisms, and
processes controlled by c-di-GMP with the long-term goal of approaching a detailed systems-level
understanding of c-di-GMP signaling. In particular the c-di-GMP dependent regulation of
developmental processes, virulence traits, exopolsaccharide synthesis and biofilm formation have
to be clarified. The presence of many orthologus GGDEF and EAL protein in one bacterial species
(C. crescentus 14, E.coli 37, P. aeruginosa 40, V. vulnificus 59) raises the question of their
interconnection and their spatial and temporal distribution within the bacterial cell. And subsequent,
what is the molecular mode of action and what are regulatory mechanisms controlling individuals
PDE and DGC activities inside the cell? What kind of external stimuli are activating the individual
DGC and PDE?s? What are the interaction partner of the diguanylate receptor proteins DgrA and
DgrB and upon which mechanism they mediate c-di-GMP dependent output functions? Are there,
beside the large family of diguanylate receptor proteins, additional, so far uncharacterized c-di-
GMP receptor proteins present? The application of the presented biochemical tools on model
organisms for c-di-GMP signaling, which are easily accessible to genetics, cell biology, and
systems approaches, may develop into powerful explanatory tools to facilitate a more complete
understanding of the molecular and cellular mechanisms of second-messenger control.
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Biochemical characterized GGDEF and EAL proteins from C. crescentus
Figure 17 Overview of the GGDEF and EAL proteins from Caulobacter crescentus.
DGC activity has been shown for PleD (25, 47), DgcA (47) and DgcB. PDE activity has been demonstrated for PdeA
(CC3396) (46) and PdeB (CC0091). No enzymatic activity has been detected for PdpA, TipF and CC3148. The Strain ID
for all overexpression strains can be found in the strain list on the following page.
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List of constructs
Strain Genotype Reference
BC425 S.typhimurium LT2 trp::T7RNAP Christen unpublished
BC428 E.coli S17-1/ pAS22::pdeA Christen et al 2005, JBC
BC430 E.coli S17-1/ pNPTS138::KOdgcA Christen et al 2006, JBC
BC431 E.coli S17-1/ pNPTS138::KOpdeA Christen et al 2005, JBC
BC432 E.coli S17-1/ pUJ142::dgcA Christen et al 2006, JBC
BC433 E.coli S17-1/ pAS22::dgcA Christen et al 2006, JBC
BC434 E.coli S17-1/ pUJ142::pdeA Christen et al 2006, JBC
BC478 S.typhimurium LT2 araBAD::dgcA Christen et al 2006, JBC
BC480 S.typhimurium LT2/ pET42b::dgcA5002-his6 Christen unpublished
BC482 S.typhimurium LT2 trp::T7RNAP/ pET42b::dgcA5002-his6 Christen unpublished
BC498 S.typhimurium LT2 araBAD::dgcA bcsA::Tn10Tc Christen unpublished
BC500 S.typhimurium LT2 araBAD::dgcA bcsA::Tn10Tc Christen unpublished
BC506 E.coli BL21(DE3)/ pET42b::ycgR Christen et al 2007, PNAS
BC512 E.coli BL21(DE3)/ pET42b::dgrAD38A Christen et al 2007, PNAS
BC514 E.coli BL21(DE3)/ pET42b::dgrARR11AA Christen et al 2007, PNAS
BC516 E.coli S17-1/ pBBR::dgrA-his6 Christen et al 2007, PNAS
BC517 E.coli S17-1/ pBBR::dgrB-his6 Christen et al 2007, PNAS
BC535 C.crescentus CB15ATCC/ pBBR::dgrA-his6 Christen et al 2007, PNAS
BC538 C.crescentus CB15ATCC/ pBBR::dgrB-his6 Christen et al 2007, PNAS
BC541 C.crescentus CB15ATCC/ pBBR Christen et al 2007, PNAS
BC546 E.coli S17-1/ pNPTS138::KOdgrA Christen et al 2007, PNAS
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Strain Genotype Reference
BC547 E.coli S17-1/ pNPTS138::KOdgrB Christen et al 2007, PNAS
BC548 E.coli DH10B/ pBBR::dgrA-his6 Christen et al 2007, PNAS
BC558 E.coli S17-1/ pBBR::dgrA-his6 Christen et al 2007, PNAS
BC559 E.coli S17-1/ pBBR::dgrB-his6 Christen et al 2007, PNAS
BC562 C.crescentus CB15ATCC ?dgrB Christen et al 2007, PNAS
BC568 C.crescentus CB15ATCC ?dgrA Christen et al 2007, PNAS
BC680 C.crescentus CB15ATCC ?dgrA ?dgrB Christen et al 2007, PNAS
BC695 S.typhimurium LT2 trp::T7RNAP/ pET42b Christen et al 2006, JBC
BC719 C.crescentus CB15ATCC/ pBBR::dgrAV74A-his6 Christen et al 2007, PNAS
BC777 C.crescentus CB15ATCC/ pUJ142 Christen et al 2007, PNAS
BC779 C.crescentus CB15ATCC/ pAS22::dgrA Christen et al 2007, PNAS
BC827 E.coli BL21(DE3)/ pET42b::dgrAW75A Christen et al 2007, PNAS
BC831 E.coli S17-1/ pBBR::dgrAW75A-his6 Christen et al 2007, PNAS
BC834 E.coli S17-1/ pBBR::dgrA-his6 Christen et al 2007, PNAS
BC862 E.coli S17-1/ pBBR::dgrARR11AA-his6 Christen et al 2007, PNAS
BC864 E.coli S17-1/ pBBR::dgrAD41A-his6 Christen et al 2007, PNAS
BC867 E.coli S17-1/ pBBR::dgrAW75A-his6 Christen et al 2007, PNAS
BC871 C.crescentus CB15ATCC/ pUJ142::dgcA Christen et al 2007, PNAS
BC877 C.crescentus CB15ATCC ?dgrA/ pUJ142::dgcA Christen et al 2007, PNAS
BC880 C.crescentus CB15ATCC ?dgrA/ pAS22::dgcA Christen et al 2007, PNAS
BC883 C.crescentus CB15ATCC ?dgrB/ pUJ142::dgcA Christen et al 2007, PNAS
BC886 C.crescentus CB15ATCC ?dgrB/ pAS22::dgcA Christen et al 2007, PNAS
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Strain Genotype Reference
BC889 C.crescentus CB15ATCC ?dgrA ?dgrB/ pUJ142::dgcA Christen et al 2007, PNAS
BC892 C.crescentus CB15ATCC ?dgrA ?dgrB/ pAS22::dgcA Christen et al 2007, PNAS
BC913 E.coli S17-1/ pBBR::dgrARR11AA-his6 Christen et al 2007, PNAS
BC915 C.crescentus CB15ATCC/ pBBR::dgrARR11AAV74A-his6 Christen et al 2007, PNAS
BC918 C.crescentus CB15ATCC/ pBBR::dgrAD38A-his6 Christen et al 2007, PNAS
BC921 C.crescentus CB15ATCC/ pBBR::dgrAW75A-his6 Christen et al 2007, PNAS
BC939 C.crescentus NA1000 ?recA/ pBBR::dgrA-his6 Christen et al 2007, PNAS
BC940 C.crescentus NA1000 ?recA/ pBBR::dgrA-his6 Christen et al 2007, PNAS
BC941 C.crescentus NA1000 ?recA/ pBBR::dgrA-his6 Christen et al 2007, PNAS
BC942 C.crescentus NA1000 ?recA/ pBBR::dgrA-his6 Christen et al 2007, PNAS
BC943 C.crescentus NA1000 ?recA/ pBBR::dgrA-his6 Christen et al 2007, PNAS
BC944 C.crescentus NA1000 ?recA/ pBBR::dgrA-his6 Christen et al 2007, PNAS
BC945 C.crescentus NA1000 ?recA/ pBBR::dgrA-his6 Christen et al 2007, PNAS
BC946 C.crescentus NA1000 ?recA/ pBBR::dgrA-his6 Christen et al 2007, PNAS
BC947 C.crescentus NA1000 ?recA/ pBBR::dgrA-his6 Christen et al 2007, PNAS
BC948 C.crescentus NA1000 ?recA/ pBBR::dgrA-his6 Christen et al 2007, PNAS
BC949 C.crescentus NA1000 ?recA/ pBBR::dgrA-his6 Christen et al 2007, PNAS
BC950 C.crescentus NA1000 ?recA/ pBBR::dgrA-his6 Christen et al 2007, PNAS
BC951 C.crescentus NA1000 ?recA/ pBBR::dgrA-his6 Christen et al 2007, PNAS
BC952 C.crescentus NA1000 ?recA/ pBBR::dgrA-his6 Christen et al 2007, PNAS
BC953 C.crescentus NA1000 ?recA/ pBBR::dgrA-his6 Christen et al 2007, PNAS
BC954 C.crescentus NA1000 ?recA/ pBBR::dgrA-his6 Christen et al 2007, PNAS
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Strain Genotype Reference
BC955 C.crescentus NA1000 ?recA/ pBBR::dgrA-his6 Christen et al 2007, PNAS
BC956 C.crescentus NA1000 ?recA/ pBBR::dgrA-his6 Christen et al 2007, PNAS
BC961 C.crescentus CB15ATCC/ pBBR::dgrAR11AA-his6 Christen et al 2007, PNAS
BC965 E.coli S17-1/ pMR10::CC2058-CC2069 Christen unpublished
BC966 E.coli S17-1/ pMR10::fliLM Christen unpublished
BC972 C.crescentus NA1000 ::Tn5Tc rpsAH323R/ pBBR::dgrA-his6 Christen et al 2007, PNAS
BC973 C.crescentus NA1000 ::Tn5Tc rpsAH323R/ pBBR::dgrA-his6 Christen et al 2007, PNAS
BC974 C.crescentus NA1000 ::Tn5Tc rpsAH323R/ pBBR::dgrA-his6 Christen et al 2007, PNAS
BC975 C.crescentus NA1000 ::Tn5Tc rpsAH323R/ pBBR::dgrA-his6 Christen et al 2007, PNAS
BC976 C.crescentus NA1000 ::Tn5Tc rpsAH323R/ pBBR::dgrA-his6 Christen et al 2007, PNAS
BC977 C.crescentus NA1000 ::Tn5Tc Christen et al 2007, PNAS
BC978 C.crescentus NA1000 ::Tn5Tc Christen et al 2007, PNAS
BC979 C.crescentus NA1000 ::Tn5Tc Christen et al 2007, PNAS
BC980 C.crescentus NA1000 ::Tn5Tc Christen et al 2007, PNAS
BC981 C.crescentus NA1000 ::Tn5Tc Christen et al 2007, PNAS
BC995 E.coli BL21(DE3)/ pET21c::dgcA Christen et al 2006, JBC
BC997 E.coli BL21(DE3)/ pET21c::pdeA Christen et al 2005, JBC
BC999 E.coli BL21(DE3)/ pET21c::dgcB Christen unpublished
BC1000 E.coli BL21(DE3)/ pET21c::pdpA Christen unpublished
BC1001 E.coli BL21(DE3)/ pET21c::CC3148 Christen unpublished
BC1002 E.coli BL21(DE3)/ pET15::pleD?1-290 Christen et al 2006, JBC
BC1003 E.coli BL21(DE3)/ pET21::pleD?1-290 Christen et al 2006, JBC
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Strain Genotype Reference
BC1004 E.coli BL21(DE3)/ pET21b Christen et al 2005, JBC
BC1005 E.coli BL21(DE3)/ pET21c Christen et al 2005, JBC
BC1007 E.coli BL21(DE3) Christen unpublished
BC1008 E.coli BL21(DE3)/ pET42b::pdeAE323Q Christen et al 2005, JBC
BC1009 E.coli BL21(DE3)/ pET21c::pdeAED213QN Christen et al 2005, JBC
BC1010 E.coli BL21(DE3)/ pET21c::pdeAthrb Christen et al 2005, JBC
BC1011 E.coli BL21(DE3)/ pET21c::pdeA?1-112 Christen et al 2005, JBC
BC1012 E.coli BL21(DE3)/ pET21c::pdeAhybrid Christen unpublished
BC1013 E.coli BL21(DE3)/ pET21c::dgrA Christen et al 2007, PNAS
BC1014 E.coli BL21(DE3)/ pET21c::dgrB Christen et al 2007, PNAS
BC1015 E.coli BL21(DE3)/ pET15::PA4608 Christen unpublished
BC1016 E.coli BL21(DE3)/ pET21::CC0095short Christen unpublished
BC1017 E.coli BL21(DE3)/ pET21c::flmAshort Christen unpublished
BC1018 E.coli BL21(DE3)/ pET21c::ppx Christen unpublished
BC1019 E.coli BL21(DE3)/ pET42b::cheYII Christen unpublished
BC1020 E.coli BL21(DE3)/ pET42b::flmA Christen unpublished
BC1021 E.coli BL21(DE3)/ pET42b::pdeB Christen unpublished
BC1022 E.coli BL21(DE3)/ pET42b::dgcA0207 Christen et al 2006, JBC
BC1023 E.coli BL21(DE3)/ pET42b::dgcA0230 Christen et al 2006, JBC
BC1024 E.coli BL21(DE3)/ pET42b::dgcA0244 Christen et al 2006, JBC
BC1025 E.coli BL21(DE3)/ pET42b::dgcA0306 Christen et al 2006, JBC
BC1026 E.coli BL21(DE3)/ pET42b::dgcA0347 Christen et al 2006, JBC
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Strain Genotype Reference
BC1027 E.coli BL21(DE3)/ pET42b::dgcA0427 Christen et al 2006, JBC
BC1028 E.coli BL21(DE3)/ pET42b::dgcA0613 Christen et al 2006, JBC
BC1029 E.coli BL21(DE3)/ pET42b::dgcA0617 Christen et al 2006, JBC
BC1030 E.coli BL21(DE3)/ pET42b::dgcA0642 Christen et al 2006, JBC
BC1031 E.coli BL21(DE3)/ pET42b::dgcA0646 Christen et al 2006, JBC
BC1032 E.coli BL21(DE3)/ pET42b::dgcA0913 Christen et al 2006, JBC
BC1033 E.coli BL21(DE3)/ pET42b::dgcA1007 Christen et al 2006, JBC
BC1034 E.coli BL21(DE3)/ pET42b::dgcA1040 Christen et al 2006, JBC
BC1035 E.coli BL21(DE3)/ pET42b::dgcA1229 Christen et al 2006, JBC
BC1036 E.coli BL21(DE3)/ pET42b::dgcA1230 Christen et al 2006, JBC
BC1037 E.coli BL21(DE3)/ pET42b::dgcA1231 Christen et al 2006, JBC
BC1038 E.coli BL21(DE3)/ pET42b::dgcA1300 Christen et al 2006, JBC
BC1039 E.coli BL21(DE3)/ pET42b::dgcA1301 Christen et al 2006, JBC
BC1040 E.coli BL21(DE3)/ pET42b::dgcA1307 Christen et al 2006, JBC
BC1041 E.coli BL21(DE3)/ pET42b::dgcA1311 Christen et al 2006, JBC
BC1043 E.coli BL21(DE3)/ pET42b::dgcA1406 Christen et al 2006, JBC
BC1044 E.coli BL21(DE3)/ pET42b::dgcA1524 Christen et al 2006, JBC
BC1045 E.coli BL21(DE3)/ pET42b::dgcA1529 Christen et al 2006, JBC
BC1046 E.coli BL21(DE3)/ pET42b::dgcA1724 Christen et al 2006, JBC
BC1047 E.coli BL21(DE3)/ pET42b::dgcA1733 Christen et al 2006, JBC
BC1048 E.coli BL21(DE3)/ pET42b::dgcA1840 Christen et al 2006, JBC
BC1049 E.coli BL21(DE3)/ pET42b::dgcA3011 Christen et al 2006, JBC
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Strain Genotype Reference
BC1050 E.coli BL21(DE3)/ pET42b::dgcA3016 Christen et al 2006, JBC
BC1051 E.coli BL21(DE3)/ pET42b::dgcA3018 Christen et al 2006, JBC
BC1052 E.coli BL21(DE3)/ pET42b::dgcA3123 Christen et al 2006, JBC
BC1053 E.coli BL21(DE3)/ pET42b::dgcA3200 Christen et al 2006, JBC
BC1054 E.coli BL21(DE3)/ pET42b::dgcA3203 Christen et al 2006, JBC
BC1055 E.coli BL21(DE3)/ pET42b::dgcA0751 Christen et al 2006, JBC
BC1056 E.coli BL21(DE3)/ pET42b::dgcA1250 Christen et al 2006, JBC
BC1057 E.coli BL21(DE3)/ pET42b::dgcA2006 Christen et al 2006, JBC
BC1058 E.coli BL21(DE3)/ pET42b::dgcAwt Christen et al 2006, JBC
BC1059 E.coli BL21(DE3)/ pET42b::dgcA?RESD Christen et al 2006, JBC
BC1060 E.coli S17-1/ pPHU281::fliLM Christen unpublished
BC1110 C.crescentus CB15ATCC dgrAW75A Christen et al 2007, PNAS
BC1113 C.crescentus CB15ATCC dgrAW75A/ pUJ142::dgcA Christen et al 2007, PNAS
BC1116 C.crescentus CB15ATCC dgrAW75A/ pAS22::dgcA Christen et al 2007, PNAS
UJ2505 C.cresentus NA1000 clpX::? xylX::pUJ175 xylR0012::Tn5 Christen unpublished
UJ2506 C.cresentus NA1000 clpX::? xylX::pUJ175 xylR0042::Tn5 Christen unpublished
UJ2507 C.cresentus NA1000 clpX::? xylX::pUJ175 xylR0046::Tn5 Christen unpublished
UJ2510 C.cresentus NA1000 clpX::? xylX::pUJ175 xylO0304 Christen unpublished
UJ2511 C.cresentus NA1000 clpX::? xylX::pUJ175 xylO0305 Christen unpublished
UJ2512 C.cresentus NA1000 clpX::? xylX::pUJ175 xylO0512 Christen unpublished
UJ2513 C.cresentus NA1000 clpX::? xylX::pUJ175 xylO0601 Christen unpublished
UJ2514 C.cresentus NA1000 clpX::? xylX::pUJ175 xylO0607 Christen unpublished
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Strain Genotype Reference
UJ2515 C.cresentus NA1000 clpX::? xylX::pUJ175 xylO0612 Christen unpublished
UJ3000 C.cresentus NA1000 / pCS225 Christen unpublished
UJ3002 C.cresentus NA1000 xylR0012::Tn5 / pCS225 Christen unpublished
UJ3003 C.cresentus NA1000 xylR0042::Tn5 / pCS225 Christen unpublished
UJ3004 C.cresentus NA1000 xylR0046::Tn5 / pCS225 Christen unpublished
M. Christen 2007 Mechanisms of c-di-GMP signaling Appendix
169
List of figures
Figure 1 Ubiquitous ribonucleotide second messengers..................................................................2
Figure 2 The cell cycle of Caulobacter crescentus and polar localization of PleD ............................5
Figure 3 Isolation of c-di-GMP binding proteins from C. crescentus.............................................118
Figure 4 Lineweaver-Burk plots of inhibited adenylosuccinate synthetase. ..................................120
Figure 5 UV cross linking of PurA with [33P]c-di-GMP in presence of GTP, IMP or AMP................121
Figure 6 The de novo AMP synthesis from IMP by PurA (EC 6.3.4.4) and PurB (EC 4.3.2.2)......122
Figure 7 Reaction mechanism of the adenylosuccinate sythetase PurA ......................................124
Figure 8: Comparison between adenylate cyclase and diguanylate cyclase ................................127
Figure 9: Model for the catalytic mechanism of c-di-GMP formation. ...........................................128
Figure 10: Crystal structure of the diguanylate cyclase PleD .......................................................130
Figure 11: Analogs of substrate and reaction intermediates and their inhibition activity on DgcA.131
Figure 12 Optimization of the reaction conditions for various DGCs ............................................136
Figure 13 Effect of c-di-GMP binding on the enzymatic DGC activity...........................................137
Figure 14 Synthesis of MANT c-di-GMP......................................................................................140
Figure 15 Intracellular c-di-GMP levels in C. crescentus..............................................................143
Figure 16 Identified components of the c-di-GMP signaling network............................................146
Figure 17 Overview of the GGDEF and EAL proteins from Caulobacter crescentus. ...................160
M. Christen 2007 Mechanisms of c-di-GMP signaling Appendix
170
Acknowledgments
I would like to thank the following people, without whom this thesis would never have been written:
My parents for introducing my brothers and me into the fascinating world of science and for their
support in founding the Elyssia-laboratories in 1994.
Yvonne for her helps and advises in scientific and non-scientific situations.
My brother Beat for his efforts in teaching genetics, his reliance during scientific collaborations and
for the wonderful three years in the same laboratory.
Marc Folcher for introducing me into the world of biochemistry and, his prospective scientific
project validation and supervision, and for the excellent teamwork we had.
Prof. Dr. Helma Wennemers for inspiration of combinatorial approaches, Prof. Dr. Tilman Schirmer
for scientific discussions, Prof. Dr. Markus Meuwly for introducing into the computational chemistry,
Dr. Paul Jenö for the wonderful MS-MS data and Prof. Dr. Wolf-D Woggon for his helpful
discussions and his support during the past 5 years,
Further, I would like to thank
Martin Allan, Sören Abel, Arnaud Basle, Carmen Chan, Wanda Dischert, Anna Dürig, Martha
Gerber, Fabienne Hamburger, Assaf Levi, Jacob Malone, Flora Mauch, Suzette Moes, Dietrich
Samoray, Salvo San Paolo and Franziska Schmid
M. Christen 2007 Mechanisms of c-di-GMP signaling Appendix
171
Curriculum vitae
Personal Information
Surname / First name CHRISTEN Matthias
Date and place of birth 20.03 1978, Basel, Switzerland
Adress Benkenstrasse 51, 4104 Oberwil
Telephone 061 / 401 07 11
E-mail matthias.christen@unibas.ch
Education
Nov. 2003 to Feb. 2007 PhD
Principal subjects Molecular Microbiology/ Signal Transduction
Departement of Microbiology, Biozentrum, University of Basel,
Klingelbergstr. 50/70, 4056 Basel, Switzerland
Supervisor Prof. Dr. Urs Jenal
Subject Mechanisms of c-di-GMP signaling
April 1998 – March 2003 Studies in Chemistry at University of Basel
02.04.2003 Diploma for Chemistry, mark 5.5
1994 – 1997 Certificate of Matura type C
Awards
März 1998 Basler Maturandenpreis der Novartis
März 2007 Swiss Society of Microbiology Encouragement Award 2007
Publications
[1] M. Christen=, B. Christen=, M. Allan, M. Folcher, S. Moes, P. Jenö, S. Grzesiek, U.
Jenal (2006): DgrA is a member of a new family of cyclic di-GMP receptors and controls
flagellar motor function in Caulobacter crescentus PNAS manuscript accepted October
25, 2006
[2] B. Christen=, M. Christen=, R. Paul, F. Schmid, M. Folcher, P. Jenö, M. Meuwly, U.
Jenal (2006): Allosteric Control of Cyclic di-GMP Signaling J Biol Chem. October 20,
2006; 281 (42):32015-24. Epub August 21. 2006
[3] M. Christen, B. Christen, M. Folcher, A. Schauerte, U. Jenal (2005): Identification and
Characterization of a c-di-GMP Specific Phosphodiesterase and its Allosteric Control by
GTP J. Biol. Chem. September 2, 2005; 280 (35):30829-37. Epub July 1, 2005
[4] J.G. Malone, R. Williams, M. Christen, U. Jenal, A.J. Spiers, and P.B. Rainey (2006):
The structure-function relationship of WspR; a Pseudomonas fluorescens response
M. Christen 2007 Mechanisms of c-di-GMP signaling Appendix
172
regulator with a GGDEF output domain Microbiology manuscript accepted November
25, 2006
[5]
Talks and Presentations on international Meetings and conferences
2006
[6] M. Christen=, B. Christen= (2006): Mechanisms of c-di-GMP Signaling Seminar at
Developmental Biology Department, Stanford University School of Medicine, May 26,
Stanford, CA USA
[7] M. Christen=, B. Christen=, M. Folcher, S. Möes, P. Jenö, U. Jenal (2006): Isolation and
Characterization of Diguanylate Receptor Proteins (DGRs) from Caulobacter
crescentus 106st General ASM Conference, May 21-25, 2006 - Orlando, FL USA
[8] M. Christen=, B. Christen=, M. Allan, M. Folcher, S. Moes, P. Jenö, S. Grzesiek, U.
Jenal (2006): The c-di-GMP receptor DgrA controls flagellar motor function in
Caulobacter crescentus Biozentrum Symposium, October 20, 2006 - Basel, Switzerland
[9] B. Christen=, M. Christen=, R. Paul, M. Folcher, U. Jenal (2006): An Allosteric Control
Mechanism Coordinates c-di-GMP Signaling 106st General ASM Conference, May 21-
25, 2006 - Orlando, FL USA
[10] M. Folcher, M. Christen, B. Christen, I. Wiederkehr, S. Moes, P. Jenö, U. Jenal (2006):
C-di-GMP regulate key enzyme in nucleotide biosynthesis pathway Biozentrum
Symposium, October 20, 2006 - Basel, Switzerland
[11] M. Allan, M. Christen, B. Christen, M. Folcher, S. Moes, P. Jenö, U. Jenal, S. Grzesiek
(2006): Structural characterization of a cyclic di-GMP receptor protein. Symposium core
program structural biology and biophysics, June 16, 2006 - Basel, Switzerland
[12] A. Dürig, M. Christen and U. Jenal (2006): A C-di-GMP Binding Protein Localizes to the
Cell Pole and Controls Cell Motility during C. crescentus Development106th General
ASM Conference, May 21-25, 2006 - Orlando, FL, USA
[13] A. Dürig, M. Christen, A. Schauerte and U. Jenal (2006):A C-di-GMP Binding Protein
Localizes to the Cell Pole and Controls Cell Motility during C. crescentus Development
SSM SGM annual Congress, March 7-8, 2006 -Lausanne, Switzerland
M. Christen 2007 Mechanisms of c-di-GMP signaling Appendix
173
2005
[14] M. Christen=, B. Christen=, M. Folcher, A. Schauerte, U. Jenal (2005): Identification and
Characterization of a c-di-GMP Specific Phosphodiesterase and its Allosteric Control by
GTP 2nd Caulobacter meeting, July 11 - 13, 2005 - Vancouver Canada
[15] M. Christen=, B. Christen=, R. Paul, T. Schirmer, P. Jenö, U. Jenal (2005): A Novel
Regulatory Mechanism Controls the Production of c-di-GMP by Diguanylate Cyclases
SSM SGM annual Congress, 31.3.-1.4, 2005 - Geneva, Switzerland
[16] M. Christen=, B. Christen=, U. Jenal (2005): The Make and Break of c-di-GMP
Biozentrum Symposium, October 21. 2005 - Basel, Switzerland
[17] M. Christen, B. Christen, M. Folcher, A. Schauerte, T. Schirmer, T. Augst, U. Jenal
(2005): Identification of a c-di-GMP specific Phosphodiesterase and its allosteric control
by GTP SWIMM Meeting, 15-17 March 2005 - ETH Zürich Switzerland
[18] B. Christen=, M. Christen=, M. Folcher, U. Jenal (2005): Biochemical and Genetic
Identification of a c-di-GMP Binding Motiv 2nd ASM Conference on Prokaryotic
Development, July 13 - 16, 2005 - Vancouver, Canada
[19] B. Christen, M. Christen, R. Paul, A. Schauerte, T. Schirmer, P. Jenö, U. Jenal (2005):
A Novel Regulatory Mechanism Controls the Production of c-di-GMP SWIMM Meeting,
15-17 March 2005 - ETH Zürich Switzerland
[20] A. Dürig, M. Christen, Alexandra Schauerte & Urs Jenal (2005):Cell Cycle dependent
Dynamic Localization of a Diguanylate Cyclase-like Protein in Caulobacter crescentus
Development Biozentrum Symposium, October 19, 2005 – Basel, Switzerland
[21] A. Dürig, M. Christen & U.Jenal (2006): Dynamic Localization of a GGDEF Domain
Protein involved in Caulobacter crescentus Development and Cell Cycle Control
Biozentrum Symposium, October 19, 2006 – Basel, Switzerland
[22] R. Paul, M. Christen, B. Christen, A. Schauerte, P. Jenö, U. Jenal (2005): The PleD
Diguanylate Cyclase is Activated Through Dimerization and is Subject to Tight Allosteric
Feedback Control 2nd ASM Conference on Prokaryotic Development, July 13 - 16, 2005
- Vancouver Canada
[23] A. Levi, D. Meyer, M. Christen & Urs Jenal (2005): Developmental Control of Microbial
Surface Colonization by the Timed Synthesis and Destruction of c-di-GMP Biozentrum
Symposium, October 19, 2005 - Basel, Switzerland
M. Christen 2007 Mechanisms of c-di-GMP signaling Appendix
174
2003-2004
[24] M. Christen, R. Paul. B. Christen, A. Schauerte, P. Jenö, U. Jenal (2004):
Characterization of the c-di-GMP binding site of the diguanylate cyclase (DGC) PleD
Biozentrum Symposium, October 14, 2004 - Basel Switzerland
[25] B. Christen, M. Christen, U. Jenal (2004): Interaction Map of two-Component Signal
Transduction Proteins in Caulobacter crescentus EuroConference on Inter- and
Intracellular Signalling and Global Regulation in Bacteria, May 8-13 , 2003 – Barcelona,
Spain
Teaching experience
Supervision of Masterthesis
M. Gerber (2006): Designing Diguanylate Cyclase Inhibitors. Masterthesis of M. Gerber
supervised by M & B. Christen, Laboratory of Prof. Dr. Urs Jenal, Oktober 2005-November
2006 - Biozentrum University of Basel
F. Mauch (2006): Genetic Identification of Diguanylate Receptor Proteins Regulating Biofilm
Formation in Salmonella enterica Serovar Typhimurium. Masterthesis of F.Mauch supervised
by B & M. Christen, Laboratory of Prof. Dr. Urs Jenal, Oktober 2005-Oktober 2006 -
Biozentrum University of Basel
Teaching assistantship
Microbiology block course 2004-2006 (2 weeks per year) - Teaching assistantship in practical
courses at the Biozentrum University of Basel
Practices and diploma thesis
Nov. 2002 – March 2003 Diploma thesis Prof. Dr. W.D. Woggon and Prof. Dr. Urs Jenal
Institut for organische Chemistry and Biozentrum der Universität
Basel
Title: Overexpression of TocA - A Tocopherol Cyase from
Anabaena sp.
March 2002 - May 2002 Praktica by Prof. Dr. Helma Wennemers, Institut für Organische
Chemie der Universität Basel
Topic: Peptide chemistry, Synthesis of oligopeptides using
combinatorial solid phase chemistry
Nov. 2001 – Feb. 2002 Praktica by Prof. Dr. Wolf D. Woggon, Institut für Organische
Chemie der Universität Basel
Topic: Synthesis of deazaflavine derivatives
